
<html lang="en"     class="pb-page"  data-request-id="c43e4a42-188c-4322-8ff2-04156e53eb02"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.0c01088;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="CDDO-imidazolide Targets Multiple Amino Acid Residues on the Nrf2 Adaptor, Keap1" /></meta><meta name="dc.Creator" content="Xiaoli  Meng" /></meta><meta name="dc.Creator" content="James C.  Waddington" /></meta><meta name="dc.Creator" content="Arun  Tailor" /></meta><meta name="dc.Creator" content="Adam  Lister" /></meta><meta name="dc.Creator" content="Jane  Hamlett" /></meta><meta name="dc.Creator" content="Neil  Berry" /></meta><meta name="dc.Creator" content="B. Kevin  Park" /></meta><meta name="dc.Creator" content="Michael B.  Sporn" /></meta><meta name="dc.Description" content="Synthetic triterpenoids including CDDO, its methyl ester (CDDO-Me, bardoxolone methyl), and its imidazolide (CDDO-Im) enhance Nrf2-mediated antioxidant and anti-inflammatory activity in many diseas..." /></meta><meta name="Description" content="Synthetic triterpenoids including CDDO, its methyl ester (CDDO-Me, bardoxolone methyl), and its imidazolide (CDDO-Im) enhance Nrf2-mediated antioxidant and anti-inflammatory activity in many diseas..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 31, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01088" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01088" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01088" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01088" /></link>
        
    
    

<title>CDDO-imidazolide Targets Multiple Amino Acid Residues on the Nrf2 Adaptor, Keap1 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01088" /></meta><meta property="og:title" content="CDDO-imidazolide Targets Multiple Amino Acid Residues on the Nrf2 Adaptor, Keap1" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0008.jpeg" /></meta><meta property="og:description" content="Synthetic triterpenoids including CDDO, its methyl ester (CDDO-Me, bardoxolone methyl), and its imidazolide (CDDO-Im) enhance Nrf2-mediated antioxidant and anti-inflammatory activity in many diseases by reacting with thiols on the adaptor protein, Keap1. Unlike monofunctional CDDO-Me, the bifunctional analog, CDDO-Im, has a second reactive site (imidazolide) and can covalently bind to amino acids other than cysteine on target proteins such as glutathione S-transferase pi (GSTP), serum albumin, or Keap1. Here we show for the first time that bifunctional CDDO-Im (in contrast to CDDO-Me), as low as 50 nM, can covalently transacylate arginine and serine residues in GSTP and cross-link them to adjacent cysteine residues. Moreover, we show that CDDO-Im binds covalently to Keap1 by forming permanent Michael adducts with eight different cysteines, and acyl adducts with lysine and several tyrosine residues. Modeling studies suggest that the Tyr 85 adduct stabilizes the Keap1-Cul3 complex, thereby enhancing the potency of CDDO-Im." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Synthetic triterpenoids including CDDO, its methyl ester (CDDO-Me, bardoxolone methyl), and its imidazolide (CDDO-Im) enhance Nrf2-mediated antioxidant and anti-inflammatory activity in many diseases by reacting with thiols on the adaptor protein, Keap1. Unlike monofunctional CDDO-Me, the bifunctional analog, CDDO-Im, has a second reactive site (imidazolide) and can covalently bind to amino acids other than cysteine on target proteins such as glutathione S-transferase pi (GSTP), serum albumin, or Keap1. Here we show for the first time that bifunctional CDDO-Im (in contrast to CDDO-Me), as low as 50 nM, can covalently transacylate arginine and serine residues in GSTP and cross-link them to adjacent cysteine residues. Moreover, we show that CDDO-Im binds covalently to Keap1 by forming permanent Michael adducts with eight different cysteines, and acyl adducts with lysine and several tyrosine residues. Modeling studies suggest that the Tyr 85 adduct stabilizes the Keap1-Cul3 complex, thereby enhancing the potency of CDDO-Im." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0008.jpeg" /></meta><meta name="twitter:title" content="CDDO-imidazolide Targets Multiple Amino Acid Residues on the Nrf2 Adaptor, Keap1" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01088"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01088">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01088&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01088&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01088&amp;href=/doi/10.1021/acs.jmedchem.0c01088" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 9965-9976</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00882" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01111" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">CDDO-imidazolide Targets Multiple Amino Acid Residues on the Nrf2 Adaptor, Keap1</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Xiaoli Meng</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaoli Meng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool L69 3GE, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Telephone: 0044 151 7948368. E-mail: <a href="/cdn-cgi/l/email-protection#d4acb8b9b1bab394b8bda2b1a6a4bbbbb8fab5b7faa1bf"><span class="__cf_email__" data-cfemail="384054555d565f7854514e5d4a4857575416595b164d53">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoli++Meng">Xiaoli Meng</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7774-2075" title="Orcid link">http://orcid.org/0000-0002-7774-2075</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">James C. Waddington</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James C. Waddington</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool L69 3GE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+C.++Waddington">James C. Waddington</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Arun Tailor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arun Tailor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool L69 3GE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arun++Tailor">Arun Tailor</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Adam Lister</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adam Lister</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool L69 3GE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Lister">Adam Lister</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jane Hamlett</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jane Hamlett</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool L69 3GE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jane++Hamlett">Jane Hamlett</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Neil Berry</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Neil Berry</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Liverpool, Liverpool L69 7ZD, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Neil++Berry">Neil Berry</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1928-0738" title="Orcid link">http://orcid.org/0000-0003-1928-0738</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">B. Kevin Park</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">B. Kevin Park</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool L69 3GE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=B.+Kevin++Park">B. Kevin Park</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Michael B. Sporn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael B. Sporn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular and Systems Biology, Dartmouth Medical School, Lebanon, New Hampshire 03756, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+B.++Sporn">Michael B. Sporn</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01088&amp;href=/doi/10.1021%2Facs.jmedchem.0c01088" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 9965â9976</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 31, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 June 2020</li><li><span class="item_label"><b>Published</b> online</span>31 July 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01088" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01088</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9965%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXiaoli%2BMeng%252C%2BJames%2BC.%2BWaddington%252C%2BArun%2BTailor%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D17%26contentID%3Dacs.jmedchem.0c01088%26title%3DCDDO-imidazolide%2BTargets%2BMultiple%2BAmino%2BAcid%2BResidues%2Bon%2Bthe%2BNrf2%2BAdaptor%252C%2BKeap1%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9976%26publicationDate%3DSeptember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01088"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">868</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01088" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;CDDO-imidazolide Targets Multiple Amino Acid Residues on the Nrf2 Adaptor, Keap1&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xiaoli&quot;,&quot;last_name&quot;:&quot;Meng&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;C. Waddington&quot;},{&quot;first_name&quot;:&quot;Arun&quot;,&quot;last_name&quot;:&quot;Tailor&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Lister&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;Hamlett&quot;},{&quot;first_name&quot;:&quot;Neil&quot;,&quot;last_name&quot;:&quot;Berry&quot;},{&quot;first_name&quot;:&quot;B.&quot;,&quot;last_name&quot;:&quot;Kevin Park&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;B. Sporn&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;9965-9976&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01088&quot;},&quot;abstract&quot;:&quot;Synthetic triterpenoids including CDDO, its methyl ester (CDDO-Me, bardoxolone methyl), and its imidazolide (CDDO-Im) enhance Nrf2-mediated antioxidant and anti-inflammatory activity in many diseases by reacting with thiols on the adaptor protein, Keap1. Unlike monofunctional CDDO-Me, the bifunctional analog, CDDO-Im, has a second reactive site (imidazolide) and can covalently bind to amino acids other than cysteine on target proteins such as glutathione S-transferase pi (GSTP), serum albumin, or Keap1. Here we show for the first time that bifunctional CDDO-Im (in contrast to CDDO-Me), as low as 50 nM, can covalently transacylate arginine and serine residues in GSTP and cross-link them to adjacent cysteine residues. Moreover, we show that CDDO-Im binds covalently to Keap1 by forming permanent Michael adducts with eight different cysteines, and acyl adducts with lysine and several tyrosine residues. Modeling studies suggest that the Tyr 85 adduct stabilizes the Keap1-Cul3 complex, thereby enhancing the potency&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01088&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01088" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01088&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01088" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01088&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01088" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01088&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01088&amp;href=/doi/10.1021/acs.jmedchem.0c01088" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01088" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01088" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01088%26sid%3Dliteratum%253Aachs%26pmid%3D32787104%26genre%3Darticle%26aulast%3DMeng%26date%3D2020%26atitle%3DCDDO-imidazolide%2BTargets%2BMultiple%2BAmino%2BAcid%2BResidues%2Bon%2Bthe%2BNrf2%2BAdaptor%252C%2BKeap1%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D17%26spage%3D9965%26epage%3D9976%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292161" title="Modification">Modification</a>,</li><li><a href="/action/doSearch?ConceptID=292547" title="Adducts">Adducts</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/17" title="Go to Volume 63, Issue 17"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/jmcmar.2020.63.issue-17/20200910/jmcmar.2020.63.issue-17.largecover.jpg" alt="Go to Volume 63, Issue 17"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Synthetic triterpenoids including CDDO, its methyl ester (CDDO-Me, bardoxolone methyl), and its imidazolide (CDDO-Im) enhance Nrf2-mediated antioxidant and anti-inflammatory activity in many diseases by reacting with thiols on the adaptor protein, Keap1. Unlike monofunctional CDDO-Me, the bifunctional analog, CDDO-Im, has a second reactive site (imidazolide) and can covalently bind to amino acids other than cysteine on target proteins such as glutathione S-transferase pi (GSTP), serum albumin, or Keap1. Here we show for the first time that bifunctional CDDO-Im (in contrast to CDDO-Me), as low as 50 nM, can covalently transacylate arginine and serine residues in GSTP and cross-link them to adjacent cysteine residues. Moreover, we show that CDDO-Im binds covalently to Keap1 by forming permanent Michael adducts with eight different cysteines, and acyl adducts with lysine and several tyrosine residues. Modeling studies suggest that the Tyr 85 adduct stabilizes the Keap1-Cul3 complex, thereby enhancing the potency of CDDO-Im.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthetic oleanane triterpenoids such as 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) derivatives are multifunctional electrophilic agents that have been used to prevent and treat many chronic diseases in both <i>in vitro</i> and <i>in vivo</i> models.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1â4)</a> The methyl ester derivative (CDDO-Me) has undergone clinical trials for the treatment of cancer, pulmonary disease, and chronic kidney disease.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The Î±,Î² unsaturated ketones in the A and C rings of CDDO derivatives are considered to be essential for their pharmacological action. It has been hypothesized that covalent binding to key cysteine residues on proteins through Michael addition disrupts proteinâprotein interaction, leading to a pharmacological response.<a onclick="showRef(event, 'ref1 ref2 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref6 ref7">(1,2,6,7)</a> Both CDDO-Me and CDDO-imidazolide (CDDO-Im) can form covalent adducts at C1 of the A ring with cysteine residues in proteins through reversible Michael addition thioalkylation (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref6 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref8">(6,8)</a> Many cellular signaling proteins such as IÎºB kinase (IKK), estrogen receptors (ER), insulin signaling proteins, and Janus kinase/signal transducers and activators of transcription (JAK/STAT) have been identified as targets for CDDO-Im in cell cultures.<a onclick="showRef(event, 'ref1 ref9'); return false;" href="javascript:void(0);" class="ref ref1 ref9">(1,9)</a></div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Potential Pathways for the Formation of TriterpenoidâProtein Adducts</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of triterpenoids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">One of the primary targets of triterpenoids is the Nrf2-Keap1 pathway, one of the most important cellular protective mechanisms against chemical/oxidative stresses.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Keap1, a cysteine-rich adaptor protein, contains an N-terminal Broad complex, Tram- track, and Bric-a-brac (BTB) domain, a central intervening region (IVR), and a Kelch domain close to the C-terminus (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). Keap1 interacts with Nrf2 through binding of its C-terminal Kelch domain to two distinct degron motifs (DLG and ETGE degron) present in the Neh2 domain of Nrf2 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B).<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> Under normal physiological conditions, Keap1 maintains low levels of Nrf2 by promoting its Cul3-Rbx1-mediated ubiquitination and subsequent proteasomal degradation. Under conditions of cellular stress, reactive species modify sensor cysteine residues within Keap1 and block the degradation of Nrf2, leading to cellular accumulation of Nrf2, which subsequently promotes cytoprotective genes (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). Several potential models have been proposed to explain how covalent modification of cysteine residues in Keap1 activates the Nrf2 pathway.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In the âhinge and latchâ model (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D), covalent modification of key cysteine residues such as Cys151, Cys273, and Cys288 in the BTB and IVR domains of Keap1 leads to conformational changes, thus disrupting the interaction between Nrf2 and Kelch.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Alternatively, in the Cul3-dissociation model (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>E), covalent modification of cysteine residues in the BTB domain decreases the binding of Cul3 to Keap1, leading to the loss of Nrf2 ubiquitination. In particular, modification of Cys151 that is in close proximity to the Cul3 binding interface is consistent with this Cul3-dissociation model.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Current models of Keap1-Nrf2 interaction.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14">(10â14)</a> (A) Domain structures of human Keap1 and important binding partners are shown. (B) Domain structures of human Nrf2. DLG and ETGE binding motif in Neh2 are highlighted. (C) Under basal conditions, Keap1 maintains low levels of Nrf2 by promoting its Cul3-Rbx1-mediated ubiquitination and subsequent proteasomal degradation. Under stressful conditions, covalent modification of key cysteine residues of Keap1 causes conformational changes. This can either disrupt the interaction between Nrf2 and Kelch (D) or decrease the binding of Cul3 to Keap1 (E), leading to nuclear accumulation of Nrf2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The triterpenoid CDDO-Im was designed to be a bifunctional drug, in contrast to the monofunctional molecule, CDDO-Me, in which only the A ring of oleanolic acid has been activated. Thus, the imidazolide moiety attached to carbonyl C-28 of CDDO-Im confers much greater potential for irreversible acylation of nucleophilic amino acid residues on proteins, compared to the less reactive methyl ester moiety of CDDO-Me (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Indeed, CDDO-Im has been found to have several biological activities not shared with CDDO-Me,<a onclick="showRef(event, 'ref1 ref15'); return false;" href="javascript:void(0);" class="ref ref1 ref15">(1,15)</a> and in some instances, though not all,<a onclick="showRef(event, 'ref6 ref16'); return false;" href="javascript:void(0);" class="ref ref6 ref16">(6,16)</a> CDDO-Im is significantly more potent than CDDO-Me. In almost every case examined, CDDO-Im is also much more potent than CDDO-free acid. The greater potency of CDDO-Im is particularly striking in the suppression of macrophage production of inducible nitric oxide synthase,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> which is an Nrf2-dependent gene.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> Thus, in primary macrophage cultures, CDDO-Im is more than 1000-fold more potent than CDDO-Me or CDDO-free acid in such assays.<a onclick="showRef(event, 'ref7 ref18'); return false;" href="javascript:void(0);" class="ref ref7 ref18">(7,18)</a> This greater activity of CDDO-Im is also seen in assays for the induction of another Nrf2-dependent gene, heme oxygenase (HO-1), in which the imidazolide is markedly more potent than the methyl ester or the free acid in enhancing both HO-1 gene and protein expression in several different cell types.<a onclick="showRef(event, 'ref15 ref19'); return false;" href="javascript:void(0);" class="ref ref15 ref19">(15,19)</a> Induction of HO-1 by CDDO-Im is almost completely abolished in Nrf2-knockout cells, compared to wild type.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Therefore, we hypothesized that additional molecular interactions between CDDO-Im and other amino acid residues in addition to cysteine could likely contribute to its potency and target selectivity. Thus, the aim of this study was to (1) investigate the binding of CDDO-Im to proteins using mass spectrometric methods and (2) explore its reactivity with Keap1 and its implication in the activation of Nrf2.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14441" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14441" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Characterization of CDDO-Im Modified-GSTP <i>in Vitro</i></h3><div class="NLM_p">To characterize the Michael adducts of CDDO-Im, human glutathione <i>S</i>-transferase pi (GSTP) was chosen as a model as it contains several reactive cysteine residues. His-GSTP captured on nickel beads was exposed to a range of concentrations of CDDO-Im (50 nM to 10 Î¼M). LCâMS/MS analysis of the tryptic digests of CDDO-Im treated GSTP revealed multiple types of adducts, including a simple Michael adduct formed by thioalkylation with cysteine, a cross-linked adduct, and an acylation adduct formed with arginine residues (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Michael addition of cysteine in GSTP to CDDO-Im followed by the hydrolysis of the imidazolide amide bond resulted in adducts with a mass addition of 491.3 amu. <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A shows a representative MS/MS spectrum for a doubly charged ion at <i>m</i>/<i>z</i> 785.986, corresponding to the tryptic peptide <sup>45</sup>ASCLYGQLPK<sup>54</sup> with an additional mass of 491.3 amu. The peptide sequence was confirmed by partial singly charged y and b series ions. The modification site was confirmed by the presence of b3* (<i>m</i>/<i>z</i> 753.57), b4* (<i>m</i>/<i>z</i> 866.64), and b8*(<i>m</i>/<i>z</i> 1328.02), all with adduction of 491.3 amu. The presence of a fragment ion of <i>m</i>/<i>z</i> 464.45 and 447.42 that was derived from CDDO carboxylic acid provided further evidence of the modification. This adduct was only detected on Cys47; no other sites were identified.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. LCâMS/MS analysis of CDDO-Im modified GSTP peptides identified <i>in vitro</i>. MS/MS spectra show (A) peptide <sup>45</sup>ASCLYGQLPK<sup>54</sup> was modified by CDDO carboxylate at Cys47 with a mass addition of 491.3 amu and (B) cross-linking adducts formed between Ser46 and Cys47 on peptide <sup>45</sup>ASCLYGQLPK<sup>54</sup> with a mass addition of 473.3 amu. Covalent binding to GSTP was concentration dependent as shown by individual sites (C) and total binding (D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. CDDO-Im Modified GSTP Peptides Detected <i>in Vitro</i><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">amino acid</th><th class="colsep0 rowsep0" align="center">peptide<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>m</i>/<i>z</i></th><th class="colsep0 rowsep0" align="center">Î<i>m</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">Cys14</td><td class="colsep0 rowsep0" align="left">GR*C*AALR</td><td class="colsep0 rowsep0" align="left">407.2529</td><td class="colsep0 rowsep0" align="left">473.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">Cys14</td><td class="colsep0 rowsep0" align="left">C*AALR</td><td class="colsep0 rowsep0" align="left">503.8094</td><td class="colsep0 rowsep0" align="left">473.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">Cys47</td><td class="colsep0 rowsep0" align="left">ASC*LYGQLPK</td><td class="colsep0 rowsep0" align="left">785.986</td><td class="colsep0 rowsep0" align="left">491.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">Cys47</td><td class="colsep0 rowsep0" align="left">AS*C*LYGQLPK</td><td class="colsep0 rowsep0" align="left">776.958</td><td class="colsep0 rowsep0" align="left">473.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">Cys101</td><td class="colsep0 rowsep0" align="left">DQQEAALVDMVNDGVEDLR*C*K</td><td class="colsep0 rowsep0" align="left">706.238</td><td class="colsep0 rowsep0" align="left">473.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">Arg186</td><td class="colsep0 rowsep0" align="left">LSAR*PK</td><td class="colsep0 rowsep0" align="left">572.9</td><td class="colsep0 rowsep0" align="left">473.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">CDDO-Im (50 nM to 10 Î¼M) was incubated with GSTP in phosphate buffer, pH 7.4, for 16 h.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">The modified amino acid is labeled with *.</p></div></div></div><div class="NLM_p">Cross-linked adducts are anticipated due to the presence of the bifunctional groups on CDDO-Im. An abundant doubly charged ion at <i>m</i>/<i>z</i> 776.989 was detected, corresponding to the tryptic peptide <sup>45</sup>ASCLYGQLPK<sup>54</sup> with an additional mass of 473.3 amu. The cross-linked adduct could be formed by reaction of CDDO-Im with Cys47 and the adjacent serine residue in the sequence <sup>45</sup>ASCLYGQLPK<sup>54</sup>. A typical MS/MS spectrum representing the tryptic peptide <sup>45</sup>ASCLYGQLPK<sup>54</sup> with a mass addition of 473.3 amu is shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B. The peptide sequence was confirmed by a series of y product ions, and the cross-linking was evidenced by the presence of b2* (<i>m</i>/<i>z</i> 632.56, Ser46) and y8* (<i>m</i>/<i>z</i> 1395.29, Cys47), both with a mass increment of 473.3 amu. The cross-linked adducts were also detected on multiple sites including Arg13-Cys14 and Arg100-Cys101 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Similar to the modifications observed with S46, a stable adduct derived from an arginine residue was also detected (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_001.pdf" class="ext-link">Figure S1</a>, Arg186, <sup>183</sup>LSARPK<sup>188</sup>) when a high concentration of CDDO-Im was used (500 Î¼M).</div><div class="NLM_p last">Covalent binding of CDDO-Im to GSTP was concentration-dependent (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C,D) with adducts being detectable at the lowest concentration of CDDO-Im (50 nM). CDDO-Me did not form adducts with GSTP except at very high concentrations (500 Î¼M). The cross-linked adducts appeared to be the major adducts formed between CDDO-Im and GSTP, probably due to the adduct stabilization through acylation at C28.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Characterization of HSA Modified by CDDO-Im <i>in Vitro</i></h3><div class="NLM_p">Human serum albumin (HSA) has long been known to exhibit great affinity for many ligands and act as an endogenous target and/or quencher for numerous electrophilic compounds such as penicillins, Î±,Î²-unsaturated aldehydes, and acyl glucuronides.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20â23)</a> Adducts could be formed in HSA with various nucleophilic amino acid residues including lysine, cysteine, and histidine. To probe the chemical basis of the putative Michael and acylation adducts of CDDO-Im with HSA, HSA was incubated with CDDO-Im at various concentrations and time points. LCâMS/MS analysis of the tryptic digests revealed 23 CDDO-Im modified peptides, including peptides containing lysine (<i>n</i> = 10), arginine (<i>n</i> = 2), serine (<i>n</i> = 7), or tyrosine (<i>n</i> = 5) residues after incubation at the highest concentration of CDDO-Im (1 mM) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_001.pdf" class="ext-link">Supporting Information Table S1</a>). At lower concentrations, CDDO-Im appeared to bind selectively to lysine and tyrosine residues and some adducts could be detected at concentrations as low as 10 nM (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. CDDO-Im Modified HSA Peptides Detected <i>in Vitro</i><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="4" align="center">CDDO-ImÂ concentrationÂ (Î¼M)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">amino acid</th><th class="colsep0 rowsep0" align="center">peptide<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>m</i>/<i>z</i></th><th class="colsep0 rowsep0" align="center">0.01</th><th class="colsep0 rowsep0" align="center">1</th><th class="colsep0 rowsep0" align="center">10</th><th class="colsep0 rowsep0" align="center">100</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">K137</td><td class="colsep0 rowsep0" align="left">K*YLYEIAR</td><td class="colsep0 rowsep0" align="left">764.94</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">Y138</td><td class="colsep0 rowsep0" align="left">KY*LYEIAR(Me)</td><td class="colsep0 rowsep0" align="left">771.9877</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">Y161</td><td class="colsep0 rowsep0" align="left">RY*K</td><td class="colsep0 rowsep0" align="left">470.3134</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">K162</td><td class="colsep0 rowsep0" align="left">YK*AAFTECCQAADK</td><td class="colsep0 rowsep0" align="left">1010.501</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">K199</td><td class="colsep0 rowsep0" align="left">LK*CASLQK</td><td class="colsep0 rowsep0" align="left">710.9803</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">K351</td><td class="colsep0 rowsep0" align="left">LAK*TYETTLEK</td><td class="colsep0 rowsep0" align="left">885.5318</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">Y353</td><td class="colsep0 rowsep0" align="left">TY*ETTLEK</td><td class="colsep0 rowsep0" align="left">729.3912</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">Y411</td><td class="colsep0 rowsep0" align="left">Y*TK</td><td class="colsep0 rowsep0" align="left">442.7766</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">K413</td><td class="colsep0 rowsep0" align="left">YTK*K</td><td class="colsep0 rowsep0" align="left">506.8359</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">K524</td><td class="colsep0 rowsep0" align="left">QIK*K</td><td class="colsep0 rowsep0" align="left">495.3375</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">K525</td><td class="colsep0 rowsep0" align="left">K*QTALVELVK</td><td class="colsep0 rowsep0" align="left">801.593</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">K541</td><td class="colsep0 rowsep0" align="left">ATK*EQLK</td><td class="colsep0 rowsep0" align="left">645.9232</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">--</td><td class="colsep0 rowsep0" align="left">â</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">CDDO-Im (10 nM to 100 Î¼M) was incubated with GSTP in phosphate buffer, pH 7.4, for 16 h.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">The modified amino acid is labeled with *.</p></div></div></div><div class="NLM_p">A typical MS/MS spectrum representing the tryptic peptide <sup>411</sup>YTK*K<sup>414</sup> with a mass addition of 473.3 amu is shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A. A missed cleavage at the proposed site of covalent binding and the presence of y2* (<i>m</i>/<i>z</i> 748.4) and y3* (<i>m</i>/<i>z</i> 849.69) ions provided firm evidence of acylation at Lys413. Similar to the modifications observed with lysine, stable adducts derived from tyrosine (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B) were also detected on multiple sites (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). A semiquantitative analysis of the modification at each site revealed a concentration- and time-dependent increase for each modified peptide (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. LCâMS/MS analysis of CDDO-Im modified HSA peptides identified <i>in vitro</i>. MS/MS spectra show (A) an acylation of Lys413 by CDDO-Im was detected on peptide <sup>411</sup>YTKK<sup>414</sup> from HSA and (B) similar adducts were also detected on Tyr411 (<sup>411</sup>YTK<sup>413</sup>). Covalent binding to HSA was time (5 Î¼M CDDO-Im) and concentration dependent (C, D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Characterization of CDDO-Im Modified Keap1 <i>in Vitro</i></h3><div class="NLM_p">LCâMS/MS analysis of the tryptic digests of CDDO-Im-treated recombinant Keap1 protein also revealed multiple types of stable adducts, including a Michael adduct formed with cysteine and acylation adducts formed with tyrosine and lysine (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). A representative MS/MS spectrum shows the peptide <sup>85</sup>YQDAPAAQFMAHK<sup>96</sup> modified by CDDO-Im at Tyr85 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). The presence of adducted a1 ion (<i>m</i>/<i>z</i> 609.37) provided firm evidence of acylation at Tyr85. Multiple cysteine residues in Keap1 including Cys13, Cys14, Cys38, Cys257, Cys288, Cys489, Cys513, and Cys613 were modified by CDDO-Im, all with a mass addition of 473.3 amu. The mass addition of 473.3 amu could correspond to either a thioester adduct or a Michael adduct followed by acylation of the N-terminal amino group of isolated peptides. The absolute structure of these adducts requires further investigation.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Covalent binding of CDDO-Im to Keap1 protein. (A) Representative MS/MS spectrum shows CDDO-Im forms an acylation adduct with Tyr85 in Keap1. (B) Covalent binding of CDDO-Im to Keap1 is concentration-dependent. (C) Relative quantification using normalized ion counts revealed that CDDO-Im (100 nM) selectively targets Tyr85 when incubated with Keap1. (D) Covalent docking of CDDO-Im with Tyr85 into BTB domain of Keap1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CXI">4CXI</a>) demonstrated that the ring system was positioned away from Cys151. (E) CDDO interacts with Met161 and Gly128 through hydrogen bonds that are denoted by dashed lines. Images are illustrated by PyMOL (The PyMOL Molecular Graphics System, version 1.3, SchrÃ¶dinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. CDDO-Im Modified Keap1 Peptides Detected <i>in Vitro</i><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">amino acid</th><th class="colsep0 rowsep0" align="center">peptide sequence<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>m</i>/<i>z</i></th><th class="colsep0 rowsep0" align="center">reported binding sites</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">Cys13</td><td class="colsep0 rowsep0" align="left">PSGAGAC*C(iodo)R</td><td class="colsep0 rowsep0" align="left">676.3366</td><td class="colsep0 rowsep0" align="left">Y</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">Cys14</td><td class="colsep0 rowsep0" align="left">PRPSGAGACC*R</td><td class="colsep0 rowsep0" align="left">541.9338</td><td class="colsep0 rowsep0" align="left">Y</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">PSGAGACC*R</td><td class="colsep0 rowsep0" align="left">685.8182</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">Cys38</td><td class="colsep0 rowsep0" align="left">ASTEC*K</td><td class="colsep0 rowsep0" align="left">556.1458</td><td class="colsep0 rowsep0" align="left">N</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">Tyr85</td><td class="colsep0 rowsep0" align="left">Y*QDAPAAQFMAHK</td><td class="colsep0 rowsep0" align="left">651.9981</td><td class="colsep0 rowsep0" align="left">N</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Y*QDAPAAQFM(O)AHK</td><td class="colsep0 rowsep0" align="left">656.3312</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">(iodo)Y*QDAPAAQFM(O)AHK</td><td class="colsep0 rowsep0" align="left">675.3446</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">Tyr208</td><td class="colsep0 rowsep0" align="left">EYIY*MHFGEVAK</td><td class="colsep0 rowsep0" align="left">654.0048</td><td class="colsep0 rowsep0" align="left">N</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">Cys257</td><td class="colsep0 rowsep0" align="left">YDC*EQR</td><td class="colsep0 rowsep0" align="left">643.801</td><td class="colsep0 rowsep0" align="left">Y</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">YDC*EQ(Me)R</td><td class="colsep0 rowsep0" align="left">650.8192</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">(Iodo)YDC*EQR</td><td class="colsep0 rowsep0" align="left">672.3263</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">Tyr263</td><td class="colsep0 rowsep0" align="left">FY*VQALLR</td><td class="colsep0 rowsep0" align="left">742.4025</td><td class="colsep0 rowsep0" align="left">N</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">Cys288</td><td class="colsep0 rowsep0" align="left">C*EILQSDSR</td><td class="colsep0 rowsep0" align="left">762.4541</td><td class="colsep0 rowsep0" align="left">Y</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">Lys323</td><td class="colsep0 rowsep0" align="left">APK*VGR</td><td class="colsep0 rowsep0" align="left">550.864</td><td class="colsep0 rowsep0" align="left">N</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">Tyr443</td><td class="colsep0 rowsep0" align="left">Y*EPER</td><td class="colsep0 rowsep0" align="left">583.812</td><td class="colsep0 rowsep0" align="left">N</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">Cys489</td><td class="colsep0 rowsep0" align="left">LNSAEC*YYPER</td><td class="colsep0 rowsep0" align="left">909.4423</td><td class="colsep0 rowsep0" align="left">Y</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">Cys513</td><td class="colsep0 rowsep0" align="left">SGAGVC*VLHN</td><td class="colsep0 rowsep0" align="left">715.3806</td><td class="colsep0 rowsep0" align="left">Y</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">Cys613</td><td class="colsep0 rowsep0" align="left">SGVGVAVTMEPC*R</td><td class="colsep0 rowsep0" align="left">897.9634</td><td class="colsep0 rowsep0" align="left">Y</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">CDDO-Im (10 Î¼M) was incubated with Keap1 in phosphate buffer, pH 7.4, for 16 h.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">The modified amino acid is labeled with *.</p></div></div></div><div class="NLM_p">A concentration dependent increase of modification was observed at most sites except for Tyr85 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). Tyr85 appeared to be the major modification site when incubated with CDDO-Im at low concentration (100 nM); more sites were bound when the concentrations of CDDO-Im increased (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B,C). Both Cys151 and Tyr85 are located in a groove formed by the side chains of His154 and His129 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_001.pdf" class="ext-link">Figure S2A</a>); it is therefore not surprising that Tyr85 is readily modified by CDDO-Im. Covalent docking of CDDO-Im with Tyr85 demonstrated that the ring system was positioned away from Cys151, with the E ring occupying a small cavity near the side chain of His154 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D). Two hydrogen bonds are formed, one is between the backbone amide nitrogen of Met161 and the nitrile nitrogen of CDDO-Im (<i>r</i><sub>NÂ·Â·Â·N</sub> = 2.96 Ã); another is formed between the backbone oxygen of Gly128 and the enolic oxygen of the C-ring (<i>r</i><sub>OÂ·Â·Â·O</sub> = 3 Ã) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>E). Surprisingly, modification of Cys151 by CDDO-Im was not detected in this study. However, Cleasby et al. have shown that when CDDO-free acid covalently bound to Cys151, the ring systems were positioned in the groove and the C-4 gem-dimethyl group occupied a small cavity near the side chain of Val 155 and the hydrophobic portion of Lys 131 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_001.pdf" class="ext-link">Figure S2B</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The close proximity of Tyr85 to the carbonyl carbon of CDDO-Im (5.7 Ã) and its flexible location makes it theoretically possible to form a cross-linked adduct (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_001.pdf" class="ext-link">Figure S2B</a>). The difficulty of identifying such a cross-linked adduct by searching algorithm may explain why Cys151 modification was not detected.</div><div class="NLM_p last">Notably, we could not detect any adducts of CDDO-Me with Keap1, even when incubated at concentrations as high as 10 Î¼M. This result again emphasizes the difference between CDDO-Im and CDDO-Me and the importance of the imidazolide moiety for irreversible covalent binding.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Modification of Keap1 by CDDO-Im Stabilizes the Keap1-Cul3 Complex</h3><div class="NLM_p">To explore the impact of CDDO-Im modified Tyr85 on the Keap1-Cul3 complex formation, covalent docking of CDDO-Im with Tyr85 was performed using the crystal structure of the Keap1-Cul3 complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NLB">5NLB</a>). As shown in the crystal structure of the Keap1-Clu3 complex, Tyr85 was identified as a key amino acid interacting with the Cul3 N terminal domain (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Covalent binding of CDDO-Im to Tyr85 positions the ring system toward Cul3, forming a bridge between the Keap1 and Cul3 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B,C). Three hydrogen bonds could be potentially formed between the nitrile nitrogen of CDDO and the guanidinium nitrogen of Arg188 in Cul3 (<i>r</i><sub>NÂ·Â·Â·N</sub> = 1.9 Ã, 3.2 Ã, and 3.6 Ã) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of CDDO-Im on Keap1-Cul3 complex formation. (A) Crystal structure of Keap1-Cul3 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NBL">5NBL</a>) highlights the importance of Tyr85 for Cul3 binding. (B) Mesh representation of Keap1-CDDO-Cul3 complex showing CDDO can stabilize the Keap1-Cul3 complex. (C) Covalent binding of CDDO-Im to Tyr85 positions the ring system toward Cul3. (D) CDDO interacts with Arg188 in Cul3 through hydrogen bonds that are denoted by dashed lines. Images are illustrated by PyMOL (The PyMOL Molecular Graphics System, version 1.3, SchrÃ¶dinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70362" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70362" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Although many electrophiles have been reported to enhance transcriptional activity of Nrf2 through covalent modifications of cysteine thiols of Keap1, the detailed mechanisms by which these species affect the activity of Keap1 remain controversial.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Multiple mechanisms have been proposed including Keap1 conformation changes (âhinge and latchâ model and Cul3-dissociation model) and increased Keap1 ubiquitination (ubiquitination switching model) owing to covalent modifications of multiple cysteine residues, all leading to disruption of Keap1-Nrf2 interaction and subsequent Nrf2 degradation.<a onclick="showRef(event, 'ref12 ref13 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref24 ref25">(12,13,24,25)</a> So far, cysteine residues in Keap1 have been identified as the only targets. Here we have demonstrated that CDDO-Im, in contrast to CDDO-Me, covalently binds to amino acid residues other than cysteine through multiple chemical mechanisms. In particular, selective binding to Tyr85 in the BTB domain of human Keap1 protein may contribute to the greater potency of CDDO-Im to activate Nrf2 in certain contexts.</div><div class="NLM_p">As a bifunctional triterpenoid, CDDO-Im has the potential to form not only thioalkyl adducts with cysteine residues in proteins as initial studies demonstrated,<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6â8)</a> but also acylation adducts with other nucleophilic amino acid residues such as lysine, arginine, serine, and tyrosine due to the presence of its reactive imidazolide group. More importantly, intra- and inter-cross-linked adducts can also be formed (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Among the 27 cysteine residues in human Keap1, eight cysteine residues were modified by CDDO-Im, among which five (Cys257, Cys288, Cys489, Cys513, and Cys613) were the most readily modified by other electrophilic reagents.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26â28)</a> Cys273 and Cys288 are essential for Keap1 to control Nrf2 under both basal and stress conditions, whereas Cys151, located in a positively charged pocket, is identified as a primary target for many electrophiles under conditions of stress.<a onclick="showRef(event, 'ref14 ref25 ref26 ref29'); return false;" href="javascript:void(0);" class="ref ref14 ref25 ref26 ref29">(14,25,26,29)</a> Surprisingly, we did not detect CDDO-Im modified Cys151, although different forms of unmodified Cys151 containing peptide (CVLHVMNGAVMYQIDSVVR) were detected, in agreement with other observations<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a>(<a href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_001.pdf" class="ext-link">Figure S1B,C</a>). Failure to detect Cys151 modification could be due to the hydrophobicity of the peptide or potential cross-linked adducts that cannot be identified by software.</div><div class="NLM_p">Modification of cysteine residues within the BTB and IVR domain (Cys151, Cys273, and Cys288) is postulated to alter the conformation of Keap1, which can either directly disrupt the interaction between Nrf2 and Kelch (âhinge and latch model) or block the ubiquitination of Nrf2 (Cul3-dissociation model), leading to Nrf2 nuclear accumulation.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> However, the direct disruption of Keap1-Nrf2 interaction caused by a cysteine modification has been controversial. For example, Cys151 is remote from the Nrf2 substrate-binding domain; hence the conformation changes caused by modification of Cys151 may be unlikely to disrupt the Keap-Nrf2 complex.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Even though Cys489 and Cys513 are located within the Kelch domain that directly binds to Nrf2, covalent binding of CDDO-Im to either cysteine residue seems unlikely to cause any disruptions as shown in the computational modeling studies (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_001.pdf" class="ext-link">Figure S3</a>). On the other hand, Cys151 modification was also postulated to cause alteration of the interface between BTB and Cul3,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> leading to downregulation of Nrf2 ubiquitination and subsequent proteasomal degradation. However, studies have shown that cysteine modifications by many Nrf2-inducing chemicals do not dissociate Keap1 from Cul3.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32â34)</a> Two possible hypotheses have been proposed to explain the downregulation of Nrf2 ubiquitination caused by modification of critical cysteine residues in Keap1. One suggested that cysteine residues within BTB and IVR domains could form thioester conjugates with ubiquitin to accomplish ubiquitin transfer from Cul3 to the lysine residues in Nrf2; modification of critical cysteine residues which are selective to different electrophiles (âcysteine codeâ) thereby inhibits Keap1-dependent ubiquitination.<a onclick="showRef(event, 'ref12 ref24 ref35'); return false;" href="javascript:void(0);" class="ref ref12 ref24 ref35">(12,24,35)</a> Alternatively, cysteine modifications might cause the switch of ubiquitination from Nrf2 to Keap1, leading to upregulation of Keap1 ubiquitination as well as Nrf2 nuclear accumulation.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">Most importantly, we demonstrated for the first time that CDDO-Im selectively targets Tyr85 in Keap1. Located at the entrance of a groove formed by the side chains of His154, His 129, and Cys151,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Tyr85 may adjust its position in response to interaction with particular ligands, and this flexibility may play an important role in the formation of the Keap1-Cul3 complex. Computational docking demonstrated that covalent binding of CDDO-Im to Tyr85 positions the CDDO ring system toward the Keap1-Cul3 binding interface. Three hydrogen bonds were formed between the CDDO nitrile nitrogen and Cul3 Arg188, which stabilize the Keap1-Cul3 complex rather than weaken or abrogate the complex formation as proposed previously.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The strong interaction between Keap1 and Cul3 was proposed to prevent Nrf2 binding to the complex for ubiquitination.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> This is in contrast with the observation that only CDDO-Im exceptionally reduces the interaction between Keap1 and Cul3, although this only occurred at high concentrations of CDDO-Im (6 or 18 Î¼M CDDO-Im).<a onclick="showRef(event, 'ref29 ref34'); return false;" href="javascript:void(0);" class="ref ref29 ref34">(29,34)</a> It is important to note that CDDO-Im does not selectively bind to Tyr85 at these concentrations, indicating multiple mechanisms may contribute to the disruption of Keap1-Cul3 complex formation. In particular, cross-linked adducts formed at high concentrations of CDDO-Im may likely cause its unique function of disrupting the Keap1-Cul3 interaction. Thus, depending on the concentration, CDDO-Im may have significantly different functions.<a onclick="showRef(event, 'ref1 ref19'); return false;" href="javascript:void(0);" class="ref ref1 ref19">(1,19)</a> Selective modification of Tyr85 by CDDO-Im at low concentrations may have a pronounced effect on the stability of Keap-Cul3 complex, which may cause the switch of ubiquitination from Nrf2 to Keap1, leading to disruption of Keap1-Nrf2 interaction and increased self-ubiquitination of Keap1. In contrast, modification of multiple cysteine residues and the formation of cross-linked adducts by CDDO-Im at high concentrations may cause large conformational changes in Keap1, leading to the dissociation of Nrf2 from Keap1.</div><div class="NLM_p">It is important to emphasize that even within the same class of compounds, CDDO-Im and CDDO-Me can have different, sometimes opposite, effects on cellular functions. It has been shown that there are major differences in the sets of genes, both Nrf2-dependent and Nrf2-independent, upregulated or downregulated by either CDDO-Im or CDDO-Me.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> It should also be noted that Nrf2 is not the only molecular target to which Keap1 binds. Significant direct interactions of Keap1 with the regulatory protein, p62, and the antioxidative protein, iASPP, have been reported.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> In all of these situations, the context, especially the dose, of CDDO-Im will be a key determinant of any final biological response. A low dose of CDDO-Im can give a certain response, and a higher dose can give an opposite effect.<a onclick="showRef(event, 'ref1 ref19 ref40'); return false;" href="javascript:void(0);" class="ref ref1 ref19 ref40">(1,19,40)</a> The dose-dependent covalent binding of CDDO-Im to many amino acid residues, which we have shown here, may account for some of these contextual variations.</div><div class="NLM_p last">In all situations, context is of critical importance. Thus, it has been published that the action of CDDO-Im as an inducer of Nrf2 is âindependent of the presence of Cys151â in Keap1 (Figure 7 in Tayaka et al., 2012),<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> while the same group, using lower concentrations of CDDO-Im, later showed data indicating that this drug is âa Cys151-preferring inducerâ (Figure 10 in Saito et al., 2016).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Studies of interaction of triterpenoid molecules with Cys151 have been performed both in silico and in cell cultures, with many different agents, including CDDO, CDDO-Me, an epoxide of CDDO-Me, CDDO-Im, new analogs of CDDO-Im, and even tricyclic eneâone analogs which are not true triterpenoids.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Different concentrations of drug have been used in different studies, and even the context of Keap1 has sometimes been different. In some experiments Keap1 has been an intact whole molecule, but in others only the BTB domain of Keap1 has been used.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> For all future studies it will be important to perform a complete doseâresponse evaluation.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74422" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74422" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have found that the bifunctional triterpenoid CDDO-Im forms covalent adducts with many nucleophilic amino acids on important target proteins at concentrations as low as 10â50 nM and can even form cross-links. The contrast with monofunctional CDDO-Me is striking, since we could not detect adduct formation by CDDO-Me at concentrations less than 500 Î¼M. Our data are directly relevant to known differences between CDDO-Im and CDDO-Me, although clearly these two molecules also share many common mechanisms of action. Altogether our results highlight novel targets for bifunctional triterpenoids that may contribute to their important potency and activity. They provide new insights into the chemical mechanisms of action and pave the way for exploring potential novel cellular signaling pathways for bifunctional triterpenoids, including even newer pyridyl imidazolide derivatives<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> that also form covalent acylation adducts, which will be described in a future publication. In all future work, it will be essential to consider context.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03284" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03284" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemicals</h3><div class="NLM_p last">CDDO-Im was provided by Triterpenoid Therapeutics, Inc. (USA). CDDO-Me and HSA (97â99% pure) were purchased from Sigma-Aldrich, trypsin was from Promega (Madison, WI), liquid chromatographyâmass spectrometry (LC-MS) grade solvents were from Fisher Scientific UK Ltd. (Loughborough, Leicestershire), and all other standard reagents were from Sigma-Aldrich.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Concentration-Dependent Modification of HSA by CDDO-Im</h3><div class="NLM_p last">CDDO-Im freshly dissolved in DMSO, followed by dilutions in phosphate buffer (10 mM, pH 7.4), was incubated with HSA (0.6 mM, 50 Î¼L) in phosphate buffer in sealed Eppendorf tubes at 37 Â°C for 16 h. The molar ratios of drug to protein were 0.00001:1, 0.0001:1, 0.001:1, 0.01:1, 0.1:1, and 1:1. Protein was precipitated twice with 9 volumes of ice-cold methanol to remove free drug and processed for LCâMS/MS analysis using previous methods.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Time-Dependent Modification of HSA by CDDO-Im</h3><div class="NLM_p last">10 Î¼M CDDO-Im was incubated with HSA (0.6 mM, 300 Î¼L) at 37 Â°C. Aliquots of 50 Î¼L were removed after 10, 30, 60, and 180 min and processed for LCâMS/MS analysis.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Concentration-Dependent Modification of His-GSTP by Triterpenoids</h3><div class="NLM_p last">His-GSTP was expressed in <i>E. coli</i> as described previously.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Purified His-GSTP captured on nickel beads was incubated with a range of concentrations of CDDO-Im (50 nM to 10 Î¼M) in phosphate buffer, pH 7.4, for 16 h. CDDO-Me (0.5 mM) was used as a positive control. The beads were then washed 5 times with 1000 Î¼L of phosphate buffer. The protein was subjected to on-bead tryptic digestion. In brief, a suspension of beads in 30 Î¼L of 50 mM ammonium bicarbonate buffer was incubated with 20 ng of trypsin for 16 h at 37 Â°C, and the digests were analyzed by LCâMS/MS.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Modification of Keap1 by CDDO-Im</h3><div class="NLM_p last">Solutions of CDDO-Im, as described above, were incubated (0.1â10 Î¼M) with recombinant Keap1 protein<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> at 37 Â°C for 16 h in phosphate buffer (10 mM, pH 7.4). The mixture was then purified by 1D gel electrophoresis using established protocol, followed by in gel digestion.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The digests were further purified by C18-ziptiping and analyzed by LCâMS/MS.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> LCâMS/MS Analysis of CDDO-Im Protein Adducts</h3><div class="NLM_p">The tryptic peptides were analyzed by a Triple TOF 5600 mass spectrometer (Sciex). Samples were reconstituted in 50 Î¼L of 0.1% formic acid, and an amount of 2 Î¼L of samples was delivered into the instrument using an Eksigent Nano-LC system mounted with a nanoACQUITY UPLC Symmetry C18 trap column and an analytical BEH C18 nanoACQUITY column (Waters, MA, USA). A NanoSpray III source was fitted with a 10 Î¼m inner diameter PicoTip emitter (New Objective). Samples were loaded in 0.1% formic acid onto the trap, which was then washed with 2% ACN/0.1% FA for 10 min at 2 Î¼L/min before switching in-line with the analytical column. A gradient of 2â50% (v/v) ACN/0.1% (v/v) FA over 90 min was applied to the column at a flow rate of 300 nL/min. Spectra were acquired automatically in positive ion mode using information-dependent acquisition, using mass ranges of 400â1600 amu in MS and 100â1400 amu in MS/MS. Up to 25 MS/MS spectra were acquired per cycle (approximately 10 Hz) using a threshold of 100 counts per s, with dynamic exclusion for 12 s and rolling collision energy.</div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Analysis of CDDO-Im Modified Proteins</h4><div class="NLM_p last">LCâMS/MS data were searched against the reviewed human proteome (UniProt/SwissProt accessed October 2018), using ProteinPilot software, version 4.0 (Sciex). Data were refined using default parameters and searches performed with the following parameters: enzymatic cleavage restriction for trypsin, fixed modification of carbamidomethylation of cysteine; variable modifications of methionine oxidation (+15.99) and asparagine and glutamine deamidation (+0.98); CDDO-Im modification of lysine, serine, tyrosine, and arginine (+473.3); CDDO-Im modification of cysteine (+473.3 or 491.3).</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Keap1 Modeling</h4><div class="NLM_p last">Crystal structures of BTB domain of human Keap1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CXI">4CXI</a>) and Keap1-Cul3 complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NBL">5NBL</a>) were used to generate models. GOLD 5.2 (CCDC software) was used for covalent docking of CDDO-Im to Tyr85. To covalently link the CDDO-Im to Tyr85, the corresponding side chain was removed from the protein and the ligand modified to contain the side chain to allow flexibility. The site of covalent attachment was at the tyrosine CÎ±.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> A generic algorithm with ChemPLP as the fitness function was used to generate 10 binding modes per ligand. Default settings were retained for the âligand flexibilityâ, âfitness and search optionsâ, and âGAâ settings.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01088" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31002" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31002" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01088?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01088</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Supplementary table and additional figures (Figures S1âS3) showing the formation of CDDO-Im protein adducts and the interaction of CDDO-Im with Keap1 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Coordinates information for structure representation; Covalent binding of CDDO-Im to Tyr85 in Keap1 (PDB 4CXI) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formul strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_003.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Coordinates information for structure representation; Covalent binding of CDDO-Im to Tyr85 in Keap1 stabilises the Keap1-Cul3 complex (PDB 5NBL) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates information for structure representation; The effect of covalent binding of CDDO-Im to Cys489 in Keap1 on the interaction between Keap1 and Nrf2 (PDB 2FUL) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_005.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_001.pdf">jm0c01088_si_001.pdf (1.67 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_002.pdb">jm0c01088_si_002.pdb (173.99 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_003.csv">jm0c01088_si_003.csv (0.37 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_004.pdb">jm0c01088_si_004.pdb (633.51 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_005.pdb">jm0c01088_si_005.pdb (386.54 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01088" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoli Meng</span> - <span class="hlFld-Affiliation affiliation">MRC
Centre for Drug Safety Science, Department of Molecular & Clinical
Pharmacology, University of Liverpool, Liverpool L69 3GE, U.K.</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7774-2075" title="Orcid link">http://orcid.org/0000-0002-7774-2075</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#aed6c2c3cbc0c9eec2c7d8cbdcdec1c1c280cfcd80dbc5"><span class="__cf_email__" data-cfemail="cbb3a7a6aea5ac8ba7a2bdaeb9bba4a4a7e5aaa8e5bea0">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James C. Waddington</span> - <span class="hlFld-Affiliation affiliation">MRC
Centre for Drug Safety Science, Department of Molecular & Clinical
Pharmacology, University of Liverpool, Liverpool L69 3GE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arun Tailor</span> - <span class="hlFld-Affiliation affiliation">MRC
Centre for Drug Safety Science, Department of Molecular & Clinical
Pharmacology, University of Liverpool, Liverpool L69 3GE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Lister</span> - <span class="hlFld-Affiliation affiliation">MRC
Centre for Drug Safety Science, Department of Molecular & Clinical
Pharmacology, University of Liverpool, Liverpool L69 3GE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane Hamlett</span> - <span class="hlFld-Affiliation affiliation">MRC
Centre for Drug Safety Science, Department of Molecular & Clinical
Pharmacology, University of Liverpool, Liverpool L69 3GE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neil Berry</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Liverpool, Liverpool L69 7ZD, U.K.</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1928-0738" title="Orcid link">http://orcid.org/0000-0003-1928-0738</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">B. Kevin Park</span> - <span class="hlFld-Affiliation affiliation">MRC
Centre for Drug Safety Science, Department of Molecular & Clinical
Pharmacology, University of Liverpool, Liverpool L69 3GE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael B. Sporn</span> - <span class="hlFld-Affiliation affiliation">Molecular
and Systems Biology, Dartmouth Medical School, Lebanon, New Hampshire 03756, United States</span></div></li></ul></li><li></li><li><span class="author-information-subsection-header">Funding</span><p>The project received funding from Triterpenoid Therapeutics, Inc. (USA) and the MRC Centre for Drug Safety Science (Grant MR/L006758/1).</p></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare the following competing financial interest(s): M. B. Sporn is an employee and shareholder of Triterpenoid Therapeutics. The other authors declare no competing financial interest.<br /></br></p></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">CDDO</td><td class="NLM_def"><p class="first last">2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid</p></td></tr><tr><td class="NLM_term">CDDO-Im</td><td class="NLM_def"><p class="first last">CDDO-imidazolide</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducers and activators of transcription</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span> <span> </span><span class="NLM_article-title">Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">972</span>â <span class="NLM_lpage">1003</span>, <span class="refDoi">Â DOI: 10.1124/pr.111.004846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1124%2Fpr.111.004846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=22966038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslaltQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=972-1003&author=K.+T.+Libyauthor=M.+B.+Sporn&title=Synthetic+Oleanane+Triterpenoids%3A+Multifunctional+Drugs+with+a+Broad+Range+of+Applications+for+Prevention+and+Treatment+of+Chronic+Disease&doi=10.1124%2Fpr.111.004846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease</span></div><div class="casAuthors">Liby, Karen T.; Sporn, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">972-1003</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We review the rationale for the use of synthetic oleanane triterpenoids (SOs) for prevention and treatment of disease, as well as extensive biol. data on this topic resulting from both cell culture and in vivo studies.  Emphasis is placed on understanding mechanisms of action.  SOs are noncytotoxic drugs with an excellent safety profile.  Several hundred SOs have now been synthesized and in vitro have been shown to: 1) suppress inflammation and oxidative stress and therefore be cytoprotective, esp. at low nanomolar doses, 2) induce differentiation, and 3) block cell proliferation and induce apoptosis at higher micromolar doses.  Animal data on the use of SOs in neurodegenerative diseases and in diseases of the eye, lung, cardiovascular system, liver, gastrointestinal tract, and kidney, as well as in cancer and in metabolic and inflammatory/autoimmune disorders, are reviewed.  The importance of the cytoprotective Kelch-like erythroid cell-derived protein with CNC homol.-assocd. protein 1/nuclear factor (erythroid-derived 2)-like 2/antioxidant response element (Keap1/Nrf2/ARE) pathway as a mechanism of action is explained, but interactions with peroxisome proliferator-activated receptor Î³ (PARPÎ³), inhibitor of nuclear factor-ÎºB kinase complex (IKK), janus tyrosine kinase/signal transducer and activator of transcription (JAK/STAT), human epidermal growth factor receptor 2 (HER2)/ErbB2/neu, phosphatase and tensin homolog (PTEN), the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway, mammalian target of rapamycin (mTOR), and the thiol proteome are also described.  In these interactions, Michael addn. of SOs to reactive cysteine residues in specific mol. targets triggers biol. activity.  Ultimately, SOs are multifunctional drugs that regulate the activity of entire networks.  Recent progress in the earliest clin. trials with 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO) Me ester (bardoxolone methyl) is also summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozzGNihQsvrrVg90H21EOLACvtfcHk0liHZNp7rYfEJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslaltQ%253D%253D&md5=5c0a741d089e6f6a504eae31a47d872c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.111.004846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.111.004846%26sid%3Dliteratum%253Aachs%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26atitle%3DSynthetic%2520Oleanane%2520Triterpenoids%253A%2520Multifunctional%2520Drugs%2520with%2520a%2520Broad%2520Range%2520of%2520Applications%2520for%2520Prevention%2520and%2520Treatment%2520of%2520Chronic%2520Disease%26jtitle%3DPharmacol.%2520Rev.%26date%3D2012%26volume%3D64%26spage%3D972%26epage%3D1003%26doi%3D10.1124%2Fpr.111.004846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2 System: A Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1169</span>â <span class="NLM_lpage">1203</span>, <span class="refDoi">Â DOI: 10.1152/physrev.00023.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1152%2Fphysrev.00023.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=29717933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvFektrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2018&pages=1169-1203&author=M.+Yamamotoauthor=T.+W.+Kenslerauthor=H.+Motohashi&title=The+Keap1-Nrf2+System%3A+A+Thiol-Based+Sensor-Effector+Apparatus+for+Maintaining+Redox+Homeostasis&doi=10.1152%2Fphysrev.00023.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis</span></div><div class="casAuthors">Yamamoto, Masayuki; Kensler, Thomas W.; Motohashi, Hozumi</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1169-1203</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">1522-1210</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The Kelch-like ECH-assocd. protein 1-NF-E2-related factor 2 (KEAP1-NRF2) system forms the major node of cellular and organismal defense against oxidative and electrophilic stresses of both exogenous and endogenous origins.  KEAP1 acts as a cysteine thiol-rich sensor of redox insults, whereas NRF2 is a transcription factor that robustly transduces chem. signals to regulate a battery of cytoprotective genes.  KEAP1 represses NRF2 activity under quiescent conditions, whereas NRF2 is liberated from KEAP1-mediated repression on exposure to stresses.  The rapid inducibility of a response based on a derepression mechanism is an important feature of the KEAP1-NRF2 system.  Recent studies have unveiled the complexities of the functional contributions of the KEAP1-NRF2 system and defined its broader involvement in biol. processes, including cell proliferation and differentiation, as well as cytoprotection.  In this review, we describe historical milestones in the initial characterization of the KEAP1-NRF2 system and provide a comprehensive overview of the mol. mechanisms governing the functions of KEAP1 and NRF2, as well as their roles in physiol. and pathol.  We also refer to the clin. significance of the KEAP1-NRF2 system as an important prophylactic and therapeutic target for various diseases, particularly aging-related disorders.  We believe that controlled harnessing of the KEAP1-NRF2 system is a key to healthy aging and well-being in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohbdKIhBBbkLVg90H21EOLACvtfcHk0li_5SZH2yRqHA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvFektrc%253D&md5=906947c8ad97c48f60e46bc44103664a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00023.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00023.2017%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DMotohashi%26aufirst%3DH.%26atitle%3DThe%2520Keap1-Nrf2%2520System%253A%2520A%2520Thiol-Based%2520Sensor-Effector%2520Apparatus%2520for%2520Maintaining%2520Redox%2520Homeostasis%26jtitle%3DPhysiol.%2520Rev.%26date%3D2018%26volume%3D98%26spage%3D1169%26epage%3D1203%26doi%3D10.1152%2Fphysrev.00023.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uruno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furusawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagishita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukutomi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2996</span>â <span class="NLM_lpage">3010</span>, <span class="refDoi">Â DOI: 10.1128/MCB.00225-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.00225-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=23716596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1arur7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=2996-3010&author=A.+Urunoauthor=Y.+Furusawaauthor=Y.+Yagishitaauthor=T.+Fukutomiauthor=H.+Muramatsuauthor=T.+Negishiauthor=A.+Sugawaraauthor=T.+W.+Kenslerauthor=M.+Yamamoto&title=The+Keap1-Nrf2+System+Prevents+Onset+of+Diabetes+Mellitus&doi=10.1128%2FMCB.00225-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Keap1-Nrf2 system prevents onset of diabetes mellitus</span></div><div class="casAuthors">Uruno, Akira; Furusawa, Yuki; Yagishita, Yoko; Fukutomi, Toshiaki; Muramatsu, Hiroyuki; Negishi, Takaaki; Sugawara, Akira; Kensler, Thomas W.; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2996-3010</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Transcription factor Nrf2 (NF-E2-related factor 2) regulates a broad cytoprotective response to environmental stresses.  Keap1 (Kelch-like ECH-assocd. protein 1) is an adaptor protein for cullin3-based ubiquitin E3 ligase and neg. regulates Nrf2.  Whereas the Keap1-Nrf2 system plays important roles in oxidative stress response and metab., the roles Nrf2 plays in the prevention of diabetes mellitus remain elusive.  Here we show that genetic activation of Nrf2 signaling by Keap1 gene hypomorphic knockdown (Keap1flox/-) markedly suppresses the onset of diabetes.  When Keap1flox/- mice were crossed with diabetic db/db mice, blood glucose levels became lower through improvement of both insulin secretion and insulin resistance.  Keap1flox/- also prevented high-calorie-diet-induced diabetes.  Oral administration of the Nrf2 inducer CDDO-Im {oleanolic acid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl] imidazole} also attenuated diabetes in db/db mice.  Nrf2 induction altered antioxidant-, energy consumption-, and gluconeogenesis-related gene expression in metabolic tissues.  Thus, the Keap1-Nrf2 system is a crit. target for preventing the onset of diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrepn_xCF-lw7Vg90H21EOLACvtfcHk0li_5SZH2yRqHA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1arur7J&md5=84157bcae46cb8b986c6cc0ed7c2648c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FMCB.00225-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00225-13%26sid%3Dliteratum%253Aachs%26aulast%3DUruno%26aufirst%3DA.%26aulast%3DFurusawa%26aufirst%3DY.%26aulast%3DYagishita%26aufirst%3DY.%26aulast%3DFukutomi%26aufirst%3DT.%26aulast%3DMuramatsu%26aufirst%3DH.%26aulast%3DNegishi%26aufirst%3DT.%26aulast%3DSugawara%26aufirst%3DA.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DThe%2520Keap1-Nrf2%2520System%2520Prevents%2520Onset%2520of%2520Diabetes%2520Mellitus%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2013%26volume%3D33%26spage%3D2996%26epage%3D3010%26doi%3D10.1128%2FMCB.00225-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egner, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wible, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutter, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groopman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roebuck, B. D.</span></span> <span> </span><span class="NLM_article-title">Complete Protection against Aflatoxin B(1)-Induced Liver Cancer with a Triterpenoid: DNA Adduct Dosimetry, Molecular Signature, and Genotoxicity Threshold</span>. <i>Cancer Prev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">658</span>â <span class="NLM_lpage">665</span>, <span class="refDoi">Â DOI: 10.1158/1940-6207.CAPR-13-0430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1158%2F1940-6207.CAPR-13-0430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=24662598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWgsb%252FK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=658-665&author=N.+M.+Johnsonauthor=P.+A.+Egnerauthor=V.+K.+Baxterauthor=M.+B.+Spornauthor=R.+S.+Wibleauthor=T.+R.+Sutterauthor=J.+D.+Groopmanauthor=T.+W.+Kenslerauthor=B.+D.+Roebuck&title=Complete+Protection+against+Aflatoxin+B%281%29-Induced+Liver+Cancer+with+a+Triterpenoid%3A+DNA+Adduct+Dosimetry%2C+Molecular+Signature%2C+and+Genotoxicity+Threshold&doi=10.1158%2F1940-6207.CAPR-13-0430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Complete Protection against Aflatoxin B1-Induced Liver Cancer with a Triterpenoid: DNA Adduct Dosimetry, Molecular Signature, and Genotoxicity Threshold</span></div><div class="casAuthors">Johnson, Natalie M.; Egner, Patricia A.; Baxter, Victoria K.; Sporn, Michael B.; Wible, Ryan S.; Sutter, Thomas R.; Groopman, John D.; Kensler, Thomas W.; Roebuck, Bill D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">658-665</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In exptl. animals and humans, aflatoxin B1 (AFB1) is a potent hepatic toxin and carcinogen.  The synthetic oleanane triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im), a powerful activator of Keap1-Nrf2 signaling, protects against AFB1-induced toxicity and preneoplastic lesion formation (GST-P-pos. foci).  This study assessed and mechanistically characterized the chemoprotective efficacy of CDDO-Im against AFB1-induced hepatocellular carcinoma (HCC).  A lifetime cancer bioassay was undertaken in F344 rats dosed with AFB1 (200 Î¼g/kg rat/day) for four weeks and receiving either vehicle or CDDO-Im (three times weekly), one week before and throughout the exposure period.  Weekly, 24-h urine samples were collected for anal. of AFB1 metabolites.  In a subset of rats, livers were analyzed for GST-P foci.  The comparative response of a toxicogenomic RNA expression signature for AFB1 was examd.  CDDO-Im completely protected (0/20) against AFB1-induced liver cancer compared with a 96% incidence (22/23) obsd. in the AFB1 group.  With CDDO-Im treatment, integrated level of urinary AFB1-N7-guanine was significantly reduced (66%) and aflatoxin-N-acetylcysteine, a detoxication product, was consistently elevated (300%) after the first AFB1 dose.  In AFB1-treated rats, the hepatic burden of GST-P-pos. foci increased substantially (0%-13.8%) over the four weeks, but was largely absent with CDDO-Im intervention.  The toxicogenomic RNA expression signature characteristic of AFB1 was absent in the AFB1 + CDDO-Im-treated rats.  The remarkable efficacy of CDDO-Im as an anticarcinogen is established even in the face of a significant aflatoxin adduct burden.  Consequently, the absence of cancer requires a concept of a threshold for DNA damage for cancer development.  Cancer Prev Res; 7(7); 658-65. Â©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI00fL13ZiuLVg90H21EOLACvtfcHk0li_5SZH2yRqHA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWgsb%252FK&md5=001712c4584629a64435a43a73bcbb71</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-13-0430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-13-0430%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DN.%2BM.%26aulast%3DEgner%26aufirst%3DP.%2BA.%26aulast%3DBaxter%26aufirst%3DV.%2BK.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DWible%26aufirst%3DR.%2BS.%26aulast%3DSutter%26aufirst%3DT.%2BR.%26aulast%3DGroopman%26aufirst%3DJ.%2BD.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DRoebuck%26aufirst%3DB.%2BD.%26atitle%3DComplete%2520Protection%2520against%2520Aflatoxin%2520B%25281%2529-Induced%2520Liver%2520Cancer%2520with%2520a%2520Triterpenoid%253A%2520DNA%2520Adduct%2520Dosimetry%252C%2520Molecular%2520Signature%252C%2520and%2520Genotoxicity%2520Threshold%26jtitle%3DCancer%2520Prev.%2520Res.%26date%3D2014%26volume%3D7%26spage%3D658%26epage%3D665%26doi%3D10.1158%2F1940-6207.CAPR-13-0430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakris, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chertow, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsberry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inker, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heerspink, H. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâGrady, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergola, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warnock, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. J.</span></span> <span> </span><span class="NLM_article-title">Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study</span>. <i>Am. J. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">40</span>â <span class="NLM_lpage">47</span>, <span class="refDoi">Â DOI: 10.1159/000486398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1159%2F000486398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=29402767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVCiu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=40-47&author=M.+P.+Chinauthor=G.+L.+Bakrisauthor=G.+A.+Blockauthor=G.+M.+Chertowauthor=A.+Goldsberryauthor=L.+A.+Inkerauthor=H.+J.+L.+Heerspinkauthor=M.+O%E2%80%99Gradyauthor=P.+E.+Pergolaauthor=C.+Wannerauthor=D.+G.+Warnockauthor=C.+J.+Meyer&title=Bardoxolone+Methyl+Improves+Kidney+Function+in+Patients+with+Chronic+Kidney+Disease+Stage+4+and+Type+2+Diabetes%3A+Post-Hoc+Analyses+from+Bardoxolone+Methyl+Evaluation+in+Patients+with+Chronic+Kidney+Disease+and+Type+2+Diabetes+Study&doi=10.1159%2F000486398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study</span></div><div class="casAuthors">Chin, Melanie P.; Bakris, George L.; Block, Geoffrey A.; Chertow, Glenn M.; Goldsberry, Angie; Inker, Lesley A.; Heerspink, Hiddo J. L.; O'Grady, Megan; Pergola, Pablo E.; Wanner, Christoph; Warnock, David G.; Meyer, Colin J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Nephrology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-47</span>CODEN:
                <span class="NLM_cas:coden">AJNED9</span>;
        ISSN:<span class="NLM_cas:issn">0250-8095</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Increases in measured inulin clearance, measured creatinine clearance, and estd. glomerular filtration rate (eGFR) have been obsd. with bardoxolone Me in 7 studies enrolling approx. 2,600 patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).  The largest of these studies was Bardoxolone Me Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes (BEACON), a multinational, randomized, double-blind, placebo-controlled phase 3 trial which enrolled patients with T2D and CKD stage 4.  The BEACON trial was terminated after preliminary analyses showed that patients randomized to bardoxolone Me experienced significantly higher rates of heart failure events.  We performed post-hoc analyses to characterize changes in kidney function induced by bardoxolone Me.  Methods: Patients in -BEACON (n = 2,185) were randomized 1: 1 to receive once-daily bardoxolone Me (20 mg) or placebo.  We compared the effects of bardoxolone Me and placebo on a post-hoc composite renal endpoint consisting of â¥30% decline from baseline in eGFR, eGFR <15 mL/min/1.73 m2, and end-stage renal disease (ESRD) events (provision of dialysis or kidney transplantation).  Results: Consistent with prior studies, patients randomized to bardoxolone Me experienced mean increases in eGFR that were sustained through study week 48.  Moreover, increases in eGFR from baseline were sustained 4 wk after cessation of treatment.  Patients randomized to bardoxolone Me were significantly less likely to experience the composite renal endpoint (hazards ratio 0.48 [95% CI 0.36-0.64]; p < 0.0001).  Conclusions: Bardoxolone Me preserves kidney function and may delay the onset of ESRD in patients with T2D and stage 4 CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjOzptzThpbVg90H21EOLACvtfcHk0li4GraDs4L26g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVCiu7Y%253D&md5=9351e5606902fd77cfe5dc042c833e66</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1159%2F000486398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000486398%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DM.%2BP.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DBlock%26aufirst%3DG.%2BA.%26aulast%3DChertow%26aufirst%3DG.%2BM.%26aulast%3DGoldsberry%26aufirst%3DA.%26aulast%3DInker%26aufirst%3DL.%2BA.%26aulast%3DHeerspink%26aufirst%3DH.%2BJ.%2BL.%26aulast%3DO%25E2%2580%2599Grady%26aufirst%3DM.%26aulast%3DPergola%26aufirst%3DP.%2BE.%26aulast%3DWanner%26aufirst%3DC.%26aulast%3DWarnock%26aufirst%3DD.%2BG.%26aulast%3DMeyer%26aufirst%3DC.%2BJ.%26atitle%3DBardoxolone%2520Methyl%2520Improves%2520Kidney%2520Function%2520in%2520Patients%2520with%2520Chronic%2520Kidney%2520Disease%2520Stage%25204%2520and%2520Type%25202%2520Diabetes%253A%2520Post-Hoc%2520Analyses%2520from%2520Bardoxolone%2520Methyl%2520Evaluation%2520in%2520Patients%2520with%2520Chronic%2520Kidney%2520Disease%2520and%2520Type%25202%2520Diabetes%2520Study%26jtitle%3DAm.%2520J.%2520Nephrol.%26date%3D2018%26volume%3D47%26spage%3D40%26epage%3D47%26doi%3D10.1159%2F000486398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzclaw, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risingsong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Extremely Potent Triterpenoid Inducers of the Phase 2 Response: Correlations of Protection against Oxidant and Inflammatory Stress</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">4584</span>â <span class="NLM_lpage">4589</span>, <span class="refDoi">Â DOI: 10.1073/pnas.0500815102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1073%2Fpnas.0500815102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=15767573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivFCqs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=4584-4589&author=A.+T.+Dinkova-Kostovaauthor=K.+T.+Libyauthor=K.+K.+Stephensonauthor=W.+D.+Holtzclawauthor=X.+Gaoauthor=N.+Suhauthor=C.+Williamsauthor=R.+Risingsongauthor=T.+Hondaauthor=G.+W.+Gribbleauthor=M.+B.+Spornauthor=P.+Talalay&title=Extremely+Potent+Triterpenoid+Inducers+of+the+Phase+2+Response%3A+Correlations+of+Protection+against+Oxidant+and+Inflammatory+Stress&doi=10.1073%2Fpnas.0500815102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Liby, Karen T.; Stephenson, Katherine K.; Holtzclaw, W. David; Gao, Xiangqun; Suh, Nanjoo; Williams, Charlotte; Risingsong, Renee; Honda, Tadashi; Gribble, Gordon W.; Sporn, Michael B.; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4584-4589</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A series of synthetic triterpenoid (TP) analogs of oleanolic acid are powerful inhibitors of cellular inflammatory processes such as the induction by IFN-Î³ of inducible nitric oxide synthase (iNOS) and of cyclooxygenase 2 in mouse macrophages.  Here, we show that these analogs are also extremely potent inducers of the phase 2 response [e.g., elevation of NAD(P)H-quinone oxidoreductase and heme oxygenase 1], which is a major protector of cells against oxidative and electrophile stress.  Moreover, like previously identified phase 2 inducers, the TP analogs use the antioxidant response element-Nrf2-Keap1 signaling pathway.  Thus, induction of the phase 2 response and suppression of the iNOS induction was abrogated in nrf2-/- and keap1-/- mouse embryonic fibroblasts.  The high potency of TP analogs in inducing the phase 2 response and blocking inflammation depends on the presence of activated Michael reaction (enone) functions at crit. positions in rings A and C.  The most potent TP doubles NAD(P)H-quinone oxidoreductase in murine hepatoma cells at 0.28 nM and has an IC50 for suppression of iNOS induction in primary mouse macrophages of 0.0035 nM.  The direct interaction of this TP with thiol groups of the Keap1 sensor for inducers is demonstrated spectroscopically.  The antiinflammatory and phase 2 inducer potencies of 18 TP are closely linearly correlated (r2 = 0.91) over 6 orders of magnitude of concn.  Thus, in addn. to blocking inflammation and promoting differentiation, these TP exhibit another very important protective property: the induction of the phase 2 response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjPGfuWcwoqbVg90H21EOLACvtfcHk0li4GraDs4L26g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivFCqs74%253D&md5=02be0d1918c1f700662a12c9a14594b6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0500815102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0500815102%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DStephenson%26aufirst%3DK.%2BK.%26aulast%3DHoltzclaw%26aufirst%3DW.%2BD.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DSuh%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DRisingsong%26aufirst%3DR.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DExtremely%2520Potent%2520Triterpenoid%2520Inducers%2520of%2520the%2520Phase%25202%2520Response%253A%2520Correlations%2520of%2520Protection%2520against%2520Oxidant%2520and%2520Inflammatory%2520Stress%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D4584%26epage%3D4589%26doi%3D10.1073%2Fpnas.0500815102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yore, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundararajan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span> <span> </span><span class="NLM_article-title">Platforms and Networks in Triterpenoid Pharmacology</span>. <i>Drug Dev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">174</span>â <span class="NLM_lpage">182</span>, <span class="refDoi">Â DOI: 10.1002/ddr.20179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1002%2Fddr.20179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlarsbjN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=174-182&author=M.+B.+Spornauthor=K.+Libyauthor=M.+M.+Yoreauthor=N.+Suhauthor=A.+Albiniauthor=T.+Hondaauthor=C.+Sundararajanauthor=G.+W.+Gribble&title=Platforms+and+Networks+in+Triterpenoid+Pharmacology&doi=10.1002%2Fddr.20179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Platforms and networks in triterpenoid pharmacology</span></div><div class="casAuthors">Sporn, Michael B.; Liby, Karen; Yore, Mark M.; Suh, Nanjoo; Albini, Adriana; Honda, Tadashi; Sundararajan, Chitra; Gribble, Gordon W.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">174-182</span>CODEN:
                <span class="NLM_cas:coden">DDREDK</span>;
        ISSN:<span class="NLM_cas:issn">0272-4391</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Using the pentacyclic, naturally occurring triterpenoids, oleanolic, ursolic, and betulinic acids, as starting materials, we have developed a new series of multifunctional drugs for potential clin. use.  These agents have anti-inflammatory, anti-oxidative, anti-proliferative, pro-apoptotic, and differentiating activities.  Two synthetic oleanane triterpenoids, 2-cyano-3, 12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO) and its C-28 Me ester (CDDO-Me), are presently in Phase I clin. trials in cancer patients.  Three themes are emphasized in this review: (1) The importance of the unique structures of the triterpenoid platforms that have been used as a start for new synthesis; (2) The concept that these new drugs interact with entire physiol. networks, rather than solely with single mol. targets; and (3) The coupling in real time between the triterpenoid platforms and the physiol. networks with which they interact, as seen in the reversibility of the Michael reactions, which mediate their activity.  We suggest that further development of such new, multifunctional drugs will most likely occur in the more flexible environment of small biotech or pharmaceutical companies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouR8MkZu3RK7Vg90H21EOLACvtfcHk0lhkCAgzlOpc0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlarsbjN&md5=8ca2a9cb8c0364b956a9e3b196b572a8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fddr.20179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.20179%26sid%3Dliteratum%253Aachs%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLiby%26aufirst%3DK.%26aulast%3DYore%26aufirst%3DM.%2BM.%26aulast%3DSuh%26aufirst%3DN.%26aulast%3DAlbini%26aufirst%3DA.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DSundararajan%26aufirst%3DC.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26atitle%3DPlatforms%2520and%2520Networks%2520in%2520Triterpenoid%2520Pharmacology%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2007%26volume%3D68%26spage%3D174%26epage%3D182%26doi%3D10.1002%2Fddr.20179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yore, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopchuk, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span> <span> </span><span class="NLM_article-title">New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">537</span>â <span class="NLM_lpage">545</span>, <span class="refDoi">Â DOI: 10.1021/np100826q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np100826q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVWisrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=537-545&author=M.+B.+Spornauthor=K.+T.+Libyauthor=M.+M.+Yoreauthor=L.+Fuauthor=J.+M.+Lopchukauthor=G.+W.+Gribble&title=New+Synthetic+Triterpenoids%3A+Potent+Agents+for+Prevention+and+Treatment+of+Tissue+Injury+Caused+by+Inflammatory+and+Oxidative+Stress&doi=10.1021%2Fnp100826q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress</span></div><div class="casAuthors">Sporn, Michael B.; Liby, Karen T.; Yore, Mark M.; Fu, Liangfeng; Lopchuk, Justin M.; Gribble, Gordon W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">537-545</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">We review the original rational for the development and the chem. of a series of new synthetic oleanane triterpenoids (SO), based on oleanolic acid (I) as a starting material.  Many of the new compds. that have been made, such as 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ["CDDO", (II; R = H)], are highly potent (activities found at levels below 1 nM) anti-inflammatory agents, as measured by their ability to block the cellular synthesis of the enzyme inducible nitric oxide synthase (iNOS) in activated macrophages.  Details of the org. synthesis of new SO and their chem. mechanisms of biol. activity are reviewed, as is formation of biotin conjugates for investigation of protein targets.  Finally, we give a brief summary of important biol. activities of SO in many organ systems in numerous animal models.  Clin. investigation of a new SO [Me 2-cyano-3,12-dioxooleana-1,9(11)dien-28-oate, "CDDO-Me", bardoxolone Me, (II; R = Me)] is currently in progress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXWMDf2Fxc3LVg90H21EOLACvtfcHk0lhkCAgzlOpc0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVWisrg%253D&md5=a6b2efe5faaba6151472b0f5f654940e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fnp100826q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp100826q%26sid%3Dliteratum%253Aachs%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DYore%26aufirst%3DM.%2BM.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DLopchuk%26aufirst%3DJ.%2BM.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26atitle%3DNew%2520Synthetic%2520Triterpenoids%253A%2520Potent%2520Agents%2520for%2520Prevention%2520and%2520Treatment%2520of%2520Tissue%2520Injury%2520Caused%2520by%2520Inflammatory%2520and%2520Oxidative%2520Stress%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D537%26epage%3D545%26doi%3D10.1021%2Fnp100826q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yore, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettenbach, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span> <span> </span><span class="NLM_article-title">Proteomic Analysis Shows Synthetic Oleanane Triterpenoid Binds to Mtor</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e22862</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0022862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1371%2Fjournal.pone.0022862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=21818401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOrsbfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e22862&author=M.+M.+Yoreauthor=A.+N.+Kettenbachauthor=M.+B.+Spornauthor=S.+A.+Gerberauthor=K.+T.+Liby&title=Proteomic+Analysis+Shows+Synthetic+Oleanane+Triterpenoid+Binds+to+Mtor&doi=10.1371%2Fjournal.pone.0022862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR</span></div><div class="casAuthors">Yore, Mark M.; Kettenbach, Arminja N.; Sporn, Michael B.; Gerber, Scott A.; Liby, Karen T.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e22862</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">New multifunctional drugs that target multiple disease-relevant networks offer a novel approach to the prevention and treatment of many diseases.  New synthetic oleanane triterpenoids (SO), such as CDDO (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) and its derivs., are multifunctional compds. originally developed for the prevention and treatment of inflammation and oxidative stress.  However, the protein binding partners and mechanisms of action of these SO are not yet fully understood.  Here we characterize the putative target profile of one SO, CDDO-Imidazolide (CDDO-Im), by combining affinity purifn. with mass spectroscopic proteomic anal. to identify 577 candidate binding proteins in whole cells.  This SO pharmaco-interactome consists of a diverse but interconnected set of signaling networks; bioinformatic anal. of the protein interactome identified canonical signaling pathways targeted by the SO, including retinoic acid receptor (RAR), estrogen receptor (ER), insulin receptor (IR), janus kinase/signal transducers and activators of transcription (JAK/STAT), and phosphatase and tensin homolog (PTEN).  Pull-down studies then further validated a subset of the putative targets.  In addn., we now show for the first time that the mammalian target of rapamycin (mTOR) is a direct target of CDDO-Im.  We also show that CDDO-Im blocks insulin-induced activation of this pathway by binding to mTOR and inhibiting its kinase activity.  Our basic studies confirm that the SO, CDDO-Im, acts on a protein network to elicit its pharmacol. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3xaGX_jtP5rVg90H21EOLACvtfcHk0lhkCAgzlOpc0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOrsbfI&md5=6a92c2cdd3bfa0720a8b80f0f48fd5e7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0022862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0022862%26sid%3Dliteratum%253Aachs%26aulast%3DYore%26aufirst%3DM.%2BM.%26aulast%3DKettenbach%26aufirst%3DA.%2BN.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26atitle%3DProteomic%2520Analysis%2520Shows%2520Synthetic%2520Oleanane%2520Triterpenoid%2520Binds%2520to%2520Mtor%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De22862%26doi%3D10.1371%2Fjournal.pone.0022862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henzl, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beamer, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Structure of the Keap1:Nrf2 Interface Provides Mechanistic Insight into Nrf2 Signaling</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3605</span>â <span class="NLM_lpage">3617</span>, <span class="refDoi">Â DOI: 10.1038/sj.emboj.7601243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1038%2Fsj.emboj.7601243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=16888629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVGlsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=3605-3617&author=S.+C.+Loauthor=X.+Liauthor=M.+T.+Henzlauthor=L.+J.+Beamerauthor=M.+Hannink&title=Structure+of+the+Keap1%3ANrf2+Interface+Provides+Mechanistic+Insight+into+Nrf2+Signaling&doi=10.1038%2Fsj.emboj.7601243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling</span></div><div class="casAuthors">Lo, Shih-Ching; Li, Xuchu; Henzl, Michael T.; Beamer, Lesa J.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3605-3617</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Keap1 is a BTB-Kelch substrate adaptor protein that regulates steady-state levels of Nrf2, a bZIP transcription factor, in response to oxidative stress.  We have detd. the structure of the Kelch domain of Keap1 bound to a 16-mer peptide from Nrf2 contg. a highly conserved DxETGE motif.  The Nrf2 peptide contains two short antiparallel Î²-strands connected by two overlapping type I Î²-turns stabilized by the aspartate and threonine residues.  The Î²-turn region fits into a binding pocket on the top face of the Kelch domain and the glutamate residues form multiple hydrogen bonds with highly conserved residues in Keap1.  Mutagenesis expts. confirmed the role of individual amino acids for binding of Nrf2 to Keap1 and for Keap1-mediated repression of Nrf2-dependent gene expression.  Our results provide a detailed picture of how a BTB-Kelch substrate adaptor protein binds to its cognate substrate and will enable the rational design of novel chemopreventive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqJXSF9pJFdLVg90H21EOLACvtfcHk0lgzDJ934HZlCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVGlsLo%253D&md5=df96ad6cb82632192d5d693ea87c85ad</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601243%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DS.%2BC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHenzl%26aufirst%3DM.%2BT.%26aulast%3DBeamer%26aufirst%3DL.%2BJ.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520Keap1%253ANrf2%2520Interface%2520Provides%2520Mechanistic%2520Insight%2520into%2520Nrf2%2520Signaling%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D3605%26epage%3D3617%26doi%3D10.1038%2Fsj.emboj.7601243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusunoki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 Recruits Neh2 through Binding to Etge and Dlg Motifs: Characterization of the Two-Site Molecular Recognition Model</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2887</span>â <span class="NLM_lpage">2900</span>, <span class="refDoi">Â DOI: 10.1128/MCB.26.8.2887-2900.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.26.8.2887-2900.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=16581765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1Slsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2887-2900&author=K.+I.+Tongauthor=Y.+Katohauthor=H.+Kusunokiauthor=K.+Itohauthor=T.+Tanakaauthor=M.+Yamamoto&title=Keap1+Recruits+Neh2+through+Binding+to+Etge+and+Dlg+Motifs%3A+Characterization+of+the+Two-Site+Molecular+Recognition+Model&doi=10.1128%2FMCB.26.8.2887-2900.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model</span></div><div class="casAuthors">Tong, Kit I.; Katoh, Yasutake; Kusunoki, Hideki; Itoh, Ken; Tanaka, Toshiyuki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2887-2900</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The expression of the phase 2 detoxification enzymes and antioxidant proteins is induced at the transcriptional level by Nrf2 and neg. regulated at the posttranslational level by Keap1 through protein-protein interactions with Nrf2 and subsequent proteolysis of Nrf2.  We found that the Neh2 domain of Nrf2 is an intrinsically disordered but biol. active regulatory domain contg. a 33-residue central Î±-helix followed by a mini antiparallel Î²-sheet.  Isothermal calorimetry anal. indicated that one Neh2 mol. interacts with two mols. of Keap1 via two binding sites, the stronger binding ETGE motif and the weaker binding DLG motif.  NMR titrn. study showed that these two motifs of the Neh2 domain bind to an overlapping site on the bottom surface of the Î²-propeller structure of Keap1.  In contrast, the central Î±-helix of the Neh2 domain does not have any observable affinity to Keap1, suggesting that this region may serve as a bridge connecting the two motifs for the assocn. with the two Î²-propeller structures of a dimer of Keap1.  Based on these observations, we propose that Keap1 recruits Nrf2 by the ETGE motif and that the DLG motif of the Neh2 domain locks its lysine-rich central Î±-helix in a correct position to benefit ubiquitin (Ub) signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW4AlViBIZg7Vg90H21EOLACvtfcHk0lgzDJ934HZlCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1Slsbw%253D&md5=f6a5af3be5757cd665f234562d48d727</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.8.2887-2900.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.8.2887-2900.2006%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DKusunoki%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKeap1%2520Recruits%2520Neh2%2520through%2520Binding%2520to%2520Etge%2520and%2520Dlg%2520Motifs%253A%2520Characterization%2520of%2520the%2520Two-Site%2520Molecular%2520Recognition%2520Model%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D2887%26epage%3D2900%26doi%3D10.1128%2FMCB.26.8.2887-2900.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">The Molecular Mechanisms Regulating the Keap1-Nrf2 Pathway</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">40</span>, <span class="refDoi">Â DOI: 10.1128/MCB.00099-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.00099-20" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&pages=40&author=L.+Bairdauthor=M.+Yamamoto&title=The+Molecular+Mechanisms+Regulating+the+Keap1-Nrf2+Pathway&doi=10.1128%2FMCB.00099-20"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FMCB.00099-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00099-20%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DThe%2520Molecular%2520Mechanisms%2520Regulating%2520the%2520Keap1-Nrf2%2520Pathway%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2020%26volume%3D40%26spage%3D40%26doi%3D10.1128%2FMCB.00099-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kansanen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuosmanen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leinonen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levonen, A. L.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2 Pathway: Mechanisms of Activation and Dysregulation in Cancer</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">45</span>â <span class="NLM_lpage">49</span>, <span class="refDoi">Â DOI: 10.1016/j.redox.2012.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.redox.2012.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=24024136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptFygsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=45-49&author=E.+Kansanenauthor=S.+M.+Kuosmanenauthor=H.+Leinonenauthor=A.+L.+Levonen&title=The+Keap1-Nrf2+Pathway%3A+Mechanisms+of+Activation+and+Dysregulation+in+Cancer&doi=10.1016%2Fj.redox.2012.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer</span></div><div class="casAuthors">Kansanen, Emilia; Kuosmanen, Suvi M.; Leinonen, Hanna; Levonen, Anna-Liisa</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-49</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Keap1-Nrf2 pathway is the major regulator of cytoprotective responses to oxidative and electrophilic stress.  Although cell signaling pathways triggered by the transcription factor Nrf2 prevent cancer initiation and progression in normal and premalignant tissues, in fully malignant cells Nrf2 activity provides growth advantage by increasing cancer chemoresistance and enhancing tumor cell growth.  In this graphical review, the authors provide an overview of the Keap1-Nrf2 pathway and its dysregulation in cancer cells.  The authors also briefly summarize the consequences of constitutive Nrf2 activation in cancer cells and how this can be exploited in cancer gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPdrFwzuAqVLVg90H21EOLACvtfcHk0lgzDJ934HZlCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptFygsw%253D%253D&md5=e931d639dcb8cd2ec722c6aebaade4b2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2012.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2012.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DKansanen%26aufirst%3DE.%26aulast%3DKuosmanen%26aufirst%3DS.%2BM.%26aulast%3DLeinonen%26aufirst%3DH.%26aulast%3DLevonen%26aufirst%3DA.%2BL.%26atitle%3DThe%2520Keap1-Nrf2%2520Pathway%253A%2520Mechanisms%2520of%2520Activation%2520and%2520Dysregulation%2520in%2520Cancer%26jtitle%3DRedox%2520Biol.%26date%3D2013%26volume%3D1%26spage%3D45%26epage%3D49%26doi%3D10.1016%2Fj.redox.2012.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tickle, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweitzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span> <span> </span><span class="NLM_article-title">Structure of the Btb Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist Cddo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e98896</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0098896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1371%2Fjournal.pone.0098896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=24896564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWlsr7I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e98896&author=A.+Cleasbyauthor=J.+Yonauthor=P.+J.+Dayauthor=C.+Richardsonauthor=I.+J.+Tickleauthor=P.+A.+Williamsauthor=J.+F.+Callahanauthor=R.+Carrauthor=N.+Conchaauthor=J.+K.+Kernsauthor=H.+Qiauthor=T.+Sweitzerauthor=P.+Wardauthor=T.+G.+Davies&title=Structure+of+the+Btb+Domain+of+Keap1+and+Its+Interaction+with+the+Triterpenoid+Antagonist+Cddo&doi=10.1371%2Fjournal.pone.0098896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO</span></div><div class="casAuthors">Cleasby, Anne; Yon, Jeff; Day, Philip J.; Richardson, Caroline; Tickle, Ian J.; Williams, Pamela A.; Callahan, James F.; Carr, Robin; Concha, Nestor; Kerns, Jeffrey K.; Qi, Hongwei; Sweitzer, Thomas; Ward, Paris; Davies, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e98896/1-e98896/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">A review.  The protein Keap1 is central to the regulation of the Nrf2-mediated cytoprotective response, and is increasingly recognized as an important target for therapeutic intervention in a range of diseases involving excessive oxidative stress and inflammation.  The BTB domain of Keap1 plays key roles in sensing environmental electrophiles and in mediating interactions with the Cul3/Rbx1 E3 ubiquitin ligase system, and is believed to be the target for several small mol. covalent activators of the Nrf2 pathway.  However, despite structural information being available for several BTB domains from related proteins, there have been no reported crystal structures of Keap1 BTB, and this has precluded a detailed understanding of its mechanism of action and interaction with antagonists.  We report here the first structure of the BTB domain of Keap1, which is thought to contain the key cysteine residue responsible for interaction with electrophiles, as well as structures of the covalent complex with the antagonist CDDO/bardoxolone, and of the constitutively inactive C151W BTB mutant.  In addn. to providing the first structural confirmation of antagonist binding to Keap1 BTB, we also present biochem. evidence that adduction of Cys 151 by CDDO is capable of inhibiting the binding of Cul3 to Keap1, and discuss how this class of compd. might exert Nrf2 activation through disruption of the BTB-Cul3 interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe-yi4jSWD-bVg90H21EOLACvtfcHk0ljgCSBNmQSOMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWlsr7I&md5=f9c6542ff2508a74313e996ccdafa0ae</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0098896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0098896%26sid%3Dliteratum%253Aachs%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DYon%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DConcha%26aufirst%3DN.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSweitzer%26aufirst%3DT.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26atitle%3DStructure%2520of%2520the%2520Btb%2520Domain%2520of%2520Keap1%2520and%2520Its%2520Interaction%2520with%2520the%2520Triterpenoid%2520Antagonist%2520Cddo%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De98896%26doi%3D10.1371%2Fjournal.pone.0098896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">To, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringelberg, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Royce, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risingsong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span> <span> </span><span class="NLM_article-title">Dimethyl Fumarate and the Oleanane Triterpenoids, Cddo-Imidazolide and Cddo-Methyl Ester, Both Activate the Nrf2 Pathway but Have Opposite Effects in the a/J Model of Lung Carcinogenesis</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">769</span>â <span class="NLM_lpage">781</span>, <span class="refDoi">Â DOI: 10.1093/carcin/bgv061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1093%2Fcarcin%2Fbgv061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=25939751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1CisLrE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=769-781&author=C.+Toauthor=C.+S.+Ringelbergauthor=D.+B.+Royceauthor=C.+R.+Williamsauthor=R.+Risingsongauthor=M.+B.+Spornauthor=K.+T.+Liby&title=Dimethyl+Fumarate+and+the+Oleanane+Triterpenoids%2C+Cddo-Imidazolide+and+Cddo-Methyl+Ester%2C+Both+Activate+the+Nrf2+Pathway+but+Have+Opposite+Effects+in+the+a%2FJ+Model+of+Lung+Carcinogenesis&doi=10.1093%2Fcarcin%2Fbgv061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis</span></div><div class="casAuthors">To, Ciric; Ringelberg, Carol S.; Royce, Darlene B.; Williams, Charlotte R.; Risingsong, Renee; Sporn, Michael B.; Liby, Karen T.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">769-781</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Lung cancer accounts for the highest no. of cancer-related deaths in the USA, highlighting the need for better prevention and therapy.  Activation of the Nrf2 pathway detoxifies harmful insults and reduces oxidative stress, thus preventing carcinogenesis in various preclin. models.  However, constitutive activation of the Nrf2 pathway has been detected in numerous cancers, which confers a survival advantage to tumor cells and a poor prognosis.  In our study, we compared the effects of two clin. relevant classes of Nrf2 activators, di-Me fumarate (DMF) and the synthetic oleanane triterpenoids, CDDO-imidazolide (CDDO-Im) and CDDO-Me ester (CDDO-Me) in RAW 264.7 mouse macrophage-like cells, in VC1 lung cancer cells and in the A/J model of lung cancer.  Although the triterpenoids and DMF both activated the Nrf2 pathway, CDDO-Im and CDDO-Me were markedly more potent than DMF.  All of these drugs reduced the prodn. of reactive oxygen species and inhibited nitric oxide prodn. in RAW264.7 cells, but the triterpenoids were 100 times more potent than DMF in these assays.  Microarray anal. revealed that only 52 of 99 Nrf2-target genes were induced by all three compds., and each drug regulated a unique subset of Nrf2 genes.  These drugs also altered the expression of other genes important in lung cancer independent of Nrf2.  Although all three compds. enhanced the phosphorylation of CREB, only DMF increased the phosphorylation of Akt.  CDDO-Me, at either 12.5 or 50mg/kg of diet, was the most effective drug in our lung cancer mouse model.  Specifically, CDDO-Me significantly reduced the av. tumor no., size and burden compared with the control group (P < 0.05).  Addnl., 52% of the tumors in the control group were high-grade tumors compared with only 14% in the CDDO-Me group.  Though less potent, CDDO-Im had similar activity as CDDO-Me.  In contrast, 61-63% of the tumors in the DMF groups (400-1200mg/kg diet) were high-grade tumors compared with 52% for the controls (P < 0.05).  Addnl., DMF significantly increased the av. no. of tumors compared with the controls (P < 0.05).  Thus, in contrast to the triterpenoids, which effectively reduced pathogenesis in A/J mice, DMF enhanced the severity of lung carcinogenesis in these mice.  Collectively, these results suggest that although CDDO-Im, CDDO-Me and DMF all activate the Nrf2 pathway, they target distinct genes and signaling pathways, resulting in opposite effects for the prevention of exptl. lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzAA91PVPWMrVg90H21EOLACvtfcHk0ljgCSBNmQSOMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1CisLrE&md5=493b4318c713bc3a0f07a0ee917544ae</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgv061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgv061%26sid%3Dliteratum%253Aachs%26aulast%3DTo%26aufirst%3DC.%26aulast%3DRingelberg%26aufirst%3DC.%2BS.%26aulast%3DRoyce%26aufirst%3DD.%2BB.%26aulast%3DWilliams%26aufirst%3DC.%2BR.%26aulast%3DRisingsong%26aufirst%3DR.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26atitle%3DDimethyl%2520Fumarate%2520and%2520the%2520Oleanane%2520Triterpenoids%252C%2520Cddo-Imidazolide%2520and%2520Cddo-Methyl%2520Ester%252C%2520Both%2520Activate%2520the%2520Nrf2%2520Pathway%2520but%2520Have%2520Opposite%2520Effects%2520in%2520the%2520a%252FJ%2520Model%2520of%2520Lung%2520Carcinogenesis%26jtitle%3DCarcinogenesis%26date%3D2015%26volume%3D36%26spage%3D769%26epage%3D781%26doi%3D10.1093%2Fcarcin%2Fbgv061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yates, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuoka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanders, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilarte, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span> <span> </span><span class="NLM_article-title">Pharmacodynamic Characterization of Chemopreventive Triterpenoids as Exceptionally Potent Inducers of Nrf2-Regulated Genes</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">154</span>â <span class="NLM_lpage">162</span>, <span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-06-0516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1158%2F1535-7163.MCT-06-0516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=17237276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsVamsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=154-162&author=M.+S.+Yatesauthor=M.+Tauchiauthor=F.+Katsuokaauthor=K.+C.+Flandersauthor=K.+T.+Libyauthor=T.+Hondaauthor=G.+W.+Gribbleauthor=D.+A.+Johnsonauthor=J.+A.+Johnsonauthor=N.+C.+Burtonauthor=T.+R.+Guilarteauthor=M.+Yamamotoauthor=M.+B.+Spornauthor=T.+W.+Kensler&title=Pharmacodynamic+Characterization+of+Chemopreventive+Triterpenoids+as+Exceptionally+Potent+Inducers+of+Nrf2-Regulated+Genes&doi=10.1158%2F1535-7163.MCT-06-0516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes</span></div><div class="casAuthors">Yates, Melinda S.; Tauchi, Masafumi; Katsuoka, Fumiki; Flanders, Kathleen C.; Liby, Karen T.; Honda, Tadashi; Gribble, Gordon W.; Johnson, Delinda A.; Johnson, Jeffrey A.; Burton, Neal C.; Guilarte, Tomas R.; Yamamoto, Masayuki; Sporn, Michael B.; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">154-162</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Synthetic triterpenoids have been developed, which are potent inducers of cytoprotective enzymes and inhibitors of inflammation, greatly improving on the weak activity of naturally occurring triterpenoids.  An imidazolide triterpenoid deriv., 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im or TP235), has been previously shown to potently protect against hepatic tumorigenesis, acting in part by inducing cytoprotective genes through Keap1-Nrf2-antioxidant response element (ARE) signaling.  In these studies, the pharmacodynamic activity of CDDO-Im is characterized in two distinct lines of ARE reporter mice and by measuring increases in Nqo1 transcript levels as a marker of cytoprotective gene induction.  Oral administration of CDDO-Im induces ARE-regulated cytoprotective genes in many tissues in the mouse, including liver, lung, kidney, intestines, brain, heart, thymus, and salivary gland.  CDDO-Im induces Nqo1 RNA transcripts in some organs at doses as low as 0.3 Î¼mol/kg body wt. (orally).  A structure activity evaluation of 15 addnl. triterpenoids (a) confirmed the importance of Michael acceptor groups on both the A and C rings, (b) showed the requirement for a nitrile group at C-2 of the A ring, and (c) indicated that substituents at C-17 dramatically affected pharmacodynamic action in vivo.  In addn. to CDDO-Im, other triterpenoids, particularly the Me ester CDDO-Me (TP155) and the dinitrile TP225, are extremely potent inducers of cytoprotective genes in mouse liver, lung, small intestine mucosa, and cerebral cortex.  This pharmacodynamic characterization highlights the chemopreventive promise of several synthetic triterpenoids in multiple target organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrafkEmJHmo6bVg90H21EOLACvtfcHk0ljgCSBNmQSOMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsVamsA%253D%253D&md5=72549a374c43397abf4fad22dede6a82</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0516%26sid%3Dliteratum%253Aachs%26aulast%3DYates%26aufirst%3DM.%2BS.%26aulast%3DTauchi%26aufirst%3DM.%26aulast%3DKatsuoka%26aufirst%3DF.%26aulast%3DFlanders%26aufirst%3DK.%2BC.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DJohnson%26aufirst%3DD.%2BA.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26aulast%3DBurton%26aufirst%3DN.%2BC.%26aulast%3DGuilarte%26aufirst%3DT.%2BR.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26atitle%3DPharmacodynamic%2520Characterization%2520of%2520Chemopreventive%2520Triterpenoids%2520as%2520Exceptionally%2520Potent%2520Inducers%2520of%2520Nrf2-Regulated%2520Genes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D154%26epage%3D162%26doi%3D10.1158%2F1535-7163.MCT-06-0516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Signaling Pathway: Pivotal Roles in Inflammation</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">585</span>â <span class="NLM_lpage">597</span>, <span class="refDoi">Â DOI: 10.1016/j.bbadis.2016.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.bbadis.2016.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=27825853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVahtLrE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2017&pages=585-597&author=S.+M.+Ahmedauthor=L.+Luoauthor=A.+Namaniauthor=X.+J.+Wangauthor=X.+Tang&title=Nrf2+Signaling+Pathway%3A+Pivotal+Roles+in+Inflammation&doi=10.1016%2Fj.bbadis.2016.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 signaling pathway: Pivotal roles in inflammation</span></div><div class="casAuthors">Ahmed, Syed Minhaj Uddin; Luo, Lin; Namani, Akhileshwar; Wang, Xiu Jun; Tang, Xiuwen</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">585-597</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Inflammation is the most common feature of many chronic diseases and complications, while playing crit. roles in carcinogenesis.  Several studies have demonstrated that Nrf2 contributes to the anti-inflammatory process by orchestrating the recruitment of inflammatory cells and regulating gene expression through the antioxidant response element (ARE).  The Keap1 (Kelch-like ECH-assocd. protein)/Nrf2 (NF-E2 p45-related factor 2)/ARE signaling pathway mainly regulates anti-inflammatory gene expression and inhibits the progression of inflammation.  Therefore, the identification of new Nrf2-dependent anti-inflammatory phytochems. has become a key point in drug discovery.  In this review, the authors discuss the members of the Keap1/Nrf2/ARE signal pathway and its downstream genes, the effects of this pathway on animal models of inflammatory diseases, and crosstalk with the NF-ÎºB pathway.  In addn. the authors also discuss about the regulation of NLRP3 inflammasome by Nrf2.  Besides this, the authors summarize the current scenario of the development of anti-inflammatory phytochems. and others that mediate the Nrf2/ARE signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmDI6VHTdR9bVg90H21EOLACvtfcHk0liDXSjwX2W8hA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVahtLrE&md5=ddd05f60f85531bcee5892695c133433</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2016.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2016.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%2BM.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DNamani%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DNrf2%2520Signaling%2520Pathway%253A%2520Pivotal%2520Roles%2520in%2520Inflammation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2017%26volume%3D1863%26spage%3D585%26epage%3D597%26doi%3D10.1016%2Fj.bbadis.2016.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funayama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Suppresses Macrophage Inflammatory Response by Blocking Proinflammatory Cytokine Transcription</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11624</span>, <span class="refDoi">Â DOI: 10.1038/ncomms11624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1038%2Fncomms11624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=27211851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos12ms7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11624&author=E.+H.+Kobayashiauthor=T.+Suzukiauthor=R.+Funayamaauthor=T.+Nagashimaauthor=M.+Hayashiauthor=H.+Sekineauthor=N.+Tanakaauthor=T.+Moriguchiauthor=H.+Motohashiauthor=K.+Nakayamaauthor=M.+Yamamoto&title=Nrf2+Suppresses+Macrophage+Inflammatory+Response+by+Blocking+Proinflammatory+Cytokine+Transcription&doi=10.1038%2Fncomms11624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription</span></div><div class="casAuthors">Kobayashi, Eri H.; Suzuki, Takafumi; Funayama, Ryo; Nagashima, Takeshi; Hayashi, Makiko; Sekine, Hiroki; Tanaka, Nobuyuki; Moriguchi, Takashi; Motohashi, Hozumi; Nakayama, Keiko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11624</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nrf2 (NF-E2-related factor-2) transcription factor regulates oxidative/xenobiotic stress response and also represses inflammation.  However, the mechanisms how Nrf2 alleviates inflammation are still unclear.  Here, we demonstrate that Nrf2 interferes with lipopolysaccharide-induced transcriptional upregulation of proinflammatory cytokines, including IL-6 and IL-1Î².  Chromatin immunopptn. (ChIP)-seq and ChIP-qPCR analyses revealed that Nrf2 binds to the proximity of these genes in macrophages and inhibits RNA Pol II recruitment.  Further, we found that Nrf2-mediated inhibition is independent of the Nrf2-binding motif and reactive oxygen species level.  Murine inflammatory models further demonstrated that Nrf2 interferes with IL6 induction and inflammatory phenotypes in vivo.  Thus, contrary to the widely accepted view that Nrf2 suppresses inflammation through redox control, we demonstrate here that Nrf2 opposes transcriptional upregulation of proinflammatory cytokine genes.  This study identifies Nrf2 as the upstream regulator of cytokine prodn. and establishes a mol. basis for an Nrf2-mediated anti-inflammation approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNH2n5UpCBKLVg90H21EOLACvtfcHk0liDXSjwX2W8hA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos12ms7w%253D&md5=95c2aebdf50ed1e8dbbdf983ff50b300</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fncomms11624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11624%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DE.%2BH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DFunayama%26aufirst%3DR.%26aulast%3DNagashima%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DSekine%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DMoriguchi%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DNrf2%2520Suppresses%2520Macrophage%2520Inflammatory%2520Response%2520by%2520Blocking%2520Proinflammatory%2520Cytokine%2520Transcription%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11624%26doi%3D10.1038%2Fncomms11624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yore, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Place, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risingsong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Royce, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill-Kapturczak, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span> <span> </span><span class="NLM_article-title">The Synthetic Triterpenoids, Cddo and Cddo-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/Are Signaling</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">4789</span>â <span class="NLM_lpage">4798</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-04-4539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1158%2F0008-5472.CAN-04-4539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=15930299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ohurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=4789-4798&author=K.+Libyauthor=T.+Hockauthor=M.+M.+Yoreauthor=N.+Suhauthor=A.+E.+Placeauthor=R.+Risingsongauthor=C.+R.+Williamsauthor=D.+B.+Royceauthor=T.+Hondaauthor=Y.+Hondaauthor=G.+W.+Gribbleauthor=N.+Hill-Kapturczakauthor=A.+Agarwalauthor=M.+B.+Sporn&title=The+Synthetic+Triterpenoids%2C+Cddo+and+Cddo-Imidazolide%2C+Are+Potent+Inducers+of+Heme+Oxygenase-1+and+Nrf2%2FAre+Signaling&doi=10.1158%2F0008-5472.CAN-04-4539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling</span></div><div class="casAuthors">Liby, Karen; Hock, Thomas; Yore, Mark M.; Suh, Nanjoo; Place, Andrew E.; Risingsong, Renee; Williams, Charlotte R.; Royce, Darlene B.; Honda, Tadashi; Honda, Yukiko; Gribble, Gordon W.; Hill-Kapturczak, Nathalie; Agarwal, Anupam; Sporn, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4789-4798</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO) and its deriv. 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im) are multifunctional mols. with potent antiproliferative, differentiating, and anti-inflammatory activities.  At nanomolar concns., these agents rapidly increase the expression of the cytoprotective heme oxygenase-1 (HO-1) enzyme in vitro and in vivo.  Transfection studies using a series of reporter constructs show that activation of the human HO-1 promoter by the triterpenoids requires an antioxidant response element (ARE), a cAMP response element, and an E Box sequence.  Inactivation of one of these response elements alone partially reduces HO-1 induction, but mutations in all three sequences entirely eliminate promoter activity in response to the triterpenoids.  Treatment with CDDO-Im also elevates protein levels of Nrf2, a transcription factor previously shown to bind ARE sequences, and increases expression of a no. of antioxidant and detoxification genes regulated by Nrf2.  The triterpenoids also reduce the formation of reactive oxygen species in cells challenged with tert-Bu hydroperoxide, but this cytoprotective activity is absent in Nrf2 deficient cells.  These studies are the first to investigate the induction of the HO-1 and Nrf2/ARE pathways by CDDO and CDDO-Im, and our results suggest that further in vivo studies are needed to explore the chemopreventive and chemotherapeutic potential of the triterpenoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFgeOrJsI-TLVg90H21EOLACvtfcHk0liDXSjwX2W8hA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ohurs%253D&md5=e5d0a67228df4cb8541bb8e3a3d21b4b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-4539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-4539%26sid%3Dliteratum%253Aachs%26aulast%3DLiby%26aufirst%3DK.%26aulast%3DHock%26aufirst%3DT.%26aulast%3DYore%26aufirst%3DM.%2BM.%26aulast%3DSuh%26aufirst%3DN.%26aulast%3DPlace%26aufirst%3DA.%2BE.%26aulast%3DRisingsong%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DC.%2BR.%26aulast%3DRoyce%26aufirst%3DD.%2BB.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DHonda%26aufirst%3DY.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DHill-Kapturczak%26aufirst%3DN.%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26atitle%3DThe%2520Synthetic%2520Triterpenoids%252C%2520Cddo%2520and%2520Cddo-Imidazolide%252C%2520Are%2520Potent%2520Inducers%2520of%2520Heme%2520Oxygenase-1%2520and%2520Nrf2%252FAre%2520Signaling%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D4789%26epage%3D4798%26doi%3D10.1158%2F0008-5472.CAN-04-4539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J. X.</span></span> <span> </span><span class="NLM_article-title">Structure of Serum Albumin</span>. <i>Adv. Protein Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">153</span>â <span class="NLM_lpage">203</span>, <span class="refDoi">Â DOI: 10.1016/S0065-3233(08)60640-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2FS0065-3233%2808%2960640-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=8154369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADyaK2cXltVajtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=153-203&author=D.+C.+Carterauthor=J.+X.+Ho&title=Structure+of+Serum+Albumin&doi=10.1016%2FS0065-3233%2808%2960640-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of serum albumin</span></div><div class="casAuthors">Carter, Daniel C.; Ho, Joseph X.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Protein Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">LIPOPROTEINS,APOLIPOPROTEINS, AND LIPASES</span>),
    <span class="NLM_cas:pages">153-203</span>CODEN:
                <span class="NLM_cas:coden">APCHA2</span>;
        ISSN:<span class="NLM_cas:issn">0065-3233</span>.
    </div><div class="casAbstract">A review, with 251 refs.  Topics discussed include the primary and 3-dimensional structure of albumin, the nature of ligand binding, and the evolution of albumin structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOuH2hDzVTp7Vg90H21EOLACvtfcHk0lg2xiYOVhNr0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltVajtLk%253D&md5=52abdfdaaedb35bb307ebf001ec50d8a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0065-3233%2808%2960640-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-3233%252808%252960640-3%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DD.%2BC.%26aulast%3DHo%26aufirst%3DJ.%2BX.%26atitle%3DStructure%2520of%2520Serum%2520Albumin%26jtitle%3DAdv.%2520Protein%2520Chem.%26date%3D1994%26volume%3D45%26spage%3D153%26epage%3D203%26doi%3D10.1016%2FS0065-3233%2808%2960640-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachulski, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naisbitt, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirmohamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Direct Evidence for the Formation of Diastereoisomeric Benzylpenicilloyl Haptens from Benzylpenicillin and Benzylpenicillenic Acid in Patients</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">841</span>â <span class="NLM_lpage">849</span>, <span class="refDoi">Â DOI: 10.1124/jpet.111.183871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1124%2Fjpet.111.183871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=21680886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaktLjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=841-849&author=X.+Mengauthor=R.+E.+Jenkinsauthor=N.+G.+Berryauthor=J.+L.+Maggsauthor=J.+Farrellauthor=C.+S.+Laneauthor=A.+V.+Stachulskiauthor=N.+S.+Frenchauthor=D.+J.+Naisbittauthor=M.+Pirmohamedauthor=B.+K.+Park&title=Direct+Evidence+for+the+Formation+of+Diastereoisomeric+Benzylpenicilloyl+Haptens+from+Benzylpenicillin+and+Benzylpenicillenic+Acid+in+Patients&doi=10.1124%2Fjpet.111.183871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patients</span></div><div class="casAuthors">Meng, Xiaoli; Jenkins, Rosalind E.; Berry, Neil G.; Maggs, James L.; Farrell, John; Lane, Catherine S.; Stachulski, Andrew V.; French, Neil S.; Naisbitt, Dean J.; Pirmohamed, Munir; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">841-849</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Covalent binding to proteins to form neoantigens is thought to be central to the pathogenesis of penicillin hypersensitivity reactions.  We have undertaken detailed mass spectrometric studies to define the mechanism and protein chem. of hapten formation from benzylpenicillin (BP) and its rearrangement product, benzylpenicillenic acid (PA).  Mass spectrometric anal. of human serum albumin exposed to BP and PA in vitro revealed that at low concns. (drug protein molar ratio 0.001:1) and during short time incubations BP and PA selectively target different residues, Lys199 and Lys525, resp.  Mol. modeling showed that the selectivity was a function of noncovalent interaction before covalent modification.  With increased exposure to higher concns. of BP and PA, multiple epitopes were detected on albumin, demonstrating that the multiplicity of hapten formation is a function of time and concn.  More importantly, we have demonstrated direct evidence that PA is a hapten accounting for the diastereoisomeric BP antigen formation in albumin isolated from the blood of patients receiving penicillin.  Furthermore, PA was found to be more potent than BP with respect to stimulation of T cells from patients with penicillin hypersensitivity, illustrating the functional relevance of diastereoisomeric hapten formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1x5SvZNBZa7Vg90H21EOLACvtfcHk0lg2xiYOVhNr0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaktLjJ&md5=e542f914e55c48d4562e9d6e4aa4fe37</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.183871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.183871%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DBerry%26aufirst%3DN.%2BG.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DFarrell%26aufirst%3DJ.%26aulast%3DLane%26aufirst%3DC.%2BS.%26aulast%3DStachulski%26aufirst%3DA.%2BV.%26aulast%3DFrench%26aufirst%3DN.%2BS.%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DDirect%2520Evidence%2520for%2520the%2520Formation%2520of%2520Diastereoisomeric%2520Benzylpenicilloyl%2520Haptens%2520from%2520Benzylpenicillin%2520and%2520Benzylpenicillenic%2520Acid%2520in%2520Patients%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D338%26spage%3D841%26epage%3D849%26doi%3D10.1124%2Fjpet.111.183871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrenson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Back, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naisbitt, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Abacavir Forms Novel Cross-Linking Abacavir Protein Adducts in Patients</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">524</span>â <span class="NLM_lpage">535</span>, <span class="refDoi">Â DOI: 10.1021/tx400406p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx400406p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1ejsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=524-535&author=X.+Mengauthor=A.+S.+Lawrensonauthor=N.+G.+Berryauthor=J.+L.+Maggsauthor=N.+S.+Frenchauthor=D.+J.+Backauthor=S.+H.+Khooauthor=D.+J.+Naisbittauthor=B.+K.+Park&title=Abacavir+Forms+Novel+Cross-Linking+Abacavir+Protein+Adducts+in+Patients&doi=10.1021%2Ftx400406p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Abacavir Forms Novel Cross-Linking Abacavir Protein Adducts in Patients</span></div><div class="casAuthors">Meng, Xiaoli; Lawrenson, Alexandre S.; Berry, Neil G.; Maggs, James L.; French, Neil S.; Back, David J.; Khoo, Saye H.; Naisbitt, Dean J.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">524-535</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Abacavir (ABC), a nucleoside-analog reverse transcriptase inhibitor, is assocd. with severe hypersensitivity reactions that are thought to involve the activation of CD8+ T cells in a HLA-B*57:01-restricted manner.  Recent studies have claimed that noncovalent interactions of ABC with HLA-B*57:01 are responsible for the immunol. reactions assocd. with ABC.  However, the formation of Hb-ABC aldehyde (ABCA) adducts in patients exposed to ABC suggests that protein conjugation might represent a pathway for antigen formation.  To further characterize protein conjugation reactions, we used mass spectrometric methods to define ABCA modifications in patients receiving ABC therapy.  ABCA formed a novel intramol. crosslinking adduct on human serum albumin (HSA) in patients and in vitro via Michael addn., followed by nucleophilic adduction of the aldehyde with a neighboring protein nucleophile.  Adducts were detected on Lys159, Lys190, His146, and Cys34 residues in the subdomain IB of HSA.  Only a cysteine adduct and a putative crosslinking adduct were detected on glutathione S-transferase Pi (GSTP).  These findings reveal that ABC forms novel types of antigens in all patients taking the drug.  It is therefore vital that the immunol. consequences of such pathways of haptenation are explored in the in vitro models that have been used by various groups to define new mechanisms of drug hypersensitivity exemplified by ABC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJinX4CqOIR7Vg90H21EOLACvtfcHk0lg2xiYOVhNr0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1ejsLk%253D&md5=d1b462af1d3b643b8e6522ed3ae92a0e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Ftx400406p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx400406p%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DLawrenson%26aufirst%3DA.%2BS.%26aulast%3DBerry%26aufirst%3DN.%2BG.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DFrench%26aufirst%3DN.%2BS.%26aulast%3DBack%26aufirst%3DD.%2BJ.%26aulast%3DKhoo%26aufirst%3DS.%2BH.%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DAbacavir%2520Forms%2520Novel%2520Cross-Linking%2520Abacavir%2520Protein%2520Adducts%2520in%2520Patients%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26spage%3D524%26epage%3D535%26doi%3D10.1021%2Ftx400406p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castelazo, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earnshaw, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aithal, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pande, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachulski, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span> <span> </span><span class="NLM_article-title">Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from a Drug Acyl Glucuronide Metabolite: Multiple Albumin Adductions in Diclofenac Patients</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">387</span>â <span class="NLM_lpage">402</span>, <span class="refDoi">Â DOI: 10.1124/jpet.114.215079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1124%2Fjpet.114.215079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=24902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Wqsb%252FK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2014&pages=387-402&author=T.+G.+Hammondauthor=X.+Mengauthor=R.+E.+Jenkinsauthor=J.+L.+Maggsauthor=A.+S.+Castelazoauthor=S.+L.+Reganauthor=S.+N.+Bennettauthor=C.+J.+Earnshawauthor=G.+P.+Aithalauthor=I.+Pandeauthor=J.+G.+Kennaauthor=A.+V.+Stachulskiauthor=B.+K.+Parkauthor=D.+P.+Williams&title=Mass+Spectrometric+Characterization+of+Circulating+Covalent+Protein+Adducts+Derived+from+a+Drug+Acyl+Glucuronide+Metabolite%3A+Multiple+Albumin+Adductions+in+Diclofenac+Patients&doi=10.1124%2Fjpet.114.215079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients</span></div><div class="casAuthors">Hammond, Thomas G.; Meng, Xiaoli; Jenkins, Rosalind E.; Maggs, James L.; Castelazo, Anahi Santoyo; Regan, Sophie L.; Bennett, Stuart N. L.; Earnshaw, Caroline J.; Aithal, Guruprasad P.; Pande, Ira; Kenna, J. Gerry; Stachulski, Andrew V.; Park, B. Kevin; Williams, Dominic P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">387-402, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Covalent protein modifications by electrophilic acyl glucuronide (AG) metabolites are hypothetical causes of hypersensitivity reactions assocd. with certain carboxylate drugs.  The complex rearrangements and reactivities of drug AG have been defined in great detail, and protein adducts of carboxylate drugs, such as diclofenac, have been found in liver and plasma of exptl. animals and humans.  However, in the absence of definitive mol. characterization, and specifically, identification of signature glycation conjugates retaining the glucuronyl and carboxyl residues, it cannot be assumed any of these adducts is derived uniquely or even fractionally from AG metabolites.  We have therefore undertaken targeted mass spectrometric analyses of human serum albumin (HSA) isolated from diclofenac patients to characterize drug-derived structures and, thereby, for the first time, have deconstructed conclusively the pathways of adduct formation from a drug AG and its isomeric rearrangement products in vivo.  These analyses were informed by a thorough understanding of the reactions of HSA with diclofenac AG in vitro.  HSA from six patients without drug-related hypersensitivities had either a single drug-derived adduct or one of five combinations of 2-8 adducts from among seven diclofenac N-acylations and three AG glycations on seven of the protein's 59 lysines.  Only acylations were found in every patient.  We present evidence that HSA modifications by diclofenac in vivo are complicated and variable, that at least a fraction of these modifications are derived from the drug's AG metabolite, and that albumin adduction is not inevitably a causation of hypersensitivity to carboxylate drugs or a coincidental assocn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJaMIu3mSolLVg90H21EOLACvtfcHk0ljpBQIkkOQsYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Wqsb%252FK&md5=4ea9902f538c70aa671bdb1df8149375</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.215079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.215079%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DCastelazo%26aufirst%3DA.%2BS.%26aulast%3DRegan%26aufirst%3DS.%2BL.%26aulast%3DBennett%26aufirst%3DS.%2BN.%26aulast%3DEarnshaw%26aufirst%3DC.%2BJ.%26aulast%3DAithal%26aufirst%3DG.%2BP.%26aulast%3DPande%26aufirst%3DI.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26aulast%3DStachulski%26aufirst%3DA.%2BV.%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26atitle%3DMass%2520Spectrometric%2520Characterization%2520of%2520Circulating%2520Covalent%2520Protein%2520Adducts%2520Derived%2520from%2520a%2520Drug%2520Acyl%2520Glucuronide%2520Metabolite%253A%2520Multiple%2520Albumin%2520Adductions%2520in%2520Diclofenac%2520Patients%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D350%26spage%3D387%26epage%3D402%26doi%3D10.1124%2Fjpet.114.215079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">8137</span>â <span class="NLM_lpage">8151</span>, <span class="refDoi">Â DOI: 10.1128/MCB.23.22.8137-8151.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.23.22.8137-8151.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=14585973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=8137-8151&author=D.+D.+Zhangauthor=M.+Hannink&title=Distinct+Cysteine+Residues+in+Keap1+Are+Required+for+Keap1-Dependent+Ubiquitination+of+Nrf2+and+for+Stabilization+of+Nrf2+by+Chemopreventive+Agents+and+Oxidative+Stress&doi=10.1128%2FMCB.23.22.8137-8151.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span></div><div class="casAuthors">Zhang, Donna D.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8137-8151</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A common feature of diverse chemopreventive agents is the ability to activate expression of a genetic program that protects cells from reactive chem. species that if left unchecked would cause mutagenic DNA damage.  The bZIP transcription factor Nrf2 has emerged as a key regulator of this cancer-preventive genetic program.  Nrf2 is normally sequestered in the cytoplasm by a protein known as Keap1.  Chemopreventive agents allow Nrf2 to escape from Keap1-mediated repression, although the mol. mechanism(s) responsible for activation of Nrf2 is not understood.  In this report, we demonstrate that Keap1 does not passively sequester Nrf2 in the cytoplasm but actively targets Nrf2 for ubiquitination and degrdn. by the proteasome under basal culture conditions.  We have identified two crit. cysteine residues in Keap1, C273 and C288, that are required for Keap1-dependent ubiquitination of Nrf2.  Both sulforaphane, a chemopreventive isothiocyanate, and oxidative stress enable Nrf2 to escape Keap1-dependent degrdn., leading to stabilization of Nrf2, increased nuclear localization of Nrf2, and activation of Nrf2-dependent cancer-protective genes.  We have identified a third cysteine residue in Keap1, C151, that is uniquely required for inhibition of Keap1-dependent degrdn. of Nrf2 by sulforaphane and oxidative stress.  This cysteine residue is also required for a novel posttranslational modification to Keap1 that is induced by oxidative stress.  We propose that Keap1 is a component of a novel E3 ubiquitin ligase complex that is specifically targeted for inhibition by both chemopreventive agents and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqys54qQ6MlRLVg90H21EOLACvtfcHk0ljpBQIkkOQsYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D&md5=9287849578d0a6b7a6d52b67e3c65190</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.22.8137-8151.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.22.8137-8151.2003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DDistinct%2520Cysteine%2520Residues%2520in%2520Keap1%2520Are%2520Required%2520for%2520Keap1-Dependent%2520Ubiquitination%2520of%2520Nrf2%2520and%2520for%2520Stabilization%2520of%2520Nrf2%2520by%2520Chemopreventive%2520Agents%2520and%2520Oxidative%2520Stress%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D8137%26epage%3D8151%26doi%3D10.1128%2FMCB.23.22.8137-8151.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eggler, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span> <span> </span><span class="NLM_article-title">Cul3-Mediated Nrf2 Ubiquitination and Antioxidant Response Element (Are) Activation Are Dependent on the Partial Molar Volume at Position 151 of Keap1</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>422</i></span>,  <span class="NLM_fpage">171</span>â <span class="NLM_lpage">180</span>, <span class="refDoi">Â DOI: 10.1042/BJ20090471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1042%2FBJ20090471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=19489739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGhs7fP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=422&publication_year=2009&pages=171-180&author=A.+L.+Egglerauthor=E.+Smallauthor=M.+Hanninkauthor=A.+D.+Mesecar&title=Cul3-Mediated+Nrf2+Ubiquitination+and+Antioxidant+Response+Element+%28Are%29+Activation+Are+Dependent+on+the+Partial+Molar+Volume+at+Position+151+of+Keap1&doi=10.1042%2FBJ20090471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1</span></div><div class="casAuthors">Eggler, Aimee L.; Small, Evan; Hannink, Mark; Mesecar, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">422</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-180</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Nrf2 (nuclear factor erythroid 2-related factor 2) is a transcription factor that activates transcription of a battery of cytoprotective genes by binding to the ARE (antioxidant response element).  Nrf2 is repressed by the cysteine-rich Keap1 (kelch-like ECH-assocd. protein 1) protein, which targets Nrf2 for ubiquitination and subsequent degrdn. by a Cul3 (cullin 3)-mediated ubiquitination complex.  We find that modification of Cys151 of human Keap1, by mutation to a tryptophan, relieves the repression by Keap1 and allows activation of the ARE by Nrf2.  The Keap1 C151W substitution has a decreased affinity for Cul3, and can no longer serve to target Nrf2 for ubiquitination, though it retains its affinity for Nrf2.  A series of 12 mutant Keap1 proteins, each contg. a different residue at position 151, was constructed to explore the chem. required for this effect.  The series reveals that the extent to which Keap1 loses the ability to target Nrf2 for degrdn., and hence the ability to repress ARE activation, correlates well with the partial molar volume of the residue.  Other physico-chem. properties do not appear to contribute significantly to the effect.  Based on this finding, a structural model is proposed whereby large residues at position 151 cause steric clashes that lead to alteration of the Keap1-Cul3 interaction.  This model has significant implications for how electrophiles which modify Cys151, disrupt the repressive function of Keap1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBipIRhBjdjbVg90H21EOLACvtfcHk0ljpBQIkkOQsYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGhs7fP&md5=acf3bbd03dcfb0a9a1d7241f701352c8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1042%2FBJ20090471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20090471%26sid%3Dliteratum%253Aachs%26aulast%3DEggler%26aufirst%3DA.%2BL.%26aulast%3DSmall%26aufirst%3DE.%26aulast%3DHannink%26aufirst%3DM.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26atitle%3DCul3-Mediated%2520Nrf2%2520Ubiquitination%2520and%2520Antioxidant%2520Response%2520Element%2520%2528Are%2529%2520Activation%2520Are%2520Dependent%2520on%2520the%2520Partial%2520Molar%2520Volume%2520at%2520Position%2520151%2520of%2520Keap1%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D422%26spage%3D171%26epage%3D180%26doi%3D10.1042%2FBJ20090471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bollong, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coukos, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lairson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moellering, R. E.</span></span> <span> </span><span class="NLM_article-title">A Metabolite-Derived Protein Modification Integrates Glycolysis with Keap1-Nrf2 Signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>562</i></span>,  <span class="NLM_fpage">600</span>â <span class="NLM_lpage">604</span>, <span class="refDoi">Â DOI: 10.1038/s41586-018-0622-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1038%2Fs41586-018-0622-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=30323285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFajsL%252FJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=562&publication_year=2018&pages=600-604&author=M.+J.+Bollongauthor=G.+Leeauthor=J.+S.+Coukosauthor=H.+Yunauthor=C.+Zambaldoauthor=J.+W.+Changauthor=E.+N.+Chinauthor=I.+Ahmadauthor=A.+K.+Chatterjeeauthor=L.+L.+Lairsonauthor=P.+G.+Schultzauthor=R.+E.+Moellering&title=A+Metabolite-Derived+Protein+Modification+Integrates+Glycolysis+with+Keap1-Nrf2+Signalling&doi=10.1038%2Fs41586-018-0622-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling</span></div><div class="casAuthors">Bollong, Michael J.; Lee, Gihoon; Coukos, John S.; Yun, Hwayoung; Zambaldo, Claudio; Chang, Jae Won; Chin, Emily N.; Ahmad, Insha; Chatterjee, Arnab K.; Lairson, Luke L.; Schultz, Peter G.; Moellering, Raymond E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">562</span>
        (<span class="NLM_cas:issue">7728</span>),
    <span class="NLM_cas:pages">600-604</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Mechanisms that integrate the metabolic state of a cell with regulatory pathways are necessary to maintain cellular homeostasis.  Endogenous, intrinsically reactive metabolites can form functional, covalent modifications on proteins without the aid of enzymes1,2, and regulate cellular functions such as metab.3-5 and transcription6.  An important 'sensor' protein that captures specific metabolic information and transforms it into an appropriate response is KEAP1, which contains reactive cysteine residues that collectively act as an electrophile sensor tuned to respond to reactive species resulting from endogenous and xenobiotic mols.  Covalent modification of KEAP1 results in reduced ubiquitination and the accumulation of NRF27,8, which then initiates the transcription of cytoprotective genes at antioxidant-response element loci.  Here we identify a small-mol. inhibitor of the glycolytic enzyme PGK1, and reveal a direct link between glycolysis and NRF2 signalling.  Inhibition of PGK1 results in accumulation of the reactive metabolite methylglyoxal, which selectively modifies KEAP1 to form a methylimidazole crosslink between proximal cysteine and arginine residues (MICA).  This post-translational modification results in the dimerization of KEAP1, the accumulation of NRF2 and activation of the NRF2 transcriptional program.  These results demonstrate the existence of direct inter-pathway communication between glycolysis and the KEAP1-NRF2 transcriptional axis, provide insight into the metabolic regulation of the cellular stress response, and suggest a therapeutic strategy for controlling the cytoprotective antioxidant response in several human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR9q3PSGgsJbVg90H21EOLACvtfcHk0lg4nzy-FaiaEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFajsL%252FJ&md5=ffa4f3f053d506dc1014427eb5269525</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0622-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0622-0%26sid%3Dliteratum%253Aachs%26aulast%3DBollong%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DCoukos%26aufirst%3DJ.%2BS.%26aulast%3DYun%26aufirst%3DH.%26aulast%3DZambaldo%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DChin%26aufirst%3DE.%2BN.%26aulast%3DAhmad%26aufirst%3DI.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DLairson%26aufirst%3DL.%2BL.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DMoellering%26aufirst%3DR.%2BE.%26atitle%3DA%2520Metabolite-Derived%2520Protein%2520Modification%2520Integrates%2520Glycolysis%2520with%2520Keap1-Nrf2%2520Signalling%26jtitle%3DNature%26date%3D2018%26volume%3D562%26spage%3D600%26epage%3D604%26doi%3D10.1038%2Fs41586-018-0622-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prag, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dikovskaya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaslona, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jedrychowski, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, A. S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hams, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szpyt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runtsch, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGouran, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGettrick, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booty, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knatko, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meakin, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashford, M. L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modis, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallon, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunji, E. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouchani, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frezza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartley, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeill, L. A.</span></span> <span> </span><span class="NLM_article-title">Itaconate Is an Anti-Inflammatory Metabolite That Activates Nrf2 Via Alkylation of Keap1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>556</i></span>,  <span class="NLM_fpage">113</span>â <span class="NLM_lpage">117</span>, <span class="refDoi">Â DOI: 10.1038/nature25986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1038%2Fnature25986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=29590092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmt1aqtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=556&publication_year=2018&pages=113-117&author=E.+L.+Millsauthor=D.+G.+Ryanauthor=H.+A.+Pragauthor=D.+Dikovskayaauthor=D.+Menonauthor=Z.+Zaslonaauthor=M.+P.+Jedrychowskiauthor=A.+S.+H.+Costaauthor=M.+Higginsauthor=E.+Hamsauthor=J.+Szpytauthor=M.+C.+Runtschauthor=M.+S.+Kingauthor=J.+F.+McGouranauthor=R.+Fischerauthor=B.+M.+Kesslerauthor=A.+F.+McGettrickauthor=M.+M.+Hughesauthor=R.+G.+Carrollauthor=L.+M.+Bootyauthor=E.+V.+Knatkoauthor=P.+J.+Meakinauthor=M.+L.+J.+Ashfordauthor=L.+K.+Modisauthor=G.+Brunoriauthor=D.+C.+Sevinauthor=P.+G.+Fallonauthor=S.+T.+Caldwellauthor=E.+R.+S.+Kunjiauthor=E.+T.+Chouchaniauthor=C.+Frezzaauthor=A.+T.+Dinkova-Kostovaauthor=R.+C.+Hartleyauthor=M.+P.+Murphyauthor=L.+A.+O%E2%80%99Neill&title=Itaconate+Is+an+Anti-Inflammatory+Metabolite+That+Activates+Nrf2+Via+Alkylation+of+Keap1&doi=10.1038%2Fnature25986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1</span></div><div class="casAuthors">Mills, Evanna L.; Ryan, Dylan G.; Prag, Hiran A.; Dikovskaya, Dina; Menon, Deepthi; Zaslona, Zbigniew; Jedrychowski, Mark P.; Costa, Ana S. H.; Higgins, Maureen; Hams, Emily; Szpyt, John; Runtsch, Marah C.; King, Martin S.; McGouran, Joanna F.; Fischer, Roman; Kessler, Benedikt M.; McGettrick, Anne F.; Hughes, Mark M.; Carroll, Richard G.; Booty, Lee M.; Knatko, Elena V.; Meakin, Paul J.; Ashford, Michael L. J.; Modis, Louise K.; Brunori, Gino; Sevin, Daniel C.; Fallon, Padraic G.; Caldwell, Stuart T.; Kunji, Edmund R. S.; Chouchani, Edward T.; Frezza, Christian; Dinkova-Kostova, Albena T.; Hartley, Richard C.; Murphy, Michael P.; O'Neill, Luke A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">556</span>
        (<span class="NLM_cas:issue">7699</span>),
    <span class="NLM_cas:pages">113-117</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The endogenous metabolite itaconate has recently emerged as a regulator of macrophage function, but its precise mechanism of action remains poorly understood.  Here we show that itaconate is required for the activation of the anti-inflammatory transcription factor Nrf2 (also known as NFE2L2) by lipopolysaccharide in mouse and human macrophages.  We find that itaconate directly modifies proteins via alkylation of cysteine residues.  Itaconate alkylates cysteine residues 151, 257, 288, 273 and 297 on the protein KEAP1, enabling Nrf2 to increase the expression of downstream genes with anti-oxidant and anti-inflammatory capacities.  The activation of Nrf2 is required for the anti-inflammatory action of itaconate.  We describe the use of a new cell-permeable itaconate deriv., 4-octyl itaconate, which is protective against lipopolysaccharide-induced lethality in vivo and decreases cytokine prodn.  We show that type I interferons boost the expression of Irg1 (also known as Acod1) and itaconate prodn.  Furthermore, we find that itaconate prodn. limits the type I interferon response, indicating a neg. feedback loop that involves interferons and itaconate.  Our findings demonstrate that itaconate is a crucial anti-inflammatory metabolite that acts via Nrf2 to limit inflammation and modulate type I interferons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoExv-0qohcf7Vg90H21EOLACvtfcHk0lg4nzy-FaiaEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmt1aqtL0%253D&md5=d0f3ac43b65cd5977d0cbfc086f80cd4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnature25986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25986%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DE.%2BL.%26aulast%3DRyan%26aufirst%3DD.%2BG.%26aulast%3DPrag%26aufirst%3DH.%2BA.%26aulast%3DDikovskaya%26aufirst%3DD.%26aulast%3DMenon%26aufirst%3DD.%26aulast%3DZaslona%26aufirst%3DZ.%26aulast%3DJedrychowski%26aufirst%3DM.%2BP.%26aulast%3DCosta%26aufirst%3DA.%2BS.%2BH.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DHams%26aufirst%3DE.%26aulast%3DSzpyt%26aufirst%3DJ.%26aulast%3DRuntsch%26aufirst%3DM.%2BC.%26aulast%3DKing%26aufirst%3DM.%2BS.%26aulast%3DMcGouran%26aufirst%3DJ.%2BF.%26aulast%3DFischer%26aufirst%3DR.%26aulast%3DKessler%26aufirst%3DB.%2BM.%26aulast%3DMcGettrick%26aufirst%3DA.%2BF.%26aulast%3DHughes%26aufirst%3DM.%2BM.%26aulast%3DCarroll%26aufirst%3DR.%2BG.%26aulast%3DBooty%26aufirst%3DL.%2BM.%26aulast%3DKnatko%26aufirst%3DE.%2BV.%26aulast%3DMeakin%26aufirst%3DP.%2BJ.%26aulast%3DAshford%26aufirst%3DM.%2BL.%2BJ.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DBrunori%26aufirst%3DG.%26aulast%3DSevin%26aufirst%3DD.%2BC.%26aulast%3DFallon%26aufirst%3DP.%2BG.%26aulast%3DCaldwell%26aufirst%3DS.%2BT.%26aulast%3DKunji%26aufirst%3DE.%2BR.%2BS.%26aulast%3DChouchani%26aufirst%3DE.%2BT.%26aulast%3DFrezza%26aufirst%3DC.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHartley%26aufirst%3DR.%2BC.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%26atitle%3DItaconate%2520Is%2520an%2520Anti-Inflammatory%2520Metabolite%2520That%2520Activates%2520Nrf2%2520Via%2520Alkylation%2520of%2520Keap1%26jtitle%3DNature%26date%3D2018%26volume%3D556%26spage%3D113%26epage%3D117%26doi%3D10.1038%2Fnature25986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Stress-Sensing Mechanisms and the Physiological Roles of the Keap1-Nrf2 System During Cellular Stress</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">16817</span>â <span class="NLM_lpage">16824</span>, <span class="refDoi">Â DOI: 10.1074/jbc.R117.800169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1074%2Fjbc.R117.800169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=28842501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GjsrzN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=16817-16824&author=T.+Suzukiauthor=M.+Yamamoto&title=Stress-Sensing+Mechanisms+and+the+Physiological+Roles+of+the+Keap1-Nrf2+System+During+Cellular+Stress&doi=10.1074%2Fjbc.R117.800169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress</span></div><div class="casAuthors">Suzuki, Takafumi; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">16817-16824</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Transcription factor Nrf2 (NF-E2-related factor 2) is a master regulator of cellular responses against environmental stresses.  Nrf2 induces the expression of detoxification and antioxidant enzymes and suppresses the induction of pro-inflammatory cytokine genes.  Keap1 (Kelch-like ECH-assocd. protein 1) is an adaptor subunit of Cullin 3-based E3 ubiquitin ligase.  Keap1 regulates the activity of Nrf2 and acts as a sensor for oxidative and electrophilic stresses.  In this review, we discuss the mol. mechanisms by which the Keap1-Nrf2 system senses and regulates the cellular response to environmental stresses.  In particular, we focus on the multiple stress-sensing mechanisms of Keap1 and novel regulatory functions of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx_R4Q7mWl67Vg90H21EOLACvtfcHk0lgkJlAAMc65-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GjsrzN&md5=478e4b84f6fd7f1cd79546b6f452b7d7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R117.800169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R117.800169%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DStress-Sensing%2520Mechanisms%2520and%2520the%2520Physiological%2520Roles%2520of%2520the%2520Keap1-Nrf2%2520System%2520During%2520Cellular%2520Stress%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D16817%26epage%3D16824%26doi%3D10.1074%2Fjbc.R117.800169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rachakonda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekhar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamer, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebler, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, M. L.</span></span> <span> </span><span class="NLM_article-title">Covalent Modification at Cys151 Dissociates the Electrophile Sensor Keap1 from the Ubiquitin Ligase Cul3</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">705</span>â <span class="NLM_lpage">710</span>, <span class="refDoi">Â DOI: 10.1021/tx700302s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx700302s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFGkt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=705-710&author=G.+Rachakondaauthor=Y.+Xiongauthor=K.+R.+Sekharauthor=S.+L.+Stamerauthor=D.+C.+Lieblerauthor=M.+L.+Freeman&title=Covalent+Modification+at+Cys151+Dissociates+the+Electrophile+Sensor+Keap1+from+the+Ubiquitin+Ligase+Cul3&doi=10.1021%2Ftx700302s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Modification at Cys151 Dissociates the Electrophile Sensor Keap1 from the Ubiquitin Ligase CUL3</span></div><div class="casAuthors">Rachakonda, Girish; Xiong, Ying; Sekhar, Konjeti R.; Stamer, Sheryl L.; Liebler, Daniel C.; Freeman, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">705-710</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The regulation of cellular stress responses to electrophiles and oxidants is mediated by the transcription factor NF-E2-related factor 2 (Nrf2), which, in turn, is regulated by CUL-E3 (CUL3) ligase-mediated ubiquitylation.  The Kelch-like ECH-assocd. protein 1 (Keap1) serves as an adapter between CUL3 and Nrf2.  We used the model electrophile N-iodoacetyl-N-biotinylhexylenediamine (IAB) to define the relationship among the adduction of Keap1 cysteine residues, structure, and function.  Exposure of Keap1 to IAB in vitro was accompanied by progressive loss of protein secondary structure, as monitored by CD spectroscopy and a loss of the ability to assoc. with recombinant CUL3.  Dissocn. of Keap1 from CUL3 in vitro was dependent upon C151 in Keap1.  A quant. mass spectrometry-based kinetic anal. of adduction in HEK293 cells expressing FLAG-Keap1 revealed that Cys151 was one of the most reactive residues in vivo and that it was required for IAB-mediated dissocn. of the Keap1-CUL3 interaction.  These results demonstrate that Cys151 adduction confers a crit. alkylation sensor function upon Keap1, making Keap1 unique among BTB CUL3 adapter proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaK6w3_TWIZLVg90H21EOLACvtfcHk0lgkJlAAMc65-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFGkt74%253D&md5=17881550b83aee61adfef4e2812d7647</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Ftx700302s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700302s%26sid%3Dliteratum%253Aachs%26aulast%3DRachakonda%26aufirst%3DG.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DSekhar%26aufirst%3DK.%2BR.%26aulast%3DStamer%26aufirst%3DS.%2BL.%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26aulast%3DFreeman%26aufirst%3DM.%2BL.%26atitle%3DCovalent%2520Modification%2520at%2520Cys151%2520Dissociates%2520the%2520Electrophile%2520Sensor%2520Keap1%2520from%2520the%2520Ubiquitin%2520Ligase%2520Cul3%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D705%26epage%3D710%26doi%3D10.1021%2Ftx700302s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copple, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibby, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeill, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2396</span>â <span class="NLM_lpage">2409</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVCis7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2396-2409&author=M.+H.+Wongauthor=H.+K.+Bryanauthor=I.+M.+Coppleauthor=R.+E.+Jenkinsauthor=P.+H.+Chiuauthor=J.+Bibbyauthor=N.+G.+Berryauthor=N.+R.+Kitteringhamauthor=C.+E.+Goldringauthor=P.+M.+O%E2%80%99Neillauthor=B.+K.+Park&title=Design+and+Synthesis+of+Irreversible+Analogues+of+Bardoxolone+Methyl+for+the+Identification+of+Pharmacologically+Relevant+Targets+and+Interaction+Sites&doi=10.1021%2Facs.jmedchem.5b01292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites</span></div><div class="casAuthors">Wong, Michael H. L.; Bryan, Holly K.; Copple, Ian M.; Jenkins, Rosalind E.; Chiu, Pak Him; Bibby, Jaclyn; Berry, Neil G.; Kitteringham, Neil R.; Goldring, Christopher E.; O'Neill, Paul M.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2396-2409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Semisynthetic triterpenoids such as bardoxolone Me (methyl-2-cyano 3,12-dioxooleano-1,9-dien-28-oate; CDDO-Me) (I) are potent inducers of antioxidant and anti-inflammatory signaling pathways, including those regulated by the transcription factor Nrf2.  However, the reversible nature of the interaction between triterpenoids and thiols has hindered attempts to identify pharmacol. relevant targets and characterize the sites of interaction.  Here, we report a shortened synthesis and SAR profiling of I, enabling the design of analogs that react irreversibly with model thiols, as well as the model protein glutathione S-transferase P1, in vitro.  We show that one of these analogs, CDDO-epoxide (II), is comparable to I in terms of cytotoxicity and potency toward Nrf2 in rat hepatoma cells and stably modifies specific cysteine residues (namely, Cys-257, -273, -288, -434, -489, and -613) within Keap1, the major repressor of Nrf2, both in vitro and in living cells.  Supported by mol. modeling, these data demonstrate the value of II for identifying site(s) of interaction with pharmacol. relevant targets and informing the continuing development of triterpenoids as novel drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjC_Ca8KocPLVg90H21EOLACvtfcHk0lgkJlAAMc65-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVCis7k%253D&md5=eb2c0d997a2b22ceb41b75c203bb27fc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01292%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DBryan%26aufirst%3DH.%2BK.%26aulast%3DCopple%26aufirst%3DI.%2BM.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DChiu%26aufirst%3DP.%2BH.%26aulast%3DBibby%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DN.%2BG.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Irreversible%2520Analogues%2520of%2520Bardoxolone%2520Methyl%2520for%2520the%2520Identification%2520of%2520Pharmacologically%2520Relevant%2520Targets%2520and%2520Interaction%2520Sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2396%26epage%3D2409%26doi%3D10.1021%2Facs.jmedchem.5b01292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eggler, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Breemen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span> <span> </span><span class="NLM_article-title">Modifying Specific Cysteines of the Electrophile-Sensing Human Keap1 Protein Is Insufficient to Disrupt Binding to the Nrf2 Domain Neh2</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">10070</span>â <span class="NLM_lpage">10075</span>, <span class="refDoi">Â DOI: 10.1073/pnas.0502402102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1073%2Fpnas.0502402102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=16006525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVeltbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=10070-10075&author=A.+L.+Egglerauthor=G.+Liuauthor=J.+M.+Pezzutoauthor=R.+B.+van+Breemenauthor=A.+D.+Mesecar&title=Modifying+Specific+Cysteines+of+the+Electrophile-Sensing+Human+Keap1+Protein+Is+Insufficient+to+Disrupt+Binding+to+the+Nrf2+Domain+Neh2&doi=10.1073%2Fpnas.0502402102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Modifying specific cysteines of the electrophile sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2</span></div><div class="casAuthors">Eggler, Aimee L.; Liu, Guowen; Pezzuto, John M.; van Breemen, Richard B.; Mesecar, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">10070-10075</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The risks of cancer and other degenerative diseases caused by reactive oxygen species and electrophiles can be reduced by the up-regulation of detoxifying enzymes.  A major mechanism whereby these protective enzymes are induced occurs through activation of the antioxidant response element (ARE) by the oxidative-stress sensor protein Kelch-like ECH-assocd. protein 1 (Keap1) and the transcription factor NF-E2-related factor 2 (Nrf2).  Under basal conditions, Keap1 sequesters Nrf2 in the cytoplasm by binding to its Neh2 domain.  Chem. inducers such as sulforaphane are known to react with Keap1 cysteine residues, thereby promoting Nrf2 nuclear accumulation and hence ARE activation.  A widely accepted model for Nrf2 nuclear accumulation is that modification of Keap1 cysteines leads directly to dissocn. of the Keap1-Nrf2 complex.  This model is based on studies with mouse proteins and has served as the exptl. basis and hypothesis for numerous investigations.  Through a combination of chem., mass spectrometry, and isothermal titrn. calorimetry methods, we have tested the direct-dissocn. model using a series of ARE inducers: sulforaphane, isoliquiritigenin, 15-deoxy-Î12,14-prostaglandin-J2, menadione, 1-Cl-2,4-dinitrobenzene, and biotinylated iodoacetamide.  Surprisingly, these data suggest that the direct disruption model for Keap1-Nrf2 is incorrect.  The relative reactivity of human Keap1 cysteines was detd.  In addn. to the same five cysteines identified for mouse Keap1, two highly reactive and previously unobserved cysteines were identified.  Based on these results, a model is proposed that should aid in the understanding of Keap1-Nrf2 signaling mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzm8XUMvM-97Vg90H21EOLACvtfcHk0lj-3VJ0AIPCZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVeltbk%253D&md5=59b797c158c043a64dfe4b57d0a0edee</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0502402102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0502402102%26sid%3Dliteratum%253Aachs%26aulast%3DEggler%26aufirst%3DA.%2BL.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26aulast%3Dvan%2BBreemen%26aufirst%3DR.%2BB.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26atitle%3DModifying%2520Specific%2520Cysteines%2520of%2520the%2520Electrophile-Sensing%2520Human%2520Keap1%2520Protein%2520Is%2520Insufficient%2520to%2520Disrupt%2520Binding%2520to%2520the%2520Nrf2%2520Domain%2520Neh2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D10070%26epage%3D10075%26doi%3D10.1073%2Fpnas.0502402102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Diffusion Dynamics of the Keap1-Cullin3 Interaction in Single Live Cells</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>433</i></span>,  <span class="NLM_fpage">58</span>â <span class="NLM_lpage">65</span>, <span class="refDoi">Â DOI: 10.1016/j.bbrc.2013.02.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.bbrc.2013.02.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=23454126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlSis7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=433&publication_year=2013&pages=58-65&author=L.+Bairdauthor=A.+T.+Dinkova-Kostova&title=Diffusion+Dynamics+of+the+Keap1-Cullin3+Interaction+in+Single+Live+Cells&doi=10.1016%2Fj.bbrc.2013.02.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Diffusion dynamics of the Keap1-Cullin3 interaction in single live cells</span></div><div class="casAuthors">Baird, Liam; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">433</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-65</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Transcription factor NF-E2 p45-related factor 2 (Nrf2) regulates the expression of a network of genes encoding drug-detoxification, anti-inflammatory, and metabolic enzymes, as well as proteins involved in the regulation of cellular redox homeostasis.  Under basal conditions, Kelch-like ECH assocd. protein 1 (Keap1) targets Nrf2 for ubiquitination and proteasomal degrdn. via assocn. with Cullin3 (Cul3)-based Rbx1 E3 ubiquitin ligase.  Various small mols. (inducers) activate Nrf2 leading to upregulation of cytoprotective gene expression.  Inducers chem. modify specific cysteine residues of Keap1 which ultimately loses its ability to target Nrf2 for degrdn.  Dissocn. of the Keap1-Cul3 complex by inducers is one possible mechanism, but evidence in single live cells is lacking.  To investigate the diffusion dynamics of the Keap1-Cul3 interaction and the effect of inducers, we developed a quant. fluorescence recovery after photobleaching (FRAP)-based system using Keap1-EGFP and mCherry-Cul3 fusion proteins.  We show that Keap1-EGFP and mCherry-Cul3 interact in single live cells.  Exposure for 1 h to small-mol. inducers of 4 different types, the oleanane triterpenoid CDDO, the isothiocyanate sulforaphane, the sulfoxythiocarbamate STCA, and the oxidant hydrogen peroxide which target distinct cysteine sensors within Keap1 with potencies which differ by nearly 4000-fold, does not dissoc. the Keap1-Cul3 complex.  As inducers cause conformational changes in Keap1, we conclude that changes in conformation rather than dissocn. from Cul3 inactivate the repressor function of Keap1 leading to Nrf2 stabilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnBuWD94zRH7Vg90H21EOLACvtfcHk0lj-3VJ0AIPCZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlSis7g%253D&md5=a18788a95811fbaca069dd986b945af2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2013.02.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2013.02.065%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DDiffusion%2520Dynamics%2520of%2520the%2520Keap1-Cullin3%2520Interaction%2520in%2520Single%2520Live%2520Cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2013%26volume%3D433%26spage%3D58%26epage%3D65%26doi%3D10.1016%2Fj.bbrc.2013.02.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paonessa, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Chemical Activation of Nrf2</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e35122</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0035122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1371%2Fjournal.pone.0035122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=22558124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFWltr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e35122&author=Y.+Liauthor=J.+D.+Paonessaauthor=Y.+Zhang&title=Mechanism+of+Chemical+Activation+of+Nrf2&doi=10.1371%2Fjournal.pone.0035122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of chemical activation of Nrf2</span></div><div class="casAuthors">Li, Yun; Paonessa, Joseph D.; Zhang, Yuesheng</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e35122</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">NF-E2 related factor-2 (Nrf2) promotes the transcription of many cytoprotective genes and is a major drug target for prevention of cancer and other diseases.  Indeed, the cancer-preventive activities of several well-known chem. agents were shown to depend on Nrf2 activation.  It is well known that chemopreventive Nrf2 activators stabilize Nrf2 by blocking its ubiquitination, but previous studies have indicated that this process occurs exclusively in the cytoplasm.  Kelch-like ECH-assocd. protein 1 (Keap1) binds to Nrf2 and orchestrates Nrf2 ubiquitination and it has been a widely-held view that inhibition of Nrf2 ubiquitination by chemopreventive agents results from the dissocn. of Nrf2 from its repressor Keap1.  Here, we show that while the activation of Nrf2 by prototypical chem. activators, including 5,6-dihydrocyclopenta-1,2-dithiole-3-thione (CPDT) and sulforaphane (SF), results solely from inhibition of its ubiquitination, such inhibition occurs predominantly in the nucleus.  Moreover, the Nrf2 activators promote Nrf2 assocn. with Keap1, rather than disassocn., which appears to result from inhibition of Nrf2 phosphorylation at Ser40.  Available evidence suggests the Nrf2 activators may block Nrf2 ubiquitination by altering Keap1 conformation via reaction with the thiols of specific Keap1 cysteines.  We further show that while the inhibitory effects of CPDT and SF on Nrf2 ubiquitination depend entirely on Keap1, Nrf2 is also degraded by a Keap1-independent mechanism.  These findings provide significant new insight about Nrf2 activation and suggest that exogenous chem. activators of Nrf2 enter the nucleus to exert most of their inhibitory impact on Nrf2 ubiquitination and degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHQw95dGtFnbVg90H21EOLACvtfcHk0lj-3VJ0AIPCZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFWltr4%253D&md5=8b9417e76f781711ba9f1d993c017d0c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0035122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0035122%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPaonessa%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DMechanism%2520of%2520Chemical%2520Activation%2520of%2520Nrf2%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De35122%26doi%3D10.1371%2Fjournal.pone.0035122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">3100</span>â <span class="NLM_lpage">3112</span>, <span class="refDoi">Â DOI: 10.1128/MCB.00389-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.00389-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=27697860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitl2muro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=3100-3112&author=T.+Isoauthor=T.+Suzukiauthor=L.+Bairdauthor=M.+Yamamoto&title=Absolute+Amounts+and+Status+of+the+Nrf2-Keap1-Cul3+Complex+within+Cells&doi=10.1128%2FMCB.00389-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Absolute amounts and status of the Nrf2-keap1-cul3 complex within cells</span></div><div class="casAuthors">Iso, Tatsuro; Suzuki, Takafumi; Baird, Liam; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3100-3112</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 (NF-E2-related-factor 2) is essential for the oxidative and electrophilic stress responses.  Keap1 (Kelch-like-ECH-assocd.-protein 1), an adaptor for a cullin-3 (Cul3)-based ubiquitin ligase, regulates Nrf2 activity through proteasomal degrdn., and acts as a sensor for oxidative and electrophilic stresses.  The Keap1-Cul3 complex is a crit. regulator of the cellular Nrf2 level, and yet quant. information regarding their endogenous intracellular concns. in homeostatic conditions and during stress responses is unknown.  We analyzed the abs. amts. of the Nrf2, Keap1, and Cul3 proteins in five murine cell lines by comparison with serial dilns. of purified recombinant protein stds. in combination with quant. immunoblot analyses.  In the basal state, the amt. of Nrf2 was maintained at lower levels than those of Keap1 and Cul3 proteins, whereas the electrophilic agent diethylmaleate dramatically increased Nrf2 to a level greater than that of Keap1 and Cul3, resulting in the accumulation of Nrf2 in the nucleus.  In contrast, Keap1 and Cul3 did not display any changes in their abundance, subcellular localization, or interaction in response to electrophilic stimuli.  Our results demonstrate that the regulation of the Nrf2 protein level during stress responses is mediated by the activity but not the compn. of the Nrf2-Keap1-Cul3 complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPGVeaDYpE2bVg90H21EOLACvtfcHk0lj-3VJ0AIPCZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitl2muro%253D&md5=934eb0d47608ff480fd6765ff1cdf49c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FMCB.00389-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00389-16%26sid%3Dliteratum%253Aachs%26aulast%3DIso%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DAbsolute%2520Amounts%2520and%2520Status%2520of%2520the%2520Nrf2-Keap1-Cul3%2520Complex%2520within%2520Cells%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2016%26volume%3D36%26spage%3D3100%26epage%3D3112%26doi%3D10.1128%2FMCB.00389-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hur, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Modulators of Antioxidant Response Pathway</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">162</span>â <span class="NLM_lpage">173</span>, <span class="refDoi">Â DOI: 10.1016/j.cbpa.2010.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.cbpa.2010.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=21195017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFKitLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=162-173&author=W.+Hurauthor=N.+S.+Gray&title=Small+Molecule+Modulators+of+Antioxidant+Response+Pathway&doi=10.1016%2Fj.cbpa.2010.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule modulators of antioxidant response pathway</span></div><div class="casAuthors">Hur, Wooyoung; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-173</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor that regulates Antioxidant Response Element (ARE)-mediated transcription of a plethora of antioxidant and protective genes to counteract the harmful effects of reactive oxygen species or environmental carcinogens.  Studies have demonstrated that pre-emptive activation of the Nrf2-ARE pathway reinforces the cellular defense mechanism against oxidative stress and leads to protection in a variety of disease models.  Non-carcinogenic ARE inducers have been identified from a variety of chem. classes that enhance the transcriptional activity of Nrf2 through S-alkylation of reactive cysteines within the cellular redox sensor protein Keap1 (Kelch-like ECH assocd. protein 1).  Here we review the currently known small mol. ARE inducers and their reported biol. activities in various models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoULkW6Xdct7rVg90H21EOLACvtfcHk0ljV5FpUCJzc5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFKitLg%253D&md5=2424082ba8c25672b6928b79461024ea</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DHur%26aufirst%3DW.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSmall%2520Molecule%2520Modulators%2520of%2520Antioxidant%2520Response%2520Pathway%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D15%26spage%3D162%26epage%3D173%26doi%3D10.1016%2Fj.cbpa.2010.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Templeton, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">10941</span>â <span class="NLM_lpage">10953</span>, <span class="refDoi">Â DOI: 10.1128/MCB.24.24.10941-10953.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.24.24.10941-10953.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=15572695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFSgsr%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=10941-10953&author=D.+D.+Zhangauthor=S.+C.+Loauthor=J.+V.+Crossauthor=D.+J.+Templetonauthor=M.+Hannink&title=Keap1+Is+a+Redox-Regulated+Substrate+Adaptor+Protein+for+a+Cul3-Dependent+Ubiquitin+Ligase+Complex&doi=10.1128%2FMCB.24.24.10941-10953.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex</span></div><div class="casAuthors">Zhang, Donna D.; Lo, Shih-Ching; Cross, Janet V.; Templeton, Dennis J.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10941-10953</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The bZIP transcription factor Nrf2 controls a genetic program that protects cells from oxidative damage and maintains cellular redox homeostasis.  Keap1, a BTB-Kelch protein, is the major upstream regulator of Nrf2 and controls both the subcellular localization and steady-state levels of Nrf2.  In this report, we demonstrate that Keap1 functions as a substrate adaptor protein for a Cul3-dependent E3 ubiquitin ligase complex.  Keap1 assembles into a functional E3 ubiquitin ligase complex with Cul3 and Rbx1 that targets multiple lysine residues located in the N-terminal Neh2 domain of Nrf2 for ubiquitin conjugation both in vivo and in vitro.  Keap1-dependent ubiquitination of Nrf2 is inhibited following exposure of cells to quinone-induced oxidative stress and sulforaphane, a cancer-preventive isothiocyanate.  A mutant Keap1 protein contg. a single cysteine-to-serine substitution at residue 151 within the BTB domain of Keap1 is markedly resistant to inhibition by either quinone-induced oxidative stress or sulforaphane.  Inhibition of Keap1-dependent ubiquitination of Nrf2 correlates with decreased assocn. of Keap1 with Cul3.  Neither quinone-induced oxidative stress nor sulforaphane disrupts assocn. between Keap1 and Nrf2.  Our results suggest that the ability of Keap1 to assemble into a functional E3 ubiquitin ligase complex is the crit. determinant that controls steady-state levels of Nrf2 in response to cancer-preventive compds. and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGone13ov1mSELVg90H21EOLACvtfcHk0ljV5FpUCJzc5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFSgsr%252FL&md5=cc8f2a059999d82c91ef482fb8e385d8</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.24.10941-10953.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.24.10941-10953.2004%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DLo%26aufirst%3DS.%2BC.%26aulast%3DCross%26aufirst%3DJ.%2BV.%26aulast%3DTempleton%26aufirst%3DD.%2BJ.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DKeap1%2520Is%2520a%2520Redox-Regulated%2520Substrate%2520Adaptor%2520Protein%2520for%2520a%2520Cul3-Dependent%2520Ubiquitin%2520Ligase%2520Complex%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D10941%26epage%3D10953%26doi%3D10.1128%2FMCB.24.24.10941-10953.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeneuve, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Activation of Nrf2 by Arsenite and Monomethylarsonous Acid Is Independent of Keap1-C151: Enhanced Keap1-Cul3 Interaction</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>230</i></span>,  <span class="NLM_fpage">383</span>â <span class="NLM_lpage">389</span>, <span class="refDoi">Â DOI: 10.1016/j.taap.2008.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.taap.2008.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=18417180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVOjsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2008&pages=383-389&author=X.+J.+Wangauthor=Z.+Sunauthor=W.+Chenauthor=Y.+Liauthor=N.+F.+Villeneuveauthor=D.+D.+Zhang&title=Activation+of+Nrf2+by+Arsenite+and+Monomethylarsonous+Acid+Is+Independent+of+Keap1-C151%3A+Enhanced+Keap1-Cul3+Interaction&doi=10.1016%2Fj.taap.2008.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction</span></div><div class="casAuthors">Wang, Xiao-Jun; Sun, Zheng; Chen, Weimin; Li, Yanjie; Villeneuve, Nicole F.; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-389</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Drinking water contaminated with arsenic, a human carcinogen, is a worldwide health issue.  An understanding of cellular signaling events in response to arsenic exposure and rational designing of strategies to reduce arsenic damages by modulating signaling events are important to fight against arsenic-induced diseases.  Previously, the authors reported that activation of the Nrf2-mediated cellular defense pathway confers protection against toxic effects induced by sodium arsenite [As(III)] or monomethylarsonous acid [MMA(III)].  Paradoxically, arsenic has been reported to induce the Nrf2-dependent signaling pathway.  Here, the authors report the unique mechanism of Nrf2 induction by arsenic.  Similar to tert-butylhydroquinone (tBHQ) or sulforaphane (SF), arsenic induced the Nrf2-dependent response through enhancing Nrf2 protein levels by inhibiting Nrf2 ubiquitination and degrdn.  However, the detailed action of arsenic in Nrf2 induction is different from that of tBHQ or SF.  Arsenic markedly enhanced the interaction between Keap1 and Cul3, subunits of the E3 ubiquitin ligase for Nrf2, which led to impaired dynamic assembly/disassembly of the E3 ubiquitin ligase and thus decreased its ligase activity.  Furthermore, induction of Nrf2 by arsenic is independent of the previously identified C151 residue in Keap1 that is required for Nrf2 activation by tBHQ or SF.  Distinct mechanisms of Nrf2 activation by seemingly harmful and beneficial reagents provide a mol. basis to design Nrf2-activating agents for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGougWtyjknTaLVg90H21EOLACvtfcHk0ljV5FpUCJzc5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVOjsLo%253D&md5=d64d1a0b41d671bb87fd69ea67053275</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2008.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2008.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DVilleneuve%26aufirst%3DN.%2BF.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DActivation%2520of%2520Nrf2%2520by%2520Arsenite%2520and%2520Monomethylarsonous%2520Acid%2520Is%2520Independent%2520of%2520Keap1-C151%253A%2520Enhanced%2520Keap1-Cul3%2520Interaction%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2008%26volume%3D230%26spage%3D383%26epage%3D389%26doi%3D10.1016%2Fj.taap.2008.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sou, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iemura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natsume, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">The Selective Autophagy Substrate P62 Activates the Stress Responsive Transcription Factor Nrf2 through Inactivation of Keap1</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">213</span>â <span class="NLM_lpage">223</span>, <span class="refDoi">Â DOI: 10.1038/ncb2021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1038%2Fncb2021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=20173742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFemsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=213-223&author=M.+Komatsuauthor=H.+Kurokawaauthor=S.+Waguriauthor=K.+Taguchiauthor=A.+Kobayashiauthor=Y.+Ichimuraauthor=Y.+S.+Souauthor=I.+Uenoauthor=A.+Sakamotoauthor=K.+I.+Tongauthor=M.+Kimauthor=Y.+Nishitoauthor=S.+Iemuraauthor=T.+Natsumeauthor=T.+Uenoauthor=E.+Kominamiauthor=H.+Motohashiauthor=K.+Tanakaauthor=M.+Yamamoto&title=The+Selective+Autophagy+Substrate+P62+Activates+the+Stress+Responsive+Transcription+Factor+Nrf2+through+Inactivation+of+Keap1&doi=10.1038%2Fncb2021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1</span></div><div class="casAuthors">Komatsu, Masaaki; Kurokawa, Hirofumi; Waguri, Satoshi; Taguchi, Keiko; Kobayashi, Akira; Ichimura, Yoshinobu; Sou, Yu-Shin; Ueno, Izumi; Sakamoto, Ayako; Tong, Kit I.; Kim, Mihee; Nishito, Yasumasa; Iemura, Shun-ichiro; Natsume, Tohru; Ueno, Takashi; Kominami, Eiki; Motohashi, Hozumi; Tanaka, Keiji; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-223</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Impaired selective turnover of p62 by autophagy causes severe liver injury accompanied by the formation of p62-pos. inclusions and upregulation of detoxifying enzymes.  These phenotypes correspond closely to the pathol. conditions seen in human liver diseases, including alc. hepatitis and hepatocellular carcinoma.  However, the mol. mechanisms and pathophysiol. processes in these events are still unknown.  Here we report the identification of a novel regulatory mechanism by p62 of the transcription factor Nrf2, whose target genes include antioxidant proteins and detoxification enzymes. p62 interacts with the Nrf2-binding site on Keap1, a component of Cullin-3-type ubiquitin ligase for Nrf2.  Thus, an overprodn. of p62 or a deficiency in autophagy competes with the interaction between Nrf2 and Keap1, resulting in stabilization of Nrf2 and transcriptional activation of Nrf2 target genes.  Our findings indicate that the pathol. process assocd. with p62 accumulation results in hyperactivation of Nrf2 and delineates unexpected roles of selective autophagy in controlling the transcription of cellular defense enzyme genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozHwUzLt-LiLVg90H21EOLACvtfcHk0li94oN7EgRZ_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFemsL8%253D&md5=f66692c056ff13937de3affac38f31c9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fncb2021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2021%26sid%3Dliteratum%253Aachs%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DKurokawa%26aufirst%3DH.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DSou%26aufirst%3DY.%2BS.%26aulast%3DUeno%26aufirst%3DI.%26aulast%3DSakamoto%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DNishito%26aufirst%3DY.%26aulast%3DIemura%26aufirst%3DS.%26aulast%3DNatsume%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DKominami%26aufirst%3DE.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DThe%2520Selective%2520Autophagy%2520Substrate%2520P62%2520Activates%2520the%2520Stress%2520Responsive%2520Transcription%2520Factor%2520Nrf2%2520through%2520Inactivation%2520of%2520Keap1%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26spage%3D213%26epage%3D223%26doi%3D10.1038%2Fncb2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Iaspp Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">561</span>â <span class="NLM_lpage">573</span>, <span class="refDoi">Â DOI: 10.1016/j.ccell.2017.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.ccell.2017.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=29033244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjs7zE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=561-573&author=W.+Geauthor=K.+Zhaoauthor=X.+Wangauthor=H.+Liauthor=M.+Yuauthor=M.+Heauthor=X.+Xueauthor=Y.+Zhuauthor=C.+Zhangauthor=Y.+Chengauthor=S.+Jiangauthor=Y.+Hu&title=Iaspp+Is+an+Antioxidative+Factor+and+Drives+Cancer+Growth+and+Drug+Resistance+by+Competing+with+Nrf2+for+Keap1+Binding&doi=10.1016%2Fj.ccell.2017.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding</span></div><div class="casAuthors">Ge, Wenjie; Zhao, Kunming; Wang, Xingwen; Li, Huayi; Yu, Miao; He, Mengmeng; Xue, Xuting; Zhu, Yifu; Zhang, Cheng; Cheng, Yiwei; Jiang, Shijian; Hu, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-573.e6</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) have emerged as important signaling mols. that play crucial roles in carcinogenesis and cytotoxic responses.  Nrf2 is the master regulator of ROS balance.  Thus, uncovering mechanisms of Nrf2 regulation is important for the development of alternative treatment strategies for cancers.  Here, we demonstrate that iASPP, a known p53 inhibitor, lowers ROS independently of p53.  Mechanistically, iASPP competes with Nrf2 for Keap1 binding via a DLT motif, leading to decreased Nrf2 ubiquitination and increased Nrf2 accumulation, nuclear translocation, and antioxidative transactivation.  This iASPP-Keap1-Nrf2 axis promotes cancer growth and drug resistance both in vitro and in vivo.  Thus, iASPP is an antioxidative factor and represents a promising target to improve cancer treatment, regardless of p53 status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgG9GfPOFfIrVg90H21EOLACvtfcHk0li94oN7EgRZ_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjs7zE&md5=f2e27a7dee5602a3aba046c0efb34ef7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2017.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2017.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DIaspp%2520Is%2520an%2520Antioxidative%2520Factor%2520and%2520Drives%2520Cancer%2520Growth%2520and%2520Drug%2520Resistance%2520by%2520Competing%2520with%2520Nrf2%2520for%2520Keap1%2520Binding%26jtitle%3DCancer%2520Cell%26date%3D2017%26volume%3D32%26spage%3D561%26epage%3D573%26doi%3D10.1016%2Fj.ccell.2017.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span> <span> </span><span class="NLM_article-title">Nrf2: Friend or Foe for Chemoprevention?</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">90</span>â <span class="NLM_lpage">99</span>, <span class="refDoi">Â DOI: 10.1093/carcin/bgp231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1093%2Fcarcin%2Fbgp231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=19793802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCgsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=90-99&author=T.+W.+Kenslerauthor=N.+Wakabayashi&title=Nrf2%3A+Friend+or+Foe+for+Chemoprevention%3F&doi=10.1093%2Fcarcin%2Fbgp231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2: friend or foe for chemoprevention?</span></div><div class="casAuthors">Kensler, Thomas W.; Wakabayashi, Nobunao</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-99</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Health reflects the ability of an organism to adapt to stress.  Stresses-metabolic, proteotoxic, mitotic, oxidative and DNA-damage stresses-not only contribute to the etiol. of cancer and other chronic degenerative diseases but are also hallmarks of the cancer phenotype.  Activation of the Kelch-like ECH-assocd. protein 1 (KEAP1)-NF-E2-related factor 2 (NRF2)-signaling pathway is an adaptive response to environmental and endogenous stresses and serves to render animals resistant to chem. carcinogenesis and other forms of toxicity, while disruption of the pathway exacerbates these outcomes.  This pathway can be induced by thiol-reactive small mols. that demonstrate protective efficacy in preclin. chemoprevention models and in clin. trials.  However, mutations and epigenetic modifications affecting the regulation and fate of NRF2 can lead to constitutive dominant hyperactivation of signaling that preserves rather than attenuates cancer phenotypes by providing selective resistance to stresses.  This review provides a synopsis of KEAP1-NRF2 signaling, compares the impact of genetic vs. pharmacol. activation and considers both the attributes and concerns of targeting the pathway in chemoprevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqshZPrMJ237bVg90H21EOLACvtfcHk0li94oN7EgRZ_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCgsQ%253D%253D&md5=dd79e8634cc9ca6ad8fde2d08f77a731</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgp231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgp231%26sid%3Dliteratum%253Aachs%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DWakabayashi%26aufirst%3DN.%26atitle%3DNrf2%253A%2520Friend%2520or%2520Foe%2520for%2520Chemoprevention%253F%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26spage%3D90%26epage%3D99%26doi%3D10.1093%2Fcarcin%2Fbgp231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takaya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satomi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Validation of the Multiple Sensor Mechanism of the Keap1-Nrf2 System</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">817</span>â <span class="NLM_lpage">827</span>, <span class="refDoi">Â DOI: 10.1016/j.freeradbiomed.2012.06.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.freeradbiomed.2012.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=22732183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKms7%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=817-827&author=K.+Takayaauthor=T.+Suzukiauthor=H.+Motohashiauthor=K.+Onoderaauthor=S.+Satomiauthor=T.+W.+Kenslerauthor=M.+Yamamoto&title=Validation+of+the+Multiple+Sensor+Mechanism+of+the+Keap1-Nrf2+System&doi=10.1016%2Fj.freeradbiomed.2012.06.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the multiple sensor mechanism of the Keap1-Nrf2 system</span></div><div class="casAuthors">Takaya, Kai; Suzuki, Takafumi; Motohashi, Hozumi; Onodera, Ko; Satomi, Susumu; Kensler, Thomas W.; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-827</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Keap1-Nrf2 system plays a crit. role in cellular defense against electrophiles and reactive O species.  Keap1 possesses a no. of Cys residues, some of which are highly reactive and serves as sensors for these insults.  Indeed, point mutation of Cys-151 abrogates the response to certain electrophiles.  However, this mutation does not affect the other set of electrophiles, suggesting that multiple sensor systems reside within the Cys residues of Keap1.  The precise contribution of each reactive Cys residue to the sensor function of Keap1 remains to be clarified.  Herem to elucidate the contribution of Cys-151 in vivo, the authors adopted transgenic complementation rescue assays.  Embryonic fibroblasts and primary peritoneal macrophages were prepd. from mice expressing the Keap1-C151S mutant.  These cells were challenged with various Nrf2 inducers.  It was found that some of the inducers triggered only marginal responses in Keap1-C151S-expressing cells, while others evoked responses in a comparable magnitude to those obsd. in the wild-type cells.  The authors found that tert-Bu hydroquinone, diethylmaleate, sulforaphane, and dimethylfumarate were Cys-151-preferable, whereas 15-deoxy-Î12,14-prostaglandin J2 (15d-PG-J2), 2-cyano-3,12-dioxooleana-1,9-diene-28-imidazolide, ebselen, nitro-oleic acid, and CdCl2 were Cys-151-independent.  Expts. with embryonic fibroblasts and primary macrophages yielded consistent results.  Expts. testing protective effects against the cytotoxicity of 1-chloro-2,4-dinitrobenzene of sulforaphane and 15d-PG-J2 in Keap1-C151S-expressing macrophages revealed that the former inducer was effective, while the latter was not.  These results thus indicate that there exists distinct utilization of Keap1 Cys residues by different chems. that trigger the response of the Keap1-Nrf2 system, and further substantiate the notion that there are multiple sensing mechanisms within Keap1 Cys residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHkfTRD-ZFrVg90H21EOLACvtfcHk0lib-i0qPwNMcQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKms7%252FN&md5=2da3a0bd9d8d0ed8008dda3b30b1570a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2012.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2012.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DTakaya%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DOnodera%26aufirst%3DK.%26aulast%3DSatomi%26aufirst%3DS.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DValidation%2520of%2520the%2520Multiple%2520Sensor%2520Mechanism%2520of%2520the%2520Keap1-Nrf2%2520System%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D817%26epage%3D827%26doi%3D10.1016%2Fj.freeradbiomed.2012.06.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saito, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naganuma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furusawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichinose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">271</span>â <span class="NLM_lpage">284</span>, <span class="refDoi">Â DOI: 10.1128/MCB.00868-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.00868-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=26527616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A280%3ADC%252BC28znvFyjsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=271-284&author=R.+Saitoauthor=T.+Suzukiauthor=K.+Hiramotoauthor=S.+Asamiauthor=E.+Naganumaauthor=H.+Sudaauthor=T.+Isoauthor=H.+Yamamotoauthor=M.+Moritaauthor=L.+Bairdauthor=Y.+Furusawaauthor=T.+Negishiauthor=M.+Ichinoseauthor=M.+Yamamoto&title=Characterizations+of+Three+Major+Cysteine+Sensors+of+Keap1+in+Stress+Response&doi=10.1128%2FMCB.00868-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response</span></div><div class="casAuthors">Saito Ryota; Suzuki Takafumi; Hiramoto Keiichiro; Asami Soichiro; Naganuma Eriko; Suda Hiromi; Iso Tatsuro; Yamamoto Hirotaka; Morita Masanobu; Baird Liam; Yamamoto Masayuki; Furusawa Yuki; Negishi Takaaki; Ichinose Masakazu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and cellular biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Keap1-Nrf2 system plays a central role in cytoprotection against electrophilic/oxidative stresses.  Although Cys151, Cys273, and Cys288 of Keap1 are major sensor cysteine residues for detecting these stresses, it has not been technically feasible to evaluate the functionality of Cys273 or Cys288, since Keap1 mutants that harbor substitutions in these residues and maintain the ability to repress Nrf2 accumulation do not exist.  To overcome this problem, we systematically introduced amino acid substitutions into Cys273/Cys288 and finally identified Cys273Trp and Cys288Glu mutations that do not affect Keap1's ability to repress Nrf2 accumulation.  Utilizing these Keap1 mutants, we generated stable murine embryonic fibroblast (MEF) cell lines and knock-in mouse lines.  Our analyses with the MEFs and peritoneal macrophages from the knock-in mice revealed that three major cysteine residues, Cys151, Cys273, and Cys288, individually and/or redundantly act as sensors.  Based on the functional necessity of these three cysteine residues, we categorized chemical inducers of Nrf2 into four classes.  Class I and II utilizes Cys151 and Cys288, respectively, while class III requires all three residues (Cys151/Cys273/Cys288), while class IV inducers function independently of all three of these cysteine residues.  This study thus demonstrates that Keap1 utilizes multiple cysteine residues specifically and/or collaboratively as sensors for the detection of a wide range of environmental stresses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ9xHanSufiLv6AExegM5LLfW6udTcc2eZXWurex_siEbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28znvFyjsQ%253D%253D&md5=ecd882849726cacd9b6a3e5d706252e8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FMCB.00868-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00868-15%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DHiramoto%26aufirst%3DK.%26aulast%3DAsami%26aufirst%3DS.%26aulast%3DNaganuma%26aufirst%3DE.%26aulast%3DSuda%26aufirst%3DH.%26aulast%3DIso%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DFurusawa%26aufirst%3DY.%26aulast%3DNegishi%26aufirst%3DT.%26aulast%3DIchinose%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DCharacterizations%2520of%2520Three%2520Major%2520Cysteine%2520Sensors%2520of%2520Keap1%2520in%2520Stress%2520Response%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2015%26volume%3D36%26spage%3D271%26epage%3D284%26doi%3D10.1128%2FMCB.00868-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naidu, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">C151 in Keap1 Is the Main Cysteine Sensor for the Cyanoenone Class of Nrf2 Activators, Irrespective of Molecular Size or Shape</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">8</span>, <span class="refDoi">Â DOI: 10.1038/s41598-018-26269-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1038%2Fs41598-018-26269-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=29311689" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=8&author=S.+D.+Naiduauthor=A.+Muramatsuauthor=R.+Saitoauthor=S.+Asamiauthor=T.+Hondaauthor=T.+Hosoyaauthor=K.+Itohauthor=M.+Yamamotoauthor=T.+Suzukiauthor=A.+T.+Dinkova-Kostova&title=C151+in+Keap1+Is+the+Main+Cysteine+Sensor+for+the+Cyanoenone+Class+of+Nrf2+Activators%2C+Irrespective+of+Molecular+Size+or+Shape&doi=10.1038%2Fs41598-018-26269-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-26269-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-26269-9%26sid%3Dliteratum%253Aachs%26aulast%3DNaidu%26aufirst%3DS.%2BD.%26aulast%3DMuramatsu%26aufirst%3DA.%26aulast%3DSaito%26aufirst%3DR.%26aulast%3DAsami%26aufirst%3DS.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DC151%2520in%2520Keap1%2520Is%2520the%2520Main%2520Cysteine%2520Sensor%2520for%2520the%2520Cyanoenone%2520Class%2520of%2520Nrf2%2520Activators%252C%2520Irrespective%2520of%2520Molecular%2520Size%2520or%2520Shape%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D8%26doi%3D10.1038%2Fs41598-018-26269-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onyango, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Royce, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span> <span> </span><span class="NLM_article-title">Novel Synthetic Pyridyl Analogues of Cddo-Imidazolide Are Useful New Tools in Cancer Prevention</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">135</span>â <span class="NLM_lpage">147</span>, <span class="refDoi">Â DOI: 10.1016/j.phrs.2015.07.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.phrs.2015.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=26238177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Ohu7nL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=135-147&author=M.+Caoauthor=E.+O.+Onyangoauthor=C.+R.+Williamsauthor=D.+B.+Royceauthor=G.+W.+Gribbleauthor=M.+B.+Spornauthor=K.+T.+Liby&title=Novel+Synthetic+Pyridyl+Analogues+of+Cddo-Imidazolide+Are+Useful+New+Tools+in+Cancer+Prevention&doi=10.1016%2Fj.phrs.2015.07.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention</span></div><div class="casAuthors">Cao, Martine; Onyango, Evans O.; Williams, Charlotte R.; Royce, Darlene B.; Gribble, Gordon W.; Sporn, Michael B.; Liby, Karen T.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">135-147</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Two new analogs of CDDO-Imidazolide (CDDO-Im), namely 1-[2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]-4(-pyridin-2-yl)-1H-imidazole ("CDDO-2P-Im") and 1-[2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]-4(-pyridin-3-yl)-1H-imidazole ("CDDO-3P-Im") have been synthesized and tested for their potential use as chemopreventive drugs.  At nanomolar concns., they were equipotent to CDDO-Im for inducing differentiation and apoptosis in U937 leukemia cells.  As inflammation and oxidative stress contribute to carcinogenesis, we also assessed their cytoprotective potential.  The new compds. suppressed inducible nitric oxide synthase (iNOS) expression in RAW264.7 macrophage-like cells and significantly elevated heme oxygenase-1 (HO-1) and quinone reductase (NQO1) mRNA and protein levels in various mouse tissues in vivo.  Most importantly, pharmacokinetic studies performed in vitro in human plasma and in vivo showed that each new analog was more stable than CDDO-Im.  Much higher concns. of the new derivs. were found in mouse liver, lung, pancreas and kidney after gavage in contrast to CDDO-Im.  Because of their better bioavailability and their excellent anti-inflammatory profile in vitro, CDDO-2P-Im and CDDO-3P-Im were tested for prevention in a highly relevant mouse lung cancer model, in which A/J mice develop lung carcinomas after injection of vinyl carbamate, a potent carcinogen.  CDDO-2P-Im and CDDO-3P-Im were as effective as CDDO-Im for reducing the size and the severity of the lung tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2mjNbgpfVX7Vg90H21EOLACvtfcHk0liPF52hWmE_cQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Ohu7nL&md5=ca75bb49f2cada81875d6ec788ce5d9d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DM.%26aulast%3DOnyango%26aufirst%3DE.%2BO.%26aulast%3DWilliams%26aufirst%3DC.%2BR.%26aulast%3DRoyce%26aufirst%3DD.%2BB.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26atitle%3DNovel%2520Synthetic%2520Pyridyl%2520Analogues%2520of%2520Cddo-Imidazolide%2520Are%2520Useful%2520New%2520Tools%2520in%2520Cancer%2520Prevention%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D100%26spage%3D135%26epage%3D147%26doi%3D10.1016%2Fj.phrs.2015.07.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earnshaw, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tailor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddington, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitaker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naisbitt, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Amoxicillin and Clavulanate Form Chemically and Immunologically Distinct Multiple Haptenic Structures in Patients</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1762</span>â <span class="NLM_lpage">1772</span>, <span class="refDoi">Â DOI: 10.1021/acs.chemrestox.6b00253</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.6b00253" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOitr%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=1762-1772&author=X.+Mengauthor=C.+J.+Earnshawauthor=A.+Tailorauthor=R.+E.+Jenkinsauthor=J.+C.+Waddingtonauthor=P.+Whitakerauthor=N.+S.+Frenchauthor=D.+J.+Naisbittauthor=B.+K.+Park&title=Amoxicillin+and+Clavulanate+Form+Chemically+and+Immunologically+Distinct+Multiple+Haptenic+Structures+in+Patients&doi=10.1021%2Facs.chemrestox.6b00253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Amoxicillin and Clavulanate Form Chemically and Immunologically Distinct Multiple Haptenic Structures in Patients</span></div><div class="casAuthors">Meng, Xiaoli; Earnshaw, Caroline J.; Tailor, Arun; Jenkins, Rosalind E.; Waddington, James C.; Whitaker, Paul; French, Neil S.; Naisbitt, Dean J.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1762-1772</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amoxicillin-clavulanate (AC) is one of the most common causes of drug induced liver injury (DILI).  The assocn. between AC-DILI and HLA alleles and the detection of drug-specific T cells in patients with AC-DILI indicate that the adaptive immune system is involved in the disease pathogenesis.  In this study, mass spectrometric methods were employed to characterize the antigen formed by AC in exposed patients and the antigenic determinants that stimulate T cells.  Amoxicillin formed penicilloyl adducts with lysine residues on human serum albumin (HSA) in vitro, with K190 and K199 being the most reactive sites.  Amoxicillin-modified K190 and K199 have also been detected in all patients, and more extensive modification was obsd. in patients exposed to higher doses of amoxicillin.  In contrast, the binding of clavulanic acid to HSA was more complicated.  Multiple adducts were identified at high concns. in vitro, including those formed by direct binding of clavulanic acid to lysine residues, novel pyrazine adducts derived from binding to the degrdn. products of clavulanic acid, and a crosslinking adduct.  Stable adducts derived from formylacetic acid were detected in all patients exposed to the drug.  Importantly, anal. of hapten-protein adducts formed in cell culture medium revealed that the highly drug-specific T-cell responses were likely driven by the markedly different haptenic structures formed by these two drugs.  In this study the unique haptenic structures on albumin in patients formed by amoxicillin and clavulanic acid have been characterized and shown to function as chem. distinct antigens which can stimulate sep., specific T-cell clones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_m2wfS4tc67Vg90H21EOLACvtfcHk0liPF52hWmE_cQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOitr%252FE&md5=58a31780a6928971a26a481119310416</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.6b00253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.6b00253%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DEarnshaw%26aufirst%3DC.%2BJ.%26aulast%3DTailor%26aufirst%3DA.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DWaddington%26aufirst%3DJ.%2BC.%26aulast%3DWhitaker%26aufirst%3DP.%26aulast%3DFrench%26aufirst%3DN.%2BS.%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DAmoxicillin%2520and%2520Clavulanate%2520Form%2520Chemically%2520and%2520Immunologically%2520Distinct%2520Multiple%2520Haptenic%2520Structures%2520in%2520Patients%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2016%26volume%3D29%26spage%3D1762%26epage%3D1772%26doi%3D10.1021%2Facs.chemrestox.6b00253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copple, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randle, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">The Hepatotoxic Metabolite of Acetaminophen Directly Activates the Keap1-Nrf2 Cell Defense System</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1292</span>â <span class="NLM_lpage">1301</span>, <span class="refDoi">Â DOI: 10.1002/hep.22472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1002%2Fhep.22472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=18785192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Khu7zN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1292-1301&author=I.+M.+Coppleauthor=C.+E.+Goldringauthor=R.+E.+Jenkinsauthor=A.+J.+Chiaauthor=L.+E.+Randleauthor=J.+D.+Hayesauthor=N.+R.+Kitteringhamauthor=B.+K.+Park&title=The+Hepatotoxic+Metabolite+of+Acetaminophen+Directly+Activates+the+Keap1-Nrf2+Cell+Defense+System&doi=10.1002%2Fhep.22472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system</span></div><div class="casAuthors">Copple, Ian M.; Goldring, Christopher E.; Jenkins, Rosalind E.; Chia, Alvin J. L.; Randle, Laura E.; Hayes, John D.; Kitteringham, Neil R.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1292-1301</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 regulates the expression of numerous cytoprotective genes in mammalian cells.  We have demonstrated previously that acetaminophen activates Nrf2 in mouse liver following administration of non-hepatotoxic and hepatotoxic doses in vivo, implying that Nrf2 may have an important role in the protection against drug-induced liver injury.  Nrf2 activation has been proposed to occur through the modification of cysteine residues within Keap1, the cytosolic repressor of Nrf2.  We hypothesized that acetaminophen activates Nrf2 via the formation of its reactive metabolite N-acetyl-p-benzoquinoneimine (NAPQI), which may disrupt the repression of Nrf2 through the modification of cysteine residues within Keap1.  Here, we show that NAPQI can directly activate the Nrf2 pathway in mouse liver cells, inducing an adaptive defense response that is antagonized by RNA interference targeted against Nrf2.  Furthermore, mass spectrometric anal. shows that NAPQI selectively modifies cysteine residues in Keap1, both in recombinant protein in vitro and in cells ectopically expressing Keap1.  Using this cell-based model, we demonstrate that activation of Nrf2 by NAPQI and a panel of probe mols. [dexamethasone 21-mesylate, 15-deoxy-Î-(12,14)-prostaglandin J2, 2,4-dinitrochlorobenzene, and iodoacetamide] correlates with the selective modification of cysteine residues located within the intervening region of Keap1.  However, substantial depletion of glutathione (to less than 15% of basal levels) by buthionine sulfoximine, which does not directly modify Keap1, is also sufficient to activate Nrf2.  Conclusion: Nrf2 can be activated via the direct modification of cysteine residues located within the intervening region of Keap1, but also via the substantial depletion of glutathione without the requirement for direct modification of Keap1.  It is possible that both of these mechanisms contribute to the activation of Nrf2 by acetaminophen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtcE46973srVg90H21EOLACvtfcHk0liPF52hWmE_cQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Khu7zN&md5=def185e4070451e65d9d921d432c4489</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fhep.22472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22472%26sid%3Dliteratum%253Aachs%26aulast%3DCopple%26aufirst%3DI.%2BM.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DChia%26aufirst%3DA.%2BJ.%26aulast%3DRandle%26aufirst%3DL.%2BE.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DThe%2520Hepatotoxic%2520Metabolite%2520of%2520Acetaminophen%2520Directly%2520Activates%2520the%2520Keap1-Nrf2%2520Cell%2520Defense%2520System%26jtitle%3DHepatology%26date%3D2008%26volume%3D48%26spage%3D1292%26epage%3D1301%26doi%3D10.1002%2Fhep.22472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuta  Horie</span>, <span class="hlFld-ContribAuthor ">Takafumi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Jin  Inoue</span>, <span class="hlFld-ContribAuthor ">Tatsuro  Iso</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Wells</span>, <span class="hlFld-ContribAuthor ">Terry W.  Moore</span>, <span class="hlFld-ContribAuthor ">Tsunehiro  Mizushima</span>, <span class="hlFld-ContribAuthor ">Albena T.  Dinkova-Kostova</span>, <span class="hlFld-ContribAuthor ">Takuma  Kasai</span>, <span class="hlFld-ContribAuthor ">Takashi  Kamei</span>, <span class="hlFld-ContribAuthor ">Seizo  Koshiba</span>, <span class="hlFld-ContribAuthor ">Masayuki  Yamamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular basis for the disruption of Keap1âNrf2 interaction via Hinge & Latch mechanism. </span><span class="cited-content_cbyCitation_journal-name">Communications Biology</span><span> <strong>2021,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s42003-021-02100-6" title="DOI URL">https://doi.org/10.1038/s42003-021-02100-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s42003-021-02100-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs42003-021-02100-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCommunications%2520Biology%26atitle%3DMolecular%252Bbasis%252Bfor%252Bthe%252Bdisruption%252Bof%252BKeap1%2525E2%252580%252593Nrf2%252Binteraction%252Bvia%252BHinge%252B%252526%252BLatch%252Bmechanism%26aulast%3DHorie%26aufirst%3DYuta%26date%3D2021%26date%3D2021%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Le  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Xu</span>, <span class="hlFld-ContribAuthor ">Haihu  Chen</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chengguo  Xing</span>, <span class="hlFld-ContribAuthor ">Zhuo  Qu</span>, <span class="hlFld-ContribAuthor ">Jianqiang  Yu</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113599. <a href="https://doi.org/10.1016/j.ejmech.2021.113599" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113599%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bmolecular%252Bhybridization%252Bdesign%252Bof%252BKeap1-Nrf2%252Binhibitors%252Bas%252Bnovel%252Bprotective%252Bagents%252Bof%252Bacute%252Blung%252Binjury%26aulast%3DZhang%26aufirst%3DLe%26date%3D2021%26volume%3D222%26spage%3D113599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lea  Winand</span>, <span class="hlFld-ContribAuthor ">Angela  Sester</span>, <span class="hlFld-ContribAuthor ">Markus  Nett</span>. </span><span class="cited-content_cbyCitation_article-title">Bioengineering of AntiâInflammatory Natural Products. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , 767-776. <a href="https://doi.org/10.1002/cmdc.202000771" title="DOI URL">https://doi.org/10.1002/cmdc.202000771</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000771%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DBioengineering%252Bof%252BAnti%2525E2%252580%252590Inflammatory%252BNatural%252BProducts%26aulast%3DWinand%26aufirst%3DLea%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D5%26spage%3D767%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji-Eun  Kim</span>, <span class="hlFld-ContribAuthor ">Hana  Park</span>, <span class="hlFld-ContribAuthor ">Tae-Cheon  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">CDDO-Me Distinctly Regulates Regional Specific Astroglial Responses to Status Epilepticus via ERK1/2-Nrf2, PTEN-PI3K-AKT and NFÎºB Signaling Pathways. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2020,</strong> <em>9 </em>
                                    (10)
                                     , 1026. <a href="https://doi.org/10.3390/antiox9101026" title="DOI URL">https://doi.org/10.3390/antiox9101026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox9101026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox9101026%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DCDDO-Me%252BDistinctly%252BRegulates%252BRegional%252BSpecific%252BAstroglial%252BResponses%252Bto%252BStatus%252BEpilepticus%252Bvia%252BERK1%25252F2-Nrf2%25252C%252BPTEN-PI3K-AKT%252Band%252BNF%2525CE%2525BAB%252BSignaling%252BPathways%26aulast%3DKim%26aufirst%3DJi-Eun%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D10%26spage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Potential Pathways for the Formation of TriterpenoidâProtein Adducts</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of triterpenoids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Current models of Keap1-Nrf2 interaction.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14">(10â14)</a> (A) Domain structures of human Keap1 and important binding partners are shown. (B) Domain structures of human Nrf2. DLG and ETGE binding motif in Neh2 are highlighted. (C) Under basal conditions, Keap1 maintains low levels of Nrf2 by promoting its Cul3-Rbx1-mediated ubiquitination and subsequent proteasomal degradation. Under stressful conditions, covalent modification of key cysteine residues of Keap1 causes conformational changes. This can either disrupt the interaction between Nrf2 and Kelch (D) or decrease the binding of Cul3 to Keap1 (E), leading to nuclear accumulation of Nrf2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. LCâMS/MS analysis of CDDO-Im modified GSTP peptides identified <i>in vitro</i>. MS/MS spectra show (A) peptide <sup>45</sup>ASCLYGQLPK<sup>54</sup> was modified by CDDO carboxylate at Cys47 with a mass addition of 491.3 amu and (B) cross-linking adducts formed between Ser46 and Cys47 on peptide <sup>45</sup>ASCLYGQLPK<sup>54</sup> with a mass addition of 473.3 amu. Covalent binding to GSTP was concentration dependent as shown by individual sites (C) and total binding (D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. LCâMS/MS analysis of CDDO-Im modified HSA peptides identified <i>in vitro</i>. MS/MS spectra show (A) an acylation of Lys413 by CDDO-Im was detected on peptide <sup>411</sup>YTKK<sup>414</sup> from HSA and (B) similar adducts were also detected on Tyr411 (<sup>411</sup>YTK<sup>413</sup>). Covalent binding to HSA was time (5 Î¼M CDDO-Im) and concentration dependent (C, D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Covalent binding of CDDO-Im to Keap1 protein. (A) Representative MS/MS spectrum shows CDDO-Im forms an acylation adduct with Tyr85 in Keap1. (B) Covalent binding of CDDO-Im to Keap1 is concentration-dependent. (C) Relative quantification using normalized ion counts revealed that CDDO-Im (100 nM) selectively targets Tyr85 when incubated with Keap1. (D) Covalent docking of CDDO-Im with Tyr85 into BTB domain of Keap1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CXI">4CXI</a>) demonstrated that the ring system was positioned away from Cys151. (E) CDDO interacts with Met161 and Gly128 through hydrogen bonds that are denoted by dashed lines. Images are illustrated by PyMOL (The PyMOL Molecular Graphics System, version 1.3, SchrÃ¶dinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/medium/jm0c01088_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of CDDO-Im on Keap1-Cul3 complex formation. (A) Crystal structure of Keap1-Cul3 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NBL">5NBL</a>) highlights the importance of Tyr85 for Cul3 binding. (B) Mesh representation of Keap1-CDDO-Cul3 complex showing CDDO can stabilize the Keap1-Cul3 complex. (C) Covalent binding of CDDO-Im to Tyr85 positions the ring system toward Cul3. (D) CDDO interacts with Arg188 in Cul3 through hydrogen bonds that are denoted by dashed lines. Images are illustrated by PyMOL (The PyMOL Molecular Graphics System, version 1.3, SchrÃ¶dinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01088/20200903/images/large/jm0c01088_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01088&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span> <span> </span><span class="NLM_article-title">Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">972</span>â <span class="NLM_lpage">1003</span>, <span class="refDoi">Â DOI: 10.1124/pr.111.004846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1124%2Fpr.111.004846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=22966038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslaltQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=972-1003&author=K.+T.+Libyauthor=M.+B.+Sporn&title=Synthetic+Oleanane+Triterpenoids%3A+Multifunctional+Drugs+with+a+Broad+Range+of+Applications+for+Prevention+and+Treatment+of+Chronic+Disease&doi=10.1124%2Fpr.111.004846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease</span></div><div class="casAuthors">Liby, Karen T.; Sporn, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">972-1003</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We review the rationale for the use of synthetic oleanane triterpenoids (SOs) for prevention and treatment of disease, as well as extensive biol. data on this topic resulting from both cell culture and in vivo studies.  Emphasis is placed on understanding mechanisms of action.  SOs are noncytotoxic drugs with an excellent safety profile.  Several hundred SOs have now been synthesized and in vitro have been shown to: 1) suppress inflammation and oxidative stress and therefore be cytoprotective, esp. at low nanomolar doses, 2) induce differentiation, and 3) block cell proliferation and induce apoptosis at higher micromolar doses.  Animal data on the use of SOs in neurodegenerative diseases and in diseases of the eye, lung, cardiovascular system, liver, gastrointestinal tract, and kidney, as well as in cancer and in metabolic and inflammatory/autoimmune disorders, are reviewed.  The importance of the cytoprotective Kelch-like erythroid cell-derived protein with CNC homol.-assocd. protein 1/nuclear factor (erythroid-derived 2)-like 2/antioxidant response element (Keap1/Nrf2/ARE) pathway as a mechanism of action is explained, but interactions with peroxisome proliferator-activated receptor Î³ (PARPÎ³), inhibitor of nuclear factor-ÎºB kinase complex (IKK), janus tyrosine kinase/signal transducer and activator of transcription (JAK/STAT), human epidermal growth factor receptor 2 (HER2)/ErbB2/neu, phosphatase and tensin homolog (PTEN), the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway, mammalian target of rapamycin (mTOR), and the thiol proteome are also described.  In these interactions, Michael addn. of SOs to reactive cysteine residues in specific mol. targets triggers biol. activity.  Ultimately, SOs are multifunctional drugs that regulate the activity of entire networks.  Recent progress in the earliest clin. trials with 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO) Me ester (bardoxolone methyl) is also summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozzGNihQsvrrVg90H21EOLACvtfcHk0ljC0eCL3BTlJA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslaltQ%253D%253D&md5=5c0a741d089e6f6a504eae31a47d872c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.111.004846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.111.004846%26sid%3Dliteratum%253Aachs%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26atitle%3DSynthetic%2520Oleanane%2520Triterpenoids%253A%2520Multifunctional%2520Drugs%2520with%2520a%2520Broad%2520Range%2520of%2520Applications%2520for%2520Prevention%2520and%2520Treatment%2520of%2520Chronic%2520Disease%26jtitle%3DPharmacol.%2520Rev.%26date%3D2012%26volume%3D64%26spage%3D972%26epage%3D1003%26doi%3D10.1124%2Fpr.111.004846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2 System: A Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1169</span>â <span class="NLM_lpage">1203</span>, <span class="refDoi">Â DOI: 10.1152/physrev.00023.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1152%2Fphysrev.00023.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=29717933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvFektrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2018&pages=1169-1203&author=M.+Yamamotoauthor=T.+W.+Kenslerauthor=H.+Motohashi&title=The+Keap1-Nrf2+System%3A+A+Thiol-Based+Sensor-Effector+Apparatus+for+Maintaining+Redox+Homeostasis&doi=10.1152%2Fphysrev.00023.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis</span></div><div class="casAuthors">Yamamoto, Masayuki; Kensler, Thomas W.; Motohashi, Hozumi</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1169-1203</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">1522-1210</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The Kelch-like ECH-assocd. protein 1-NF-E2-related factor 2 (KEAP1-NRF2) system forms the major node of cellular and organismal defense against oxidative and electrophilic stresses of both exogenous and endogenous origins.  KEAP1 acts as a cysteine thiol-rich sensor of redox insults, whereas NRF2 is a transcription factor that robustly transduces chem. signals to regulate a battery of cytoprotective genes.  KEAP1 represses NRF2 activity under quiescent conditions, whereas NRF2 is liberated from KEAP1-mediated repression on exposure to stresses.  The rapid inducibility of a response based on a derepression mechanism is an important feature of the KEAP1-NRF2 system.  Recent studies have unveiled the complexities of the functional contributions of the KEAP1-NRF2 system and defined its broader involvement in biol. processes, including cell proliferation and differentiation, as well as cytoprotection.  In this review, we describe historical milestones in the initial characterization of the KEAP1-NRF2 system and provide a comprehensive overview of the mol. mechanisms governing the functions of KEAP1 and NRF2, as well as their roles in physiol. and pathol.  We also refer to the clin. significance of the KEAP1-NRF2 system as an important prophylactic and therapeutic target for various diseases, particularly aging-related disorders.  We believe that controlled harnessing of the KEAP1-NRF2 system is a key to healthy aging and well-being in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohbdKIhBBbkLVg90H21EOLACvtfcHk0ljC0eCL3BTlJA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvFektrc%253D&md5=906947c8ad97c48f60e46bc44103664a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00023.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00023.2017%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DMotohashi%26aufirst%3DH.%26atitle%3DThe%2520Keap1-Nrf2%2520System%253A%2520A%2520Thiol-Based%2520Sensor-Effector%2520Apparatus%2520for%2520Maintaining%2520Redox%2520Homeostasis%26jtitle%3DPhysiol.%2520Rev.%26date%3D2018%26volume%3D98%26spage%3D1169%26epage%3D1203%26doi%3D10.1152%2Fphysrev.00023.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uruno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furusawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagishita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukutomi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2996</span>â <span class="NLM_lpage">3010</span>, <span class="refDoi">Â DOI: 10.1128/MCB.00225-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.00225-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=23716596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1arur7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=2996-3010&author=A.+Urunoauthor=Y.+Furusawaauthor=Y.+Yagishitaauthor=T.+Fukutomiauthor=H.+Muramatsuauthor=T.+Negishiauthor=A.+Sugawaraauthor=T.+W.+Kenslerauthor=M.+Yamamoto&title=The+Keap1-Nrf2+System+Prevents+Onset+of+Diabetes+Mellitus&doi=10.1128%2FMCB.00225-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Keap1-Nrf2 system prevents onset of diabetes mellitus</span></div><div class="casAuthors">Uruno, Akira; Furusawa, Yuki; Yagishita, Yoko; Fukutomi, Toshiaki; Muramatsu, Hiroyuki; Negishi, Takaaki; Sugawara, Akira; Kensler, Thomas W.; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2996-3010</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Transcription factor Nrf2 (NF-E2-related factor 2) regulates a broad cytoprotective response to environmental stresses.  Keap1 (Kelch-like ECH-assocd. protein 1) is an adaptor protein for cullin3-based ubiquitin E3 ligase and neg. regulates Nrf2.  Whereas the Keap1-Nrf2 system plays important roles in oxidative stress response and metab., the roles Nrf2 plays in the prevention of diabetes mellitus remain elusive.  Here we show that genetic activation of Nrf2 signaling by Keap1 gene hypomorphic knockdown (Keap1flox/-) markedly suppresses the onset of diabetes.  When Keap1flox/- mice were crossed with diabetic db/db mice, blood glucose levels became lower through improvement of both insulin secretion and insulin resistance.  Keap1flox/- also prevented high-calorie-diet-induced diabetes.  Oral administration of the Nrf2 inducer CDDO-Im {oleanolic acid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl] imidazole} also attenuated diabetes in db/db mice.  Nrf2 induction altered antioxidant-, energy consumption-, and gluconeogenesis-related gene expression in metabolic tissues.  Thus, the Keap1-Nrf2 system is a crit. target for preventing the onset of diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrepn_xCF-lw7Vg90H21EOLACvtfcHk0lg38LV-2rm6sQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1arur7J&md5=84157bcae46cb8b986c6cc0ed7c2648c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FMCB.00225-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00225-13%26sid%3Dliteratum%253Aachs%26aulast%3DUruno%26aufirst%3DA.%26aulast%3DFurusawa%26aufirst%3DY.%26aulast%3DYagishita%26aufirst%3DY.%26aulast%3DFukutomi%26aufirst%3DT.%26aulast%3DMuramatsu%26aufirst%3DH.%26aulast%3DNegishi%26aufirst%3DT.%26aulast%3DSugawara%26aufirst%3DA.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DThe%2520Keap1-Nrf2%2520System%2520Prevents%2520Onset%2520of%2520Diabetes%2520Mellitus%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2013%26volume%3D33%26spage%3D2996%26epage%3D3010%26doi%3D10.1128%2FMCB.00225-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egner, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wible, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutter, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groopman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roebuck, B. D.</span></span> <span> </span><span class="NLM_article-title">Complete Protection against Aflatoxin B(1)-Induced Liver Cancer with a Triterpenoid: DNA Adduct Dosimetry, Molecular Signature, and Genotoxicity Threshold</span>. <i>Cancer Prev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">658</span>â <span class="NLM_lpage">665</span>, <span class="refDoi">Â DOI: 10.1158/1940-6207.CAPR-13-0430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1158%2F1940-6207.CAPR-13-0430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=24662598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWgsb%252FK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=658-665&author=N.+M.+Johnsonauthor=P.+A.+Egnerauthor=V.+K.+Baxterauthor=M.+B.+Spornauthor=R.+S.+Wibleauthor=T.+R.+Sutterauthor=J.+D.+Groopmanauthor=T.+W.+Kenslerauthor=B.+D.+Roebuck&title=Complete+Protection+against+Aflatoxin+B%281%29-Induced+Liver+Cancer+with+a+Triterpenoid%3A+DNA+Adduct+Dosimetry%2C+Molecular+Signature%2C+and+Genotoxicity+Threshold&doi=10.1158%2F1940-6207.CAPR-13-0430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Complete Protection against Aflatoxin B1-Induced Liver Cancer with a Triterpenoid: DNA Adduct Dosimetry, Molecular Signature, and Genotoxicity Threshold</span></div><div class="casAuthors">Johnson, Natalie M.; Egner, Patricia A.; Baxter, Victoria K.; Sporn, Michael B.; Wible, Ryan S.; Sutter, Thomas R.; Groopman, John D.; Kensler, Thomas W.; Roebuck, Bill D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">658-665</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In exptl. animals and humans, aflatoxin B1 (AFB1) is a potent hepatic toxin and carcinogen.  The synthetic oleanane triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im), a powerful activator of Keap1-Nrf2 signaling, protects against AFB1-induced toxicity and preneoplastic lesion formation (GST-P-pos. foci).  This study assessed and mechanistically characterized the chemoprotective efficacy of CDDO-Im against AFB1-induced hepatocellular carcinoma (HCC).  A lifetime cancer bioassay was undertaken in F344 rats dosed with AFB1 (200 Î¼g/kg rat/day) for four weeks and receiving either vehicle or CDDO-Im (three times weekly), one week before and throughout the exposure period.  Weekly, 24-h urine samples were collected for anal. of AFB1 metabolites.  In a subset of rats, livers were analyzed for GST-P foci.  The comparative response of a toxicogenomic RNA expression signature for AFB1 was examd.  CDDO-Im completely protected (0/20) against AFB1-induced liver cancer compared with a 96% incidence (22/23) obsd. in the AFB1 group.  With CDDO-Im treatment, integrated level of urinary AFB1-N7-guanine was significantly reduced (66%) and aflatoxin-N-acetylcysteine, a detoxication product, was consistently elevated (300%) after the first AFB1 dose.  In AFB1-treated rats, the hepatic burden of GST-P-pos. foci increased substantially (0%-13.8%) over the four weeks, but was largely absent with CDDO-Im intervention.  The toxicogenomic RNA expression signature characteristic of AFB1 was absent in the AFB1 + CDDO-Im-treated rats.  The remarkable efficacy of CDDO-Im as an anticarcinogen is established even in the face of a significant aflatoxin adduct burden.  Consequently, the absence of cancer requires a concept of a threshold for DNA damage for cancer development.  Cancer Prev Res; 7(7); 658-65. Â©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI00fL13ZiuLVg90H21EOLACvtfcHk0lg38LV-2rm6sQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWgsb%252FK&md5=001712c4584629a64435a43a73bcbb71</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-13-0430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-13-0430%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DN.%2BM.%26aulast%3DEgner%26aufirst%3DP.%2BA.%26aulast%3DBaxter%26aufirst%3DV.%2BK.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DWible%26aufirst%3DR.%2BS.%26aulast%3DSutter%26aufirst%3DT.%2BR.%26aulast%3DGroopman%26aufirst%3DJ.%2BD.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DRoebuck%26aufirst%3DB.%2BD.%26atitle%3DComplete%2520Protection%2520against%2520Aflatoxin%2520B%25281%2529-Induced%2520Liver%2520Cancer%2520with%2520a%2520Triterpenoid%253A%2520DNA%2520Adduct%2520Dosimetry%252C%2520Molecular%2520Signature%252C%2520and%2520Genotoxicity%2520Threshold%26jtitle%3DCancer%2520Prev.%2520Res.%26date%3D2014%26volume%3D7%26spage%3D658%26epage%3D665%26doi%3D10.1158%2F1940-6207.CAPR-13-0430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakris, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chertow, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsberry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inker, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heerspink, H. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâGrady, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergola, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warnock, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. J.</span></span> <span> </span><span class="NLM_article-title">Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study</span>. <i>Am. J. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">40</span>â <span class="NLM_lpage">47</span>, <span class="refDoi">Â DOI: 10.1159/000486398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1159%2F000486398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=29402767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVCiu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=40-47&author=M.+P.+Chinauthor=G.+L.+Bakrisauthor=G.+A.+Blockauthor=G.+M.+Chertowauthor=A.+Goldsberryauthor=L.+A.+Inkerauthor=H.+J.+L.+Heerspinkauthor=M.+O%E2%80%99Gradyauthor=P.+E.+Pergolaauthor=C.+Wannerauthor=D.+G.+Warnockauthor=C.+J.+Meyer&title=Bardoxolone+Methyl+Improves+Kidney+Function+in+Patients+with+Chronic+Kidney+Disease+Stage+4+and+Type+2+Diabetes%3A+Post-Hoc+Analyses+from+Bardoxolone+Methyl+Evaluation+in+Patients+with+Chronic+Kidney+Disease+and+Type+2+Diabetes+Study&doi=10.1159%2F000486398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study</span></div><div class="casAuthors">Chin, Melanie P.; Bakris, George L.; Block, Geoffrey A.; Chertow, Glenn M.; Goldsberry, Angie; Inker, Lesley A.; Heerspink, Hiddo J. L.; O'Grady, Megan; Pergola, Pablo E.; Wanner, Christoph; Warnock, David G.; Meyer, Colin J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Nephrology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-47</span>CODEN:
                <span class="NLM_cas:coden">AJNED9</span>;
        ISSN:<span class="NLM_cas:issn">0250-8095</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Increases in measured inulin clearance, measured creatinine clearance, and estd. glomerular filtration rate (eGFR) have been obsd. with bardoxolone Me in 7 studies enrolling approx. 2,600 patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).  The largest of these studies was Bardoxolone Me Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes (BEACON), a multinational, randomized, double-blind, placebo-controlled phase 3 trial which enrolled patients with T2D and CKD stage 4.  The BEACON trial was terminated after preliminary analyses showed that patients randomized to bardoxolone Me experienced significantly higher rates of heart failure events.  We performed post-hoc analyses to characterize changes in kidney function induced by bardoxolone Me.  Methods: Patients in -BEACON (n = 2,185) were randomized 1: 1 to receive once-daily bardoxolone Me (20 mg) or placebo.  We compared the effects of bardoxolone Me and placebo on a post-hoc composite renal endpoint consisting of â¥30% decline from baseline in eGFR, eGFR <15 mL/min/1.73 m2, and end-stage renal disease (ESRD) events (provision of dialysis or kidney transplantation).  Results: Consistent with prior studies, patients randomized to bardoxolone Me experienced mean increases in eGFR that were sustained through study week 48.  Moreover, increases in eGFR from baseline were sustained 4 wk after cessation of treatment.  Patients randomized to bardoxolone Me were significantly less likely to experience the composite renal endpoint (hazards ratio 0.48 [95% CI 0.36-0.64]; p < 0.0001).  Conclusions: Bardoxolone Me preserves kidney function and may delay the onset of ESRD in patients with T2D and stage 4 CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjOzptzThpbVg90H21EOLACvtfcHk0lg38LV-2rm6sQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVCiu7Y%253D&md5=9351e5606902fd77cfe5dc042c833e66</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1159%2F000486398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000486398%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DM.%2BP.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DBlock%26aufirst%3DG.%2BA.%26aulast%3DChertow%26aufirst%3DG.%2BM.%26aulast%3DGoldsberry%26aufirst%3DA.%26aulast%3DInker%26aufirst%3DL.%2BA.%26aulast%3DHeerspink%26aufirst%3DH.%2BJ.%2BL.%26aulast%3DO%25E2%2580%2599Grady%26aufirst%3DM.%26aulast%3DPergola%26aufirst%3DP.%2BE.%26aulast%3DWanner%26aufirst%3DC.%26aulast%3DWarnock%26aufirst%3DD.%2BG.%26aulast%3DMeyer%26aufirst%3DC.%2BJ.%26atitle%3DBardoxolone%2520Methyl%2520Improves%2520Kidney%2520Function%2520in%2520Patients%2520with%2520Chronic%2520Kidney%2520Disease%2520Stage%25204%2520and%2520Type%25202%2520Diabetes%253A%2520Post-Hoc%2520Analyses%2520from%2520Bardoxolone%2520Methyl%2520Evaluation%2520in%2520Patients%2520with%2520Chronic%2520Kidney%2520Disease%2520and%2520Type%25202%2520Diabetes%2520Study%26jtitle%3DAm.%2520J.%2520Nephrol.%26date%3D2018%26volume%3D47%26spage%3D40%26epage%3D47%26doi%3D10.1159%2F000486398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzclaw, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risingsong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Extremely Potent Triterpenoid Inducers of the Phase 2 Response: Correlations of Protection against Oxidant and Inflammatory Stress</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">4584</span>â <span class="NLM_lpage">4589</span>, <span class="refDoi">Â DOI: 10.1073/pnas.0500815102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1073%2Fpnas.0500815102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=15767573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivFCqs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=4584-4589&author=A.+T.+Dinkova-Kostovaauthor=K.+T.+Libyauthor=K.+K.+Stephensonauthor=W.+D.+Holtzclawauthor=X.+Gaoauthor=N.+Suhauthor=C.+Williamsauthor=R.+Risingsongauthor=T.+Hondaauthor=G.+W.+Gribbleauthor=M.+B.+Spornauthor=P.+Talalay&title=Extremely+Potent+Triterpenoid+Inducers+of+the+Phase+2+Response%3A+Correlations+of+Protection+against+Oxidant+and+Inflammatory+Stress&doi=10.1073%2Fpnas.0500815102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Liby, Karen T.; Stephenson, Katherine K.; Holtzclaw, W. David; Gao, Xiangqun; Suh, Nanjoo; Williams, Charlotte; Risingsong, Renee; Honda, Tadashi; Gribble, Gordon W.; Sporn, Michael B.; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4584-4589</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A series of synthetic triterpenoid (TP) analogs of oleanolic acid are powerful inhibitors of cellular inflammatory processes such as the induction by IFN-Î³ of inducible nitric oxide synthase (iNOS) and of cyclooxygenase 2 in mouse macrophages.  Here, we show that these analogs are also extremely potent inducers of the phase 2 response [e.g., elevation of NAD(P)H-quinone oxidoreductase and heme oxygenase 1], which is a major protector of cells against oxidative and electrophile stress.  Moreover, like previously identified phase 2 inducers, the TP analogs use the antioxidant response element-Nrf2-Keap1 signaling pathway.  Thus, induction of the phase 2 response and suppression of the iNOS induction was abrogated in nrf2-/- and keap1-/- mouse embryonic fibroblasts.  The high potency of TP analogs in inducing the phase 2 response and blocking inflammation depends on the presence of activated Michael reaction (enone) functions at crit. positions in rings A and C.  The most potent TP doubles NAD(P)H-quinone oxidoreductase in murine hepatoma cells at 0.28 nM and has an IC50 for suppression of iNOS induction in primary mouse macrophages of 0.0035 nM.  The direct interaction of this TP with thiol groups of the Keap1 sensor for inducers is demonstrated spectroscopically.  The antiinflammatory and phase 2 inducer potencies of 18 TP are closely linearly correlated (r2 = 0.91) over 6 orders of magnitude of concn.  Thus, in addn. to blocking inflammation and promoting differentiation, these TP exhibit another very important protective property: the induction of the phase 2 response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjPGfuWcwoqbVg90H21EOLACvtfcHk0ljaPUGAfLbx5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivFCqs74%253D&md5=02be0d1918c1f700662a12c9a14594b6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0500815102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0500815102%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DStephenson%26aufirst%3DK.%2BK.%26aulast%3DHoltzclaw%26aufirst%3DW.%2BD.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DSuh%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DRisingsong%26aufirst%3DR.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DExtremely%2520Potent%2520Triterpenoid%2520Inducers%2520of%2520the%2520Phase%25202%2520Response%253A%2520Correlations%2520of%2520Protection%2520against%2520Oxidant%2520and%2520Inflammatory%2520Stress%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D4584%26epage%3D4589%26doi%3D10.1073%2Fpnas.0500815102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yore, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundararajan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span> <span> </span><span class="NLM_article-title">Platforms and Networks in Triterpenoid Pharmacology</span>. <i>Drug Dev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">174</span>â <span class="NLM_lpage">182</span>, <span class="refDoi">Â DOI: 10.1002/ddr.20179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1002%2Fddr.20179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlarsbjN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=174-182&author=M.+B.+Spornauthor=K.+Libyauthor=M.+M.+Yoreauthor=N.+Suhauthor=A.+Albiniauthor=T.+Hondaauthor=C.+Sundararajanauthor=G.+W.+Gribble&title=Platforms+and+Networks+in+Triterpenoid+Pharmacology&doi=10.1002%2Fddr.20179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Platforms and networks in triterpenoid pharmacology</span></div><div class="casAuthors">Sporn, Michael B.; Liby, Karen; Yore, Mark M.; Suh, Nanjoo; Albini, Adriana; Honda, Tadashi; Sundararajan, Chitra; Gribble, Gordon W.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">174-182</span>CODEN:
                <span class="NLM_cas:coden">DDREDK</span>;
        ISSN:<span class="NLM_cas:issn">0272-4391</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Using the pentacyclic, naturally occurring triterpenoids, oleanolic, ursolic, and betulinic acids, as starting materials, we have developed a new series of multifunctional drugs for potential clin. use.  These agents have anti-inflammatory, anti-oxidative, anti-proliferative, pro-apoptotic, and differentiating activities.  Two synthetic oleanane triterpenoids, 2-cyano-3, 12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO) and its C-28 Me ester (CDDO-Me), are presently in Phase I clin. trials in cancer patients.  Three themes are emphasized in this review: (1) The importance of the unique structures of the triterpenoid platforms that have been used as a start for new synthesis; (2) The concept that these new drugs interact with entire physiol. networks, rather than solely with single mol. targets; and (3) The coupling in real time between the triterpenoid platforms and the physiol. networks with which they interact, as seen in the reversibility of the Michael reactions, which mediate their activity.  We suggest that further development of such new, multifunctional drugs will most likely occur in the more flexible environment of small biotech or pharmaceutical companies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouR8MkZu3RK7Vg90H21EOLACvtfcHk0ljaPUGAfLbx5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlarsbjN&md5=8ca2a9cb8c0364b956a9e3b196b572a8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fddr.20179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.20179%26sid%3Dliteratum%253Aachs%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLiby%26aufirst%3DK.%26aulast%3DYore%26aufirst%3DM.%2BM.%26aulast%3DSuh%26aufirst%3DN.%26aulast%3DAlbini%26aufirst%3DA.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DSundararajan%26aufirst%3DC.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26atitle%3DPlatforms%2520and%2520Networks%2520in%2520Triterpenoid%2520Pharmacology%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2007%26volume%3D68%26spage%3D174%26epage%3D182%26doi%3D10.1002%2Fddr.20179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yore, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopchuk, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span> <span> </span><span class="NLM_article-title">New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">537</span>â <span class="NLM_lpage">545</span>, <span class="refDoi">Â DOI: 10.1021/np100826q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np100826q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVWisrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=537-545&author=M.+B.+Spornauthor=K.+T.+Libyauthor=M.+M.+Yoreauthor=L.+Fuauthor=J.+M.+Lopchukauthor=G.+W.+Gribble&title=New+Synthetic+Triterpenoids%3A+Potent+Agents+for+Prevention+and+Treatment+of+Tissue+Injury+Caused+by+Inflammatory+and+Oxidative+Stress&doi=10.1021%2Fnp100826q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress</span></div><div class="casAuthors">Sporn, Michael B.; Liby, Karen T.; Yore, Mark M.; Fu, Liangfeng; Lopchuk, Justin M.; Gribble, Gordon W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">537-545</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">We review the original rational for the development and the chem. of a series of new synthetic oleanane triterpenoids (SO), based on oleanolic acid (I) as a starting material.  Many of the new compds. that have been made, such as 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ["CDDO", (II; R = H)], are highly potent (activities found at levels below 1 nM) anti-inflammatory agents, as measured by their ability to block the cellular synthesis of the enzyme inducible nitric oxide synthase (iNOS) in activated macrophages.  Details of the org. synthesis of new SO and their chem. mechanisms of biol. activity are reviewed, as is formation of biotin conjugates for investigation of protein targets.  Finally, we give a brief summary of important biol. activities of SO in many organ systems in numerous animal models.  Clin. investigation of a new SO [Me 2-cyano-3,12-dioxooleana-1,9(11)dien-28-oate, "CDDO-Me", bardoxolone Me, (II; R = Me)] is currently in progress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXWMDf2Fxc3LVg90H21EOLACvtfcHk0ljaPUGAfLbx5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVWisrg%253D&md5=a6b2efe5faaba6151472b0f5f654940e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fnp100826q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp100826q%26sid%3Dliteratum%253Aachs%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DYore%26aufirst%3DM.%2BM.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DLopchuk%26aufirst%3DJ.%2BM.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26atitle%3DNew%2520Synthetic%2520Triterpenoids%253A%2520Potent%2520Agents%2520for%2520Prevention%2520and%2520Treatment%2520of%2520Tissue%2520Injury%2520Caused%2520by%2520Inflammatory%2520and%2520Oxidative%2520Stress%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D537%26epage%3D545%26doi%3D10.1021%2Fnp100826q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yore, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettenbach, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span> <span> </span><span class="NLM_article-title">Proteomic Analysis Shows Synthetic Oleanane Triterpenoid Binds to Mtor</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e22862</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0022862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1371%2Fjournal.pone.0022862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=21818401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOrsbfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e22862&author=M.+M.+Yoreauthor=A.+N.+Kettenbachauthor=M.+B.+Spornauthor=S.+A.+Gerberauthor=K.+T.+Liby&title=Proteomic+Analysis+Shows+Synthetic+Oleanane+Triterpenoid+Binds+to+Mtor&doi=10.1371%2Fjournal.pone.0022862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR</span></div><div class="casAuthors">Yore, Mark M.; Kettenbach, Arminja N.; Sporn, Michael B.; Gerber, Scott A.; Liby, Karen T.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e22862</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">New multifunctional drugs that target multiple disease-relevant networks offer a novel approach to the prevention and treatment of many diseases.  New synthetic oleanane triterpenoids (SO), such as CDDO (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) and its derivs., are multifunctional compds. originally developed for the prevention and treatment of inflammation and oxidative stress.  However, the protein binding partners and mechanisms of action of these SO are not yet fully understood.  Here we characterize the putative target profile of one SO, CDDO-Imidazolide (CDDO-Im), by combining affinity purifn. with mass spectroscopic proteomic anal. to identify 577 candidate binding proteins in whole cells.  This SO pharmaco-interactome consists of a diverse but interconnected set of signaling networks; bioinformatic anal. of the protein interactome identified canonical signaling pathways targeted by the SO, including retinoic acid receptor (RAR), estrogen receptor (ER), insulin receptor (IR), janus kinase/signal transducers and activators of transcription (JAK/STAT), and phosphatase and tensin homolog (PTEN).  Pull-down studies then further validated a subset of the putative targets.  In addn., we now show for the first time that the mammalian target of rapamycin (mTOR) is a direct target of CDDO-Im.  We also show that CDDO-Im blocks insulin-induced activation of this pathway by binding to mTOR and inhibiting its kinase activity.  Our basic studies confirm that the SO, CDDO-Im, acts on a protein network to elicit its pharmacol. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3xaGX_jtP5rVg90H21EOLACvtfcHk0ljLqw5qMbgJaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOrsbfI&md5=6a92c2cdd3bfa0720a8b80f0f48fd5e7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0022862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0022862%26sid%3Dliteratum%253Aachs%26aulast%3DYore%26aufirst%3DM.%2BM.%26aulast%3DKettenbach%26aufirst%3DA.%2BN.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26atitle%3DProteomic%2520Analysis%2520Shows%2520Synthetic%2520Oleanane%2520Triterpenoid%2520Binds%2520to%2520Mtor%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De22862%26doi%3D10.1371%2Fjournal.pone.0022862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henzl, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beamer, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Structure of the Keap1:Nrf2 Interface Provides Mechanistic Insight into Nrf2 Signaling</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3605</span>â <span class="NLM_lpage">3617</span>, <span class="refDoi">Â DOI: 10.1038/sj.emboj.7601243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1038%2Fsj.emboj.7601243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=16888629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVGlsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=3605-3617&author=S.+C.+Loauthor=X.+Liauthor=M.+T.+Henzlauthor=L.+J.+Beamerauthor=M.+Hannink&title=Structure+of+the+Keap1%3ANrf2+Interface+Provides+Mechanistic+Insight+into+Nrf2+Signaling&doi=10.1038%2Fsj.emboj.7601243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling</span></div><div class="casAuthors">Lo, Shih-Ching; Li, Xuchu; Henzl, Michael T.; Beamer, Lesa J.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3605-3617</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Keap1 is a BTB-Kelch substrate adaptor protein that regulates steady-state levels of Nrf2, a bZIP transcription factor, in response to oxidative stress.  We have detd. the structure of the Kelch domain of Keap1 bound to a 16-mer peptide from Nrf2 contg. a highly conserved DxETGE motif.  The Nrf2 peptide contains two short antiparallel Î²-strands connected by two overlapping type I Î²-turns stabilized by the aspartate and threonine residues.  The Î²-turn region fits into a binding pocket on the top face of the Kelch domain and the glutamate residues form multiple hydrogen bonds with highly conserved residues in Keap1.  Mutagenesis expts. confirmed the role of individual amino acids for binding of Nrf2 to Keap1 and for Keap1-mediated repression of Nrf2-dependent gene expression.  Our results provide a detailed picture of how a BTB-Kelch substrate adaptor protein binds to its cognate substrate and will enable the rational design of novel chemopreventive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqJXSF9pJFdLVg90H21EOLACvtfcHk0ljLqw5qMbgJaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVGlsLo%253D&md5=df96ad6cb82632192d5d693ea87c85ad</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601243%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DS.%2BC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHenzl%26aufirst%3DM.%2BT.%26aulast%3DBeamer%26aufirst%3DL.%2BJ.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520Keap1%253ANrf2%2520Interface%2520Provides%2520Mechanistic%2520Insight%2520into%2520Nrf2%2520Signaling%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D3605%26epage%3D3617%26doi%3D10.1038%2Fsj.emboj.7601243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusunoki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 Recruits Neh2 through Binding to Etge and Dlg Motifs: Characterization of the Two-Site Molecular Recognition Model</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2887</span>â <span class="NLM_lpage">2900</span>, <span class="refDoi">Â DOI: 10.1128/MCB.26.8.2887-2900.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.26.8.2887-2900.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=16581765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1Slsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2887-2900&author=K.+I.+Tongauthor=Y.+Katohauthor=H.+Kusunokiauthor=K.+Itohauthor=T.+Tanakaauthor=M.+Yamamoto&title=Keap1+Recruits+Neh2+through+Binding+to+Etge+and+Dlg+Motifs%3A+Characterization+of+the+Two-Site+Molecular+Recognition+Model&doi=10.1128%2FMCB.26.8.2887-2900.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model</span></div><div class="casAuthors">Tong, Kit I.; Katoh, Yasutake; Kusunoki, Hideki; Itoh, Ken; Tanaka, Toshiyuki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2887-2900</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The expression of the phase 2 detoxification enzymes and antioxidant proteins is induced at the transcriptional level by Nrf2 and neg. regulated at the posttranslational level by Keap1 through protein-protein interactions with Nrf2 and subsequent proteolysis of Nrf2.  We found that the Neh2 domain of Nrf2 is an intrinsically disordered but biol. active regulatory domain contg. a 33-residue central Î±-helix followed by a mini antiparallel Î²-sheet.  Isothermal calorimetry anal. indicated that one Neh2 mol. interacts with two mols. of Keap1 via two binding sites, the stronger binding ETGE motif and the weaker binding DLG motif.  NMR titrn. study showed that these two motifs of the Neh2 domain bind to an overlapping site on the bottom surface of the Î²-propeller structure of Keap1.  In contrast, the central Î±-helix of the Neh2 domain does not have any observable affinity to Keap1, suggesting that this region may serve as a bridge connecting the two motifs for the assocn. with the two Î²-propeller structures of a dimer of Keap1.  Based on these observations, we propose that Keap1 recruits Nrf2 by the ETGE motif and that the DLG motif of the Neh2 domain locks its lysine-rich central Î±-helix in a correct position to benefit ubiquitin (Ub) signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW4AlViBIZg7Vg90H21EOLACvtfcHk0ljLqw5qMbgJaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1Slsbw%253D&md5=f6a5af3be5757cd665f234562d48d727</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.8.2887-2900.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.8.2887-2900.2006%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DKusunoki%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKeap1%2520Recruits%2520Neh2%2520through%2520Binding%2520to%2520Etge%2520and%2520Dlg%2520Motifs%253A%2520Characterization%2520of%2520the%2520Two-Site%2520Molecular%2520Recognition%2520Model%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D2887%26epage%3D2900%26doi%3D10.1128%2FMCB.26.8.2887-2900.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">The Molecular Mechanisms Regulating the Keap1-Nrf2 Pathway</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">40</span>, <span class="refDoi">Â DOI: 10.1128/MCB.00099-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.00099-20" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&pages=40&author=L.+Bairdauthor=M.+Yamamoto&title=The+Molecular+Mechanisms+Regulating+the+Keap1-Nrf2+Pathway&doi=10.1128%2FMCB.00099-20"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FMCB.00099-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00099-20%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DThe%2520Molecular%2520Mechanisms%2520Regulating%2520the%2520Keap1-Nrf2%2520Pathway%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2020%26volume%3D40%26spage%3D40%26doi%3D10.1128%2FMCB.00099-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kansanen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuosmanen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leinonen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levonen, A. L.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2 Pathway: Mechanisms of Activation and Dysregulation in Cancer</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">45</span>â <span class="NLM_lpage">49</span>, <span class="refDoi">Â DOI: 10.1016/j.redox.2012.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.redox.2012.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=24024136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptFygsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=45-49&author=E.+Kansanenauthor=S.+M.+Kuosmanenauthor=H.+Leinonenauthor=A.+L.+Levonen&title=The+Keap1-Nrf2+Pathway%3A+Mechanisms+of+Activation+and+Dysregulation+in+Cancer&doi=10.1016%2Fj.redox.2012.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer</span></div><div class="casAuthors">Kansanen, Emilia; Kuosmanen, Suvi M.; Leinonen, Hanna; Levonen, Anna-Liisa</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-49</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Keap1-Nrf2 pathway is the major regulator of cytoprotective responses to oxidative and electrophilic stress.  Although cell signaling pathways triggered by the transcription factor Nrf2 prevent cancer initiation and progression in normal and premalignant tissues, in fully malignant cells Nrf2 activity provides growth advantage by increasing cancer chemoresistance and enhancing tumor cell growth.  In this graphical review, the authors provide an overview of the Keap1-Nrf2 pathway and its dysregulation in cancer cells.  The authors also briefly summarize the consequences of constitutive Nrf2 activation in cancer cells and how this can be exploited in cancer gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPdrFwzuAqVLVg90H21EOLACvtfcHk0lghxeC2FByTJg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptFygsw%253D%253D&md5=e931d639dcb8cd2ec722c6aebaade4b2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2012.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2012.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DKansanen%26aufirst%3DE.%26aulast%3DKuosmanen%26aufirst%3DS.%2BM.%26aulast%3DLeinonen%26aufirst%3DH.%26aulast%3DLevonen%26aufirst%3DA.%2BL.%26atitle%3DThe%2520Keap1-Nrf2%2520Pathway%253A%2520Mechanisms%2520of%2520Activation%2520and%2520Dysregulation%2520in%2520Cancer%26jtitle%3DRedox%2520Biol.%26date%3D2013%26volume%3D1%26spage%3D45%26epage%3D49%26doi%3D10.1016%2Fj.redox.2012.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tickle, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweitzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span> <span> </span><span class="NLM_article-title">Structure of the Btb Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist Cddo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e98896</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0098896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1371%2Fjournal.pone.0098896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=24896564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWlsr7I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e98896&author=A.+Cleasbyauthor=J.+Yonauthor=P.+J.+Dayauthor=C.+Richardsonauthor=I.+J.+Tickleauthor=P.+A.+Williamsauthor=J.+F.+Callahanauthor=R.+Carrauthor=N.+Conchaauthor=J.+K.+Kernsauthor=H.+Qiauthor=T.+Sweitzerauthor=P.+Wardauthor=T.+G.+Davies&title=Structure+of+the+Btb+Domain+of+Keap1+and+Its+Interaction+with+the+Triterpenoid+Antagonist+Cddo&doi=10.1371%2Fjournal.pone.0098896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO</span></div><div class="casAuthors">Cleasby, Anne; Yon, Jeff; Day, Philip J.; Richardson, Caroline; Tickle, Ian J.; Williams, Pamela A.; Callahan, James F.; Carr, Robin; Concha, Nestor; Kerns, Jeffrey K.; Qi, Hongwei; Sweitzer, Thomas; Ward, Paris; Davies, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e98896/1-e98896/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">A review.  The protein Keap1 is central to the regulation of the Nrf2-mediated cytoprotective response, and is increasingly recognized as an important target for therapeutic intervention in a range of diseases involving excessive oxidative stress and inflammation.  The BTB domain of Keap1 plays key roles in sensing environmental electrophiles and in mediating interactions with the Cul3/Rbx1 E3 ubiquitin ligase system, and is believed to be the target for several small mol. covalent activators of the Nrf2 pathway.  However, despite structural information being available for several BTB domains from related proteins, there have been no reported crystal structures of Keap1 BTB, and this has precluded a detailed understanding of its mechanism of action and interaction with antagonists.  We report here the first structure of the BTB domain of Keap1, which is thought to contain the key cysteine residue responsible for interaction with electrophiles, as well as structures of the covalent complex with the antagonist CDDO/bardoxolone, and of the constitutively inactive C151W BTB mutant.  In addn. to providing the first structural confirmation of antagonist binding to Keap1 BTB, we also present biochem. evidence that adduction of Cys 151 by CDDO is capable of inhibiting the binding of Cul3 to Keap1, and discuss how this class of compd. might exert Nrf2 activation through disruption of the BTB-Cul3 interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe-yi4jSWD-bVg90H21EOLACvtfcHk0lghxeC2FByTJg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWlsr7I&md5=f9c6542ff2508a74313e996ccdafa0ae</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0098896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0098896%26sid%3Dliteratum%253Aachs%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DYon%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DConcha%26aufirst%3DN.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSweitzer%26aufirst%3DT.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26atitle%3DStructure%2520of%2520the%2520Btb%2520Domain%2520of%2520Keap1%2520and%2520Its%2520Interaction%2520with%2520the%2520Triterpenoid%2520Antagonist%2520Cddo%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De98896%26doi%3D10.1371%2Fjournal.pone.0098896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">To, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringelberg, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Royce, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risingsong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span> <span> </span><span class="NLM_article-title">Dimethyl Fumarate and the Oleanane Triterpenoids, Cddo-Imidazolide and Cddo-Methyl Ester, Both Activate the Nrf2 Pathway but Have Opposite Effects in the a/J Model of Lung Carcinogenesis</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">769</span>â <span class="NLM_lpage">781</span>, <span class="refDoi">Â DOI: 10.1093/carcin/bgv061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1093%2Fcarcin%2Fbgv061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=25939751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1CisLrE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=769-781&author=C.+Toauthor=C.+S.+Ringelbergauthor=D.+B.+Royceauthor=C.+R.+Williamsauthor=R.+Risingsongauthor=M.+B.+Spornauthor=K.+T.+Liby&title=Dimethyl+Fumarate+and+the+Oleanane+Triterpenoids%2C+Cddo-Imidazolide+and+Cddo-Methyl+Ester%2C+Both+Activate+the+Nrf2+Pathway+but+Have+Opposite+Effects+in+the+a%2FJ+Model+of+Lung+Carcinogenesis&doi=10.1093%2Fcarcin%2Fbgv061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis</span></div><div class="casAuthors">To, Ciric; Ringelberg, Carol S.; Royce, Darlene B.; Williams, Charlotte R.; Risingsong, Renee; Sporn, Michael B.; Liby, Karen T.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">769-781</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Lung cancer accounts for the highest no. of cancer-related deaths in the USA, highlighting the need for better prevention and therapy.  Activation of the Nrf2 pathway detoxifies harmful insults and reduces oxidative stress, thus preventing carcinogenesis in various preclin. models.  However, constitutive activation of the Nrf2 pathway has been detected in numerous cancers, which confers a survival advantage to tumor cells and a poor prognosis.  In our study, we compared the effects of two clin. relevant classes of Nrf2 activators, di-Me fumarate (DMF) and the synthetic oleanane triterpenoids, CDDO-imidazolide (CDDO-Im) and CDDO-Me ester (CDDO-Me) in RAW 264.7 mouse macrophage-like cells, in VC1 lung cancer cells and in the A/J model of lung cancer.  Although the triterpenoids and DMF both activated the Nrf2 pathway, CDDO-Im and CDDO-Me were markedly more potent than DMF.  All of these drugs reduced the prodn. of reactive oxygen species and inhibited nitric oxide prodn. in RAW264.7 cells, but the triterpenoids were 100 times more potent than DMF in these assays.  Microarray anal. revealed that only 52 of 99 Nrf2-target genes were induced by all three compds., and each drug regulated a unique subset of Nrf2 genes.  These drugs also altered the expression of other genes important in lung cancer independent of Nrf2.  Although all three compds. enhanced the phosphorylation of CREB, only DMF increased the phosphorylation of Akt.  CDDO-Me, at either 12.5 or 50mg/kg of diet, was the most effective drug in our lung cancer mouse model.  Specifically, CDDO-Me significantly reduced the av. tumor no., size and burden compared with the control group (P < 0.05).  Addnl., 52% of the tumors in the control group were high-grade tumors compared with only 14% in the CDDO-Me group.  Though less potent, CDDO-Im had similar activity as CDDO-Me.  In contrast, 61-63% of the tumors in the DMF groups (400-1200mg/kg diet) were high-grade tumors compared with 52% for the controls (P < 0.05).  Addnl., DMF significantly increased the av. no. of tumors compared with the controls (P < 0.05).  Thus, in contrast to the triterpenoids, which effectively reduced pathogenesis in A/J mice, DMF enhanced the severity of lung carcinogenesis in these mice.  Collectively, these results suggest that although CDDO-Im, CDDO-Me and DMF all activate the Nrf2 pathway, they target distinct genes and signaling pathways, resulting in opposite effects for the prevention of exptl. lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzAA91PVPWMrVg90H21EOLACvtfcHk0lghxeC2FByTJg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1CisLrE&md5=493b4318c713bc3a0f07a0ee917544ae</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgv061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgv061%26sid%3Dliteratum%253Aachs%26aulast%3DTo%26aufirst%3DC.%26aulast%3DRingelberg%26aufirst%3DC.%2BS.%26aulast%3DRoyce%26aufirst%3DD.%2BB.%26aulast%3DWilliams%26aufirst%3DC.%2BR.%26aulast%3DRisingsong%26aufirst%3DR.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26atitle%3DDimethyl%2520Fumarate%2520and%2520the%2520Oleanane%2520Triterpenoids%252C%2520Cddo-Imidazolide%2520and%2520Cddo-Methyl%2520Ester%252C%2520Both%2520Activate%2520the%2520Nrf2%2520Pathway%2520but%2520Have%2520Opposite%2520Effects%2520in%2520the%2520a%252FJ%2520Model%2520of%2520Lung%2520Carcinogenesis%26jtitle%3DCarcinogenesis%26date%3D2015%26volume%3D36%26spage%3D769%26epage%3D781%26doi%3D10.1093%2Fcarcin%2Fbgv061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yates, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuoka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanders, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilarte, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span> <span> </span><span class="NLM_article-title">Pharmacodynamic Characterization of Chemopreventive Triterpenoids as Exceptionally Potent Inducers of Nrf2-Regulated Genes</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">154</span>â <span class="NLM_lpage">162</span>, <span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-06-0516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1158%2F1535-7163.MCT-06-0516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=17237276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsVamsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=154-162&author=M.+S.+Yatesauthor=M.+Tauchiauthor=F.+Katsuokaauthor=K.+C.+Flandersauthor=K.+T.+Libyauthor=T.+Hondaauthor=G.+W.+Gribbleauthor=D.+A.+Johnsonauthor=J.+A.+Johnsonauthor=N.+C.+Burtonauthor=T.+R.+Guilarteauthor=M.+Yamamotoauthor=M.+B.+Spornauthor=T.+W.+Kensler&title=Pharmacodynamic+Characterization+of+Chemopreventive+Triterpenoids+as+Exceptionally+Potent+Inducers+of+Nrf2-Regulated+Genes&doi=10.1158%2F1535-7163.MCT-06-0516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes</span></div><div class="casAuthors">Yates, Melinda S.; Tauchi, Masafumi; Katsuoka, Fumiki; Flanders, Kathleen C.; Liby, Karen T.; Honda, Tadashi; Gribble, Gordon W.; Johnson, Delinda A.; Johnson, Jeffrey A.; Burton, Neal C.; Guilarte, Tomas R.; Yamamoto, Masayuki; Sporn, Michael B.; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">154-162</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Synthetic triterpenoids have been developed, which are potent inducers of cytoprotective enzymes and inhibitors of inflammation, greatly improving on the weak activity of naturally occurring triterpenoids.  An imidazolide triterpenoid deriv., 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im or TP235), has been previously shown to potently protect against hepatic tumorigenesis, acting in part by inducing cytoprotective genes through Keap1-Nrf2-antioxidant response element (ARE) signaling.  In these studies, the pharmacodynamic activity of CDDO-Im is characterized in two distinct lines of ARE reporter mice and by measuring increases in Nqo1 transcript levels as a marker of cytoprotective gene induction.  Oral administration of CDDO-Im induces ARE-regulated cytoprotective genes in many tissues in the mouse, including liver, lung, kidney, intestines, brain, heart, thymus, and salivary gland.  CDDO-Im induces Nqo1 RNA transcripts in some organs at doses as low as 0.3 Î¼mol/kg body wt. (orally).  A structure activity evaluation of 15 addnl. triterpenoids (a) confirmed the importance of Michael acceptor groups on both the A and C rings, (b) showed the requirement for a nitrile group at C-2 of the A ring, and (c) indicated that substituents at C-17 dramatically affected pharmacodynamic action in vivo.  In addn. to CDDO-Im, other triterpenoids, particularly the Me ester CDDO-Me (TP155) and the dinitrile TP225, are extremely potent inducers of cytoprotective genes in mouse liver, lung, small intestine mucosa, and cerebral cortex.  This pharmacodynamic characterization highlights the chemopreventive promise of several synthetic triterpenoids in multiple target organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrafkEmJHmo6bVg90H21EOLACvtfcHk0liMg_CuW2sFCw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsVamsA%253D%253D&md5=72549a374c43397abf4fad22dede6a82</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0516%26sid%3Dliteratum%253Aachs%26aulast%3DYates%26aufirst%3DM.%2BS.%26aulast%3DTauchi%26aufirst%3DM.%26aulast%3DKatsuoka%26aufirst%3DF.%26aulast%3DFlanders%26aufirst%3DK.%2BC.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DJohnson%26aufirst%3DD.%2BA.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26aulast%3DBurton%26aufirst%3DN.%2BC.%26aulast%3DGuilarte%26aufirst%3DT.%2BR.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26atitle%3DPharmacodynamic%2520Characterization%2520of%2520Chemopreventive%2520Triterpenoids%2520as%2520Exceptionally%2520Potent%2520Inducers%2520of%2520Nrf2-Regulated%2520Genes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D154%26epage%3D162%26doi%3D10.1158%2F1535-7163.MCT-06-0516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Signaling Pathway: Pivotal Roles in Inflammation</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">585</span>â <span class="NLM_lpage">597</span>, <span class="refDoi">Â DOI: 10.1016/j.bbadis.2016.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.bbadis.2016.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=27825853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVahtLrE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2017&pages=585-597&author=S.+M.+Ahmedauthor=L.+Luoauthor=A.+Namaniauthor=X.+J.+Wangauthor=X.+Tang&title=Nrf2+Signaling+Pathway%3A+Pivotal+Roles+in+Inflammation&doi=10.1016%2Fj.bbadis.2016.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 signaling pathway: Pivotal roles in inflammation</span></div><div class="casAuthors">Ahmed, Syed Minhaj Uddin; Luo, Lin; Namani, Akhileshwar; Wang, Xiu Jun; Tang, Xiuwen</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">585-597</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Inflammation is the most common feature of many chronic diseases and complications, while playing crit. roles in carcinogenesis.  Several studies have demonstrated that Nrf2 contributes to the anti-inflammatory process by orchestrating the recruitment of inflammatory cells and regulating gene expression through the antioxidant response element (ARE).  The Keap1 (Kelch-like ECH-assocd. protein)/Nrf2 (NF-E2 p45-related factor 2)/ARE signaling pathway mainly regulates anti-inflammatory gene expression and inhibits the progression of inflammation.  Therefore, the identification of new Nrf2-dependent anti-inflammatory phytochems. has become a key point in drug discovery.  In this review, the authors discuss the members of the Keap1/Nrf2/ARE signal pathway and its downstream genes, the effects of this pathway on animal models of inflammatory diseases, and crosstalk with the NF-ÎºB pathway.  In addn. the authors also discuss about the regulation of NLRP3 inflammasome by Nrf2.  Besides this, the authors summarize the current scenario of the development of anti-inflammatory phytochems. and others that mediate the Nrf2/ARE signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmDI6VHTdR9bVg90H21EOLACvtfcHk0liMg_CuW2sFCw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVahtLrE&md5=ddd05f60f85531bcee5892695c133433</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2016.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2016.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%2BM.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DNamani%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DNrf2%2520Signaling%2520Pathway%253A%2520Pivotal%2520Roles%2520in%2520Inflammation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2017%26volume%3D1863%26spage%3D585%26epage%3D597%26doi%3D10.1016%2Fj.bbadis.2016.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funayama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Suppresses Macrophage Inflammatory Response by Blocking Proinflammatory Cytokine Transcription</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11624</span>, <span class="refDoi">Â DOI: 10.1038/ncomms11624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1038%2Fncomms11624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=27211851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos12ms7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11624&author=E.+H.+Kobayashiauthor=T.+Suzukiauthor=R.+Funayamaauthor=T.+Nagashimaauthor=M.+Hayashiauthor=H.+Sekineauthor=N.+Tanakaauthor=T.+Moriguchiauthor=H.+Motohashiauthor=K.+Nakayamaauthor=M.+Yamamoto&title=Nrf2+Suppresses+Macrophage+Inflammatory+Response+by+Blocking+Proinflammatory+Cytokine+Transcription&doi=10.1038%2Fncomms11624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription</span></div><div class="casAuthors">Kobayashi, Eri H.; Suzuki, Takafumi; Funayama, Ryo; Nagashima, Takeshi; Hayashi, Makiko; Sekine, Hiroki; Tanaka, Nobuyuki; Moriguchi, Takashi; Motohashi, Hozumi; Nakayama, Keiko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11624</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nrf2 (NF-E2-related factor-2) transcription factor regulates oxidative/xenobiotic stress response and also represses inflammation.  However, the mechanisms how Nrf2 alleviates inflammation are still unclear.  Here, we demonstrate that Nrf2 interferes with lipopolysaccharide-induced transcriptional upregulation of proinflammatory cytokines, including IL-6 and IL-1Î².  Chromatin immunopptn. (ChIP)-seq and ChIP-qPCR analyses revealed that Nrf2 binds to the proximity of these genes in macrophages and inhibits RNA Pol II recruitment.  Further, we found that Nrf2-mediated inhibition is independent of the Nrf2-binding motif and reactive oxygen species level.  Murine inflammatory models further demonstrated that Nrf2 interferes with IL6 induction and inflammatory phenotypes in vivo.  Thus, contrary to the widely accepted view that Nrf2 suppresses inflammation through redox control, we demonstrate here that Nrf2 opposes transcriptional upregulation of proinflammatory cytokine genes.  This study identifies Nrf2 as the upstream regulator of cytokine prodn. and establishes a mol. basis for an Nrf2-mediated anti-inflammation approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNH2n5UpCBKLVg90H21EOLACvtfcHk0liMg_CuW2sFCw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos12ms7w%253D&md5=95c2aebdf50ed1e8dbbdf983ff50b300</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fncomms11624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11624%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DE.%2BH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DFunayama%26aufirst%3DR.%26aulast%3DNagashima%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DSekine%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DMoriguchi%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DNrf2%2520Suppresses%2520Macrophage%2520Inflammatory%2520Response%2520by%2520Blocking%2520Proinflammatory%2520Cytokine%2520Transcription%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11624%26doi%3D10.1038%2Fncomms11624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yore, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Place, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risingsong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Royce, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill-Kapturczak, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span> <span> </span><span class="NLM_article-title">The Synthetic Triterpenoids, Cddo and Cddo-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/Are Signaling</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">4789</span>â <span class="NLM_lpage">4798</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-04-4539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1158%2F0008-5472.CAN-04-4539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=15930299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ohurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=4789-4798&author=K.+Libyauthor=T.+Hockauthor=M.+M.+Yoreauthor=N.+Suhauthor=A.+E.+Placeauthor=R.+Risingsongauthor=C.+R.+Williamsauthor=D.+B.+Royceauthor=T.+Hondaauthor=Y.+Hondaauthor=G.+W.+Gribbleauthor=N.+Hill-Kapturczakauthor=A.+Agarwalauthor=M.+B.+Sporn&title=The+Synthetic+Triterpenoids%2C+Cddo+and+Cddo-Imidazolide%2C+Are+Potent+Inducers+of+Heme+Oxygenase-1+and+Nrf2%2FAre+Signaling&doi=10.1158%2F0008-5472.CAN-04-4539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling</span></div><div class="casAuthors">Liby, Karen; Hock, Thomas; Yore, Mark M.; Suh, Nanjoo; Place, Andrew E.; Risingsong, Renee; Williams, Charlotte R.; Royce, Darlene B.; Honda, Tadashi; Honda, Yukiko; Gribble, Gordon W.; Hill-Kapturczak, Nathalie; Agarwal, Anupam; Sporn, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4789-4798</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO) and its deriv. 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im) are multifunctional mols. with potent antiproliferative, differentiating, and anti-inflammatory activities.  At nanomolar concns., these agents rapidly increase the expression of the cytoprotective heme oxygenase-1 (HO-1) enzyme in vitro and in vivo.  Transfection studies using a series of reporter constructs show that activation of the human HO-1 promoter by the triterpenoids requires an antioxidant response element (ARE), a cAMP response element, and an E Box sequence.  Inactivation of one of these response elements alone partially reduces HO-1 induction, but mutations in all three sequences entirely eliminate promoter activity in response to the triterpenoids.  Treatment with CDDO-Im also elevates protein levels of Nrf2, a transcription factor previously shown to bind ARE sequences, and increases expression of a no. of antioxidant and detoxification genes regulated by Nrf2.  The triterpenoids also reduce the formation of reactive oxygen species in cells challenged with tert-Bu hydroperoxide, but this cytoprotective activity is absent in Nrf2 deficient cells.  These studies are the first to investigate the induction of the HO-1 and Nrf2/ARE pathways by CDDO and CDDO-Im, and our results suggest that further in vivo studies are needed to explore the chemopreventive and chemotherapeutic potential of the triterpenoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFgeOrJsI-TLVg90H21EOLACvtfcHk0lhns1KnczRpSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ohurs%253D&md5=e5d0a67228df4cb8541bb8e3a3d21b4b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-4539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-4539%26sid%3Dliteratum%253Aachs%26aulast%3DLiby%26aufirst%3DK.%26aulast%3DHock%26aufirst%3DT.%26aulast%3DYore%26aufirst%3DM.%2BM.%26aulast%3DSuh%26aufirst%3DN.%26aulast%3DPlace%26aufirst%3DA.%2BE.%26aulast%3DRisingsong%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DC.%2BR.%26aulast%3DRoyce%26aufirst%3DD.%2BB.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DHonda%26aufirst%3DY.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DHill-Kapturczak%26aufirst%3DN.%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26atitle%3DThe%2520Synthetic%2520Triterpenoids%252C%2520Cddo%2520and%2520Cddo-Imidazolide%252C%2520Are%2520Potent%2520Inducers%2520of%2520Heme%2520Oxygenase-1%2520and%2520Nrf2%252FAre%2520Signaling%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D4789%26epage%3D4798%26doi%3D10.1158%2F0008-5472.CAN-04-4539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J. X.</span></span> <span> </span><span class="NLM_article-title">Structure of Serum Albumin</span>. <i>Adv. Protein Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">153</span>â <span class="NLM_lpage">203</span>, <span class="refDoi">Â DOI: 10.1016/S0065-3233(08)60640-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2FS0065-3233%2808%2960640-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=8154369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADyaK2cXltVajtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=153-203&author=D.+C.+Carterauthor=J.+X.+Ho&title=Structure+of+Serum+Albumin&doi=10.1016%2FS0065-3233%2808%2960640-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of serum albumin</span></div><div class="casAuthors">Carter, Daniel C.; Ho, Joseph X.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Protein Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">LIPOPROTEINS,APOLIPOPROTEINS, AND LIPASES</span>),
    <span class="NLM_cas:pages">153-203</span>CODEN:
                <span class="NLM_cas:coden">APCHA2</span>;
        ISSN:<span class="NLM_cas:issn">0065-3233</span>.
    </div><div class="casAbstract">A review, with 251 refs.  Topics discussed include the primary and 3-dimensional structure of albumin, the nature of ligand binding, and the evolution of albumin structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOuH2hDzVTp7Vg90H21EOLACvtfcHk0lhns1KnczRpSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltVajtLk%253D&md5=52abdfdaaedb35bb307ebf001ec50d8a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0065-3233%2808%2960640-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-3233%252808%252960640-3%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DD.%2BC.%26aulast%3DHo%26aufirst%3DJ.%2BX.%26atitle%3DStructure%2520of%2520Serum%2520Albumin%26jtitle%3DAdv.%2520Protein%2520Chem.%26date%3D1994%26volume%3D45%26spage%3D153%26epage%3D203%26doi%3D10.1016%2FS0065-3233%2808%2960640-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachulski, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naisbitt, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirmohamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Direct Evidence for the Formation of Diastereoisomeric Benzylpenicilloyl Haptens from Benzylpenicillin and Benzylpenicillenic Acid in Patients</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">841</span>â <span class="NLM_lpage">849</span>, <span class="refDoi">Â DOI: 10.1124/jpet.111.183871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1124%2Fjpet.111.183871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=21680886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaktLjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=841-849&author=X.+Mengauthor=R.+E.+Jenkinsauthor=N.+G.+Berryauthor=J.+L.+Maggsauthor=J.+Farrellauthor=C.+S.+Laneauthor=A.+V.+Stachulskiauthor=N.+S.+Frenchauthor=D.+J.+Naisbittauthor=M.+Pirmohamedauthor=B.+K.+Park&title=Direct+Evidence+for+the+Formation+of+Diastereoisomeric+Benzylpenicilloyl+Haptens+from+Benzylpenicillin+and+Benzylpenicillenic+Acid+in+Patients&doi=10.1124%2Fjpet.111.183871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patients</span></div><div class="casAuthors">Meng, Xiaoli; Jenkins, Rosalind E.; Berry, Neil G.; Maggs, James L.; Farrell, John; Lane, Catherine S.; Stachulski, Andrew V.; French, Neil S.; Naisbitt, Dean J.; Pirmohamed, Munir; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">841-849</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Covalent binding to proteins to form neoantigens is thought to be central to the pathogenesis of penicillin hypersensitivity reactions.  We have undertaken detailed mass spectrometric studies to define the mechanism and protein chem. of hapten formation from benzylpenicillin (BP) and its rearrangement product, benzylpenicillenic acid (PA).  Mass spectrometric anal. of human serum albumin exposed to BP and PA in vitro revealed that at low concns. (drug protein molar ratio 0.001:1) and during short time incubations BP and PA selectively target different residues, Lys199 and Lys525, resp.  Mol. modeling showed that the selectivity was a function of noncovalent interaction before covalent modification.  With increased exposure to higher concns. of BP and PA, multiple epitopes were detected on albumin, demonstrating that the multiplicity of hapten formation is a function of time and concn.  More importantly, we have demonstrated direct evidence that PA is a hapten accounting for the diastereoisomeric BP antigen formation in albumin isolated from the blood of patients receiving penicillin.  Furthermore, PA was found to be more potent than BP with respect to stimulation of T cells from patients with penicillin hypersensitivity, illustrating the functional relevance of diastereoisomeric hapten formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1x5SvZNBZa7Vg90H21EOLACvtfcHk0lhns1KnczRpSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaktLjJ&md5=e542f914e55c48d4562e9d6e4aa4fe37</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.183871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.183871%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DBerry%26aufirst%3DN.%2BG.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DFarrell%26aufirst%3DJ.%26aulast%3DLane%26aufirst%3DC.%2BS.%26aulast%3DStachulski%26aufirst%3DA.%2BV.%26aulast%3DFrench%26aufirst%3DN.%2BS.%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DDirect%2520Evidence%2520for%2520the%2520Formation%2520of%2520Diastereoisomeric%2520Benzylpenicilloyl%2520Haptens%2520from%2520Benzylpenicillin%2520and%2520Benzylpenicillenic%2520Acid%2520in%2520Patients%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D338%26spage%3D841%26epage%3D849%26doi%3D10.1124%2Fjpet.111.183871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrenson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Back, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naisbitt, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Abacavir Forms Novel Cross-Linking Abacavir Protein Adducts in Patients</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">524</span>â <span class="NLM_lpage">535</span>, <span class="refDoi">Â DOI: 10.1021/tx400406p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx400406p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1ejsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=524-535&author=X.+Mengauthor=A.+S.+Lawrensonauthor=N.+G.+Berryauthor=J.+L.+Maggsauthor=N.+S.+Frenchauthor=D.+J.+Backauthor=S.+H.+Khooauthor=D.+J.+Naisbittauthor=B.+K.+Park&title=Abacavir+Forms+Novel+Cross-Linking+Abacavir+Protein+Adducts+in+Patients&doi=10.1021%2Ftx400406p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Abacavir Forms Novel Cross-Linking Abacavir Protein Adducts in Patients</span></div><div class="casAuthors">Meng, Xiaoli; Lawrenson, Alexandre S.; Berry, Neil G.; Maggs, James L.; French, Neil S.; Back, David J.; Khoo, Saye H.; Naisbitt, Dean J.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">524-535</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Abacavir (ABC), a nucleoside-analog reverse transcriptase inhibitor, is assocd. with severe hypersensitivity reactions that are thought to involve the activation of CD8+ T cells in a HLA-B*57:01-restricted manner.  Recent studies have claimed that noncovalent interactions of ABC with HLA-B*57:01 are responsible for the immunol. reactions assocd. with ABC.  However, the formation of Hb-ABC aldehyde (ABCA) adducts in patients exposed to ABC suggests that protein conjugation might represent a pathway for antigen formation.  To further characterize protein conjugation reactions, we used mass spectrometric methods to define ABCA modifications in patients receiving ABC therapy.  ABCA formed a novel intramol. crosslinking adduct on human serum albumin (HSA) in patients and in vitro via Michael addn., followed by nucleophilic adduction of the aldehyde with a neighboring protein nucleophile.  Adducts were detected on Lys159, Lys190, His146, and Cys34 residues in the subdomain IB of HSA.  Only a cysteine adduct and a putative crosslinking adduct were detected on glutathione S-transferase Pi (GSTP).  These findings reveal that ABC forms novel types of antigens in all patients taking the drug.  It is therefore vital that the immunol. consequences of such pathways of haptenation are explored in the in vitro models that have been used by various groups to define new mechanisms of drug hypersensitivity exemplified by ABC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJinX4CqOIR7Vg90H21EOLACvtfcHk0lie93uWHeOLLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1ejsLk%253D&md5=d1b462af1d3b643b8e6522ed3ae92a0e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Ftx400406p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx400406p%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DLawrenson%26aufirst%3DA.%2BS.%26aulast%3DBerry%26aufirst%3DN.%2BG.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DFrench%26aufirst%3DN.%2BS.%26aulast%3DBack%26aufirst%3DD.%2BJ.%26aulast%3DKhoo%26aufirst%3DS.%2BH.%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DAbacavir%2520Forms%2520Novel%2520Cross-Linking%2520Abacavir%2520Protein%2520Adducts%2520in%2520Patients%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26spage%3D524%26epage%3D535%26doi%3D10.1021%2Ftx400406p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castelazo, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earnshaw, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aithal, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pande, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachulski, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span> <span> </span><span class="NLM_article-title">Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from a Drug Acyl Glucuronide Metabolite: Multiple Albumin Adductions in Diclofenac Patients</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">387</span>â <span class="NLM_lpage">402</span>, <span class="refDoi">Â DOI: 10.1124/jpet.114.215079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1124%2Fjpet.114.215079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=24902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Wqsb%252FK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2014&pages=387-402&author=T.+G.+Hammondauthor=X.+Mengauthor=R.+E.+Jenkinsauthor=J.+L.+Maggsauthor=A.+S.+Castelazoauthor=S.+L.+Reganauthor=S.+N.+Bennettauthor=C.+J.+Earnshawauthor=G.+P.+Aithalauthor=I.+Pandeauthor=J.+G.+Kennaauthor=A.+V.+Stachulskiauthor=B.+K.+Parkauthor=D.+P.+Williams&title=Mass+Spectrometric+Characterization+of+Circulating+Covalent+Protein+Adducts+Derived+from+a+Drug+Acyl+Glucuronide+Metabolite%3A+Multiple+Albumin+Adductions+in+Diclofenac+Patients&doi=10.1124%2Fjpet.114.215079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients</span></div><div class="casAuthors">Hammond, Thomas G.; Meng, Xiaoli; Jenkins, Rosalind E.; Maggs, James L.; Castelazo, Anahi Santoyo; Regan, Sophie L.; Bennett, Stuart N. L.; Earnshaw, Caroline J.; Aithal, Guruprasad P.; Pande, Ira; Kenna, J. Gerry; Stachulski, Andrew V.; Park, B. Kevin; Williams, Dominic P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">387-402, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Covalent protein modifications by electrophilic acyl glucuronide (AG) metabolites are hypothetical causes of hypersensitivity reactions assocd. with certain carboxylate drugs.  The complex rearrangements and reactivities of drug AG have been defined in great detail, and protein adducts of carboxylate drugs, such as diclofenac, have been found in liver and plasma of exptl. animals and humans.  However, in the absence of definitive mol. characterization, and specifically, identification of signature glycation conjugates retaining the glucuronyl and carboxyl residues, it cannot be assumed any of these adducts is derived uniquely or even fractionally from AG metabolites.  We have therefore undertaken targeted mass spectrometric analyses of human serum albumin (HSA) isolated from diclofenac patients to characterize drug-derived structures and, thereby, for the first time, have deconstructed conclusively the pathways of adduct formation from a drug AG and its isomeric rearrangement products in vivo.  These analyses were informed by a thorough understanding of the reactions of HSA with diclofenac AG in vitro.  HSA from six patients without drug-related hypersensitivities had either a single drug-derived adduct or one of five combinations of 2-8 adducts from among seven diclofenac N-acylations and three AG glycations on seven of the protein's 59 lysines.  Only acylations were found in every patient.  We present evidence that HSA modifications by diclofenac in vivo are complicated and variable, that at least a fraction of these modifications are derived from the drug's AG metabolite, and that albumin adduction is not inevitably a causation of hypersensitivity to carboxylate drugs or a coincidental assocn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJaMIu3mSolLVg90H21EOLACvtfcHk0lie93uWHeOLLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Wqsb%252FK&md5=4ea9902f538c70aa671bdb1df8149375</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.215079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.215079%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DCastelazo%26aufirst%3DA.%2BS.%26aulast%3DRegan%26aufirst%3DS.%2BL.%26aulast%3DBennett%26aufirst%3DS.%2BN.%26aulast%3DEarnshaw%26aufirst%3DC.%2BJ.%26aulast%3DAithal%26aufirst%3DG.%2BP.%26aulast%3DPande%26aufirst%3DI.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26aulast%3DStachulski%26aufirst%3DA.%2BV.%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26atitle%3DMass%2520Spectrometric%2520Characterization%2520of%2520Circulating%2520Covalent%2520Protein%2520Adducts%2520Derived%2520from%2520a%2520Drug%2520Acyl%2520Glucuronide%2520Metabolite%253A%2520Multiple%2520Albumin%2520Adductions%2520in%2520Diclofenac%2520Patients%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D350%26spage%3D387%26epage%3D402%26doi%3D10.1124%2Fjpet.114.215079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">8137</span>â <span class="NLM_lpage">8151</span>, <span class="refDoi">Â DOI: 10.1128/MCB.23.22.8137-8151.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.23.22.8137-8151.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=14585973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=8137-8151&author=D.+D.+Zhangauthor=M.+Hannink&title=Distinct+Cysteine+Residues+in+Keap1+Are+Required+for+Keap1-Dependent+Ubiquitination+of+Nrf2+and+for+Stabilization+of+Nrf2+by+Chemopreventive+Agents+and+Oxidative+Stress&doi=10.1128%2FMCB.23.22.8137-8151.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span></div><div class="casAuthors">Zhang, Donna D.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8137-8151</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A common feature of diverse chemopreventive agents is the ability to activate expression of a genetic program that protects cells from reactive chem. species that if left unchecked would cause mutagenic DNA damage.  The bZIP transcription factor Nrf2 has emerged as a key regulator of this cancer-preventive genetic program.  Nrf2 is normally sequestered in the cytoplasm by a protein known as Keap1.  Chemopreventive agents allow Nrf2 to escape from Keap1-mediated repression, although the mol. mechanism(s) responsible for activation of Nrf2 is not understood.  In this report, we demonstrate that Keap1 does not passively sequester Nrf2 in the cytoplasm but actively targets Nrf2 for ubiquitination and degrdn. by the proteasome under basal culture conditions.  We have identified two crit. cysteine residues in Keap1, C273 and C288, that are required for Keap1-dependent ubiquitination of Nrf2.  Both sulforaphane, a chemopreventive isothiocyanate, and oxidative stress enable Nrf2 to escape Keap1-dependent degrdn., leading to stabilization of Nrf2, increased nuclear localization of Nrf2, and activation of Nrf2-dependent cancer-protective genes.  We have identified a third cysteine residue in Keap1, C151, that is uniquely required for inhibition of Keap1-dependent degrdn. of Nrf2 by sulforaphane and oxidative stress.  This cysteine residue is also required for a novel posttranslational modification to Keap1 that is induced by oxidative stress.  We propose that Keap1 is a component of a novel E3 ubiquitin ligase complex that is specifically targeted for inhibition by both chemopreventive agents and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqys54qQ6MlRLVg90H21EOLACvtfcHk0lhrXaCWHdi4yA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D&md5=9287849578d0a6b7a6d52b67e3c65190</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.22.8137-8151.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.22.8137-8151.2003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DDistinct%2520Cysteine%2520Residues%2520in%2520Keap1%2520Are%2520Required%2520for%2520Keap1-Dependent%2520Ubiquitination%2520of%2520Nrf2%2520and%2520for%2520Stabilization%2520of%2520Nrf2%2520by%2520Chemopreventive%2520Agents%2520and%2520Oxidative%2520Stress%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D8137%26epage%3D8151%26doi%3D10.1128%2FMCB.23.22.8137-8151.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eggler, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span> <span> </span><span class="NLM_article-title">Cul3-Mediated Nrf2 Ubiquitination and Antioxidant Response Element (Are) Activation Are Dependent on the Partial Molar Volume at Position 151 of Keap1</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>422</i></span>,  <span class="NLM_fpage">171</span>â <span class="NLM_lpage">180</span>, <span class="refDoi">Â DOI: 10.1042/BJ20090471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1042%2FBJ20090471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=19489739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGhs7fP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=422&publication_year=2009&pages=171-180&author=A.+L.+Egglerauthor=E.+Smallauthor=M.+Hanninkauthor=A.+D.+Mesecar&title=Cul3-Mediated+Nrf2+Ubiquitination+and+Antioxidant+Response+Element+%28Are%29+Activation+Are+Dependent+on+the+Partial+Molar+Volume+at+Position+151+of+Keap1&doi=10.1042%2FBJ20090471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1</span></div><div class="casAuthors">Eggler, Aimee L.; Small, Evan; Hannink, Mark; Mesecar, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">422</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-180</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Nrf2 (nuclear factor erythroid 2-related factor 2) is a transcription factor that activates transcription of a battery of cytoprotective genes by binding to the ARE (antioxidant response element).  Nrf2 is repressed by the cysteine-rich Keap1 (kelch-like ECH-assocd. protein 1) protein, which targets Nrf2 for ubiquitination and subsequent degrdn. by a Cul3 (cullin 3)-mediated ubiquitination complex.  We find that modification of Cys151 of human Keap1, by mutation to a tryptophan, relieves the repression by Keap1 and allows activation of the ARE by Nrf2.  The Keap1 C151W substitution has a decreased affinity for Cul3, and can no longer serve to target Nrf2 for ubiquitination, though it retains its affinity for Nrf2.  A series of 12 mutant Keap1 proteins, each contg. a different residue at position 151, was constructed to explore the chem. required for this effect.  The series reveals that the extent to which Keap1 loses the ability to target Nrf2 for degrdn., and hence the ability to repress ARE activation, correlates well with the partial molar volume of the residue.  Other physico-chem. properties do not appear to contribute significantly to the effect.  Based on this finding, a structural model is proposed whereby large residues at position 151 cause steric clashes that lead to alteration of the Keap1-Cul3 interaction.  This model has significant implications for how electrophiles which modify Cys151, disrupt the repressive function of Keap1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBipIRhBjdjbVg90H21EOLACvtfcHk0lg9rFFVoNfGGA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGhs7fP&md5=acf3bbd03dcfb0a9a1d7241f701352c8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1042%2FBJ20090471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20090471%26sid%3Dliteratum%253Aachs%26aulast%3DEggler%26aufirst%3DA.%2BL.%26aulast%3DSmall%26aufirst%3DE.%26aulast%3DHannink%26aufirst%3DM.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26atitle%3DCul3-Mediated%2520Nrf2%2520Ubiquitination%2520and%2520Antioxidant%2520Response%2520Element%2520%2528Are%2529%2520Activation%2520Are%2520Dependent%2520on%2520the%2520Partial%2520Molar%2520Volume%2520at%2520Position%2520151%2520of%2520Keap1%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D422%26spage%3D171%26epage%3D180%26doi%3D10.1042%2FBJ20090471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bollong, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coukos, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lairson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moellering, R. E.</span></span> <span> </span><span class="NLM_article-title">A Metabolite-Derived Protein Modification Integrates Glycolysis with Keap1-Nrf2 Signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>562</i></span>,  <span class="NLM_fpage">600</span>â <span class="NLM_lpage">604</span>, <span class="refDoi">Â DOI: 10.1038/s41586-018-0622-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1038%2Fs41586-018-0622-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=30323285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFajsL%252FJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=562&publication_year=2018&pages=600-604&author=M.+J.+Bollongauthor=G.+Leeauthor=J.+S.+Coukosauthor=H.+Yunauthor=C.+Zambaldoauthor=J.+W.+Changauthor=E.+N.+Chinauthor=I.+Ahmadauthor=A.+K.+Chatterjeeauthor=L.+L.+Lairsonauthor=P.+G.+Schultzauthor=R.+E.+Moellering&title=A+Metabolite-Derived+Protein+Modification+Integrates+Glycolysis+with+Keap1-Nrf2+Signalling&doi=10.1038%2Fs41586-018-0622-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling</span></div><div class="casAuthors">Bollong, Michael J.; Lee, Gihoon; Coukos, John S.; Yun, Hwayoung; Zambaldo, Claudio; Chang, Jae Won; Chin, Emily N.; Ahmad, Insha; Chatterjee, Arnab K.; Lairson, Luke L.; Schultz, Peter G.; Moellering, Raymond E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">562</span>
        (<span class="NLM_cas:issue">7728</span>),
    <span class="NLM_cas:pages">600-604</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Mechanisms that integrate the metabolic state of a cell with regulatory pathways are necessary to maintain cellular homeostasis.  Endogenous, intrinsically reactive metabolites can form functional, covalent modifications on proteins without the aid of enzymes1,2, and regulate cellular functions such as metab.3-5 and transcription6.  An important 'sensor' protein that captures specific metabolic information and transforms it into an appropriate response is KEAP1, which contains reactive cysteine residues that collectively act as an electrophile sensor tuned to respond to reactive species resulting from endogenous and xenobiotic mols.  Covalent modification of KEAP1 results in reduced ubiquitination and the accumulation of NRF27,8, which then initiates the transcription of cytoprotective genes at antioxidant-response element loci.  Here we identify a small-mol. inhibitor of the glycolytic enzyme PGK1, and reveal a direct link between glycolysis and NRF2 signalling.  Inhibition of PGK1 results in accumulation of the reactive metabolite methylglyoxal, which selectively modifies KEAP1 to form a methylimidazole crosslink between proximal cysteine and arginine residues (MICA).  This post-translational modification results in the dimerization of KEAP1, the accumulation of NRF2 and activation of the NRF2 transcriptional program.  These results demonstrate the existence of direct inter-pathway communication between glycolysis and the KEAP1-NRF2 transcriptional axis, provide insight into the metabolic regulation of the cellular stress response, and suggest a therapeutic strategy for controlling the cytoprotective antioxidant response in several human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR9q3PSGgsJbVg90H21EOLACvtfcHk0lg9rFFVoNfGGA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFajsL%252FJ&md5=ffa4f3f053d506dc1014427eb5269525</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0622-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0622-0%26sid%3Dliteratum%253Aachs%26aulast%3DBollong%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DCoukos%26aufirst%3DJ.%2BS.%26aulast%3DYun%26aufirst%3DH.%26aulast%3DZambaldo%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DChin%26aufirst%3DE.%2BN.%26aulast%3DAhmad%26aufirst%3DI.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DLairson%26aufirst%3DL.%2BL.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DMoellering%26aufirst%3DR.%2BE.%26atitle%3DA%2520Metabolite-Derived%2520Protein%2520Modification%2520Integrates%2520Glycolysis%2520with%2520Keap1-Nrf2%2520Signalling%26jtitle%3DNature%26date%3D2018%26volume%3D562%26spage%3D600%26epage%3D604%26doi%3D10.1038%2Fs41586-018-0622-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prag, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dikovskaya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaslona, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jedrychowski, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, A. S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hams, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szpyt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runtsch, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGouran, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGettrick, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booty, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knatko, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meakin, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashford, M. L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modis, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallon, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunji, E. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouchani, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frezza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartley, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeill, L. A.</span></span> <span> </span><span class="NLM_article-title">Itaconate Is an Anti-Inflammatory Metabolite That Activates Nrf2 Via Alkylation of Keap1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>556</i></span>,  <span class="NLM_fpage">113</span>â <span class="NLM_lpage">117</span>, <span class="refDoi">Â DOI: 10.1038/nature25986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1038%2Fnature25986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=29590092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmt1aqtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=556&publication_year=2018&pages=113-117&author=E.+L.+Millsauthor=D.+G.+Ryanauthor=H.+A.+Pragauthor=D.+Dikovskayaauthor=D.+Menonauthor=Z.+Zaslonaauthor=M.+P.+Jedrychowskiauthor=A.+S.+H.+Costaauthor=M.+Higginsauthor=E.+Hamsauthor=J.+Szpytauthor=M.+C.+Runtschauthor=M.+S.+Kingauthor=J.+F.+McGouranauthor=R.+Fischerauthor=B.+M.+Kesslerauthor=A.+F.+McGettrickauthor=M.+M.+Hughesauthor=R.+G.+Carrollauthor=L.+M.+Bootyauthor=E.+V.+Knatkoauthor=P.+J.+Meakinauthor=M.+L.+J.+Ashfordauthor=L.+K.+Modisauthor=G.+Brunoriauthor=D.+C.+Sevinauthor=P.+G.+Fallonauthor=S.+T.+Caldwellauthor=E.+R.+S.+Kunjiauthor=E.+T.+Chouchaniauthor=C.+Frezzaauthor=A.+T.+Dinkova-Kostovaauthor=R.+C.+Hartleyauthor=M.+P.+Murphyauthor=L.+A.+O%E2%80%99Neill&title=Itaconate+Is+an+Anti-Inflammatory+Metabolite+That+Activates+Nrf2+Via+Alkylation+of+Keap1&doi=10.1038%2Fnature25986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1</span></div><div class="casAuthors">Mills, Evanna L.; Ryan, Dylan G.; Prag, Hiran A.; Dikovskaya, Dina; Menon, Deepthi; Zaslona, Zbigniew; Jedrychowski, Mark P.; Costa, Ana S. H.; Higgins, Maureen; Hams, Emily; Szpyt, John; Runtsch, Marah C.; King, Martin S.; McGouran, Joanna F.; Fischer, Roman; Kessler, Benedikt M.; McGettrick, Anne F.; Hughes, Mark M.; Carroll, Richard G.; Booty, Lee M.; Knatko, Elena V.; Meakin, Paul J.; Ashford, Michael L. J.; Modis, Louise K.; Brunori, Gino; Sevin, Daniel C.; Fallon, Padraic G.; Caldwell, Stuart T.; Kunji, Edmund R. S.; Chouchani, Edward T.; Frezza, Christian; Dinkova-Kostova, Albena T.; Hartley, Richard C.; Murphy, Michael P.; O'Neill, Luke A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">556</span>
        (<span class="NLM_cas:issue">7699</span>),
    <span class="NLM_cas:pages">113-117</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The endogenous metabolite itaconate has recently emerged as a regulator of macrophage function, but its precise mechanism of action remains poorly understood.  Here we show that itaconate is required for the activation of the anti-inflammatory transcription factor Nrf2 (also known as NFE2L2) by lipopolysaccharide in mouse and human macrophages.  We find that itaconate directly modifies proteins via alkylation of cysteine residues.  Itaconate alkylates cysteine residues 151, 257, 288, 273 and 297 on the protein KEAP1, enabling Nrf2 to increase the expression of downstream genes with anti-oxidant and anti-inflammatory capacities.  The activation of Nrf2 is required for the anti-inflammatory action of itaconate.  We describe the use of a new cell-permeable itaconate deriv., 4-octyl itaconate, which is protective against lipopolysaccharide-induced lethality in vivo and decreases cytokine prodn.  We show that type I interferons boost the expression of Irg1 (also known as Acod1) and itaconate prodn.  Furthermore, we find that itaconate prodn. limits the type I interferon response, indicating a neg. feedback loop that involves interferons and itaconate.  Our findings demonstrate that itaconate is a crucial anti-inflammatory metabolite that acts via Nrf2 to limit inflammation and modulate type I interferons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoExv-0qohcf7Vg90H21EOLACvtfcHk0lg9rFFVoNfGGA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmt1aqtL0%253D&md5=d0f3ac43b65cd5977d0cbfc086f80cd4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnature25986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25986%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DE.%2BL.%26aulast%3DRyan%26aufirst%3DD.%2BG.%26aulast%3DPrag%26aufirst%3DH.%2BA.%26aulast%3DDikovskaya%26aufirst%3DD.%26aulast%3DMenon%26aufirst%3DD.%26aulast%3DZaslona%26aufirst%3DZ.%26aulast%3DJedrychowski%26aufirst%3DM.%2BP.%26aulast%3DCosta%26aufirst%3DA.%2BS.%2BH.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DHams%26aufirst%3DE.%26aulast%3DSzpyt%26aufirst%3DJ.%26aulast%3DRuntsch%26aufirst%3DM.%2BC.%26aulast%3DKing%26aufirst%3DM.%2BS.%26aulast%3DMcGouran%26aufirst%3DJ.%2BF.%26aulast%3DFischer%26aufirst%3DR.%26aulast%3DKessler%26aufirst%3DB.%2BM.%26aulast%3DMcGettrick%26aufirst%3DA.%2BF.%26aulast%3DHughes%26aufirst%3DM.%2BM.%26aulast%3DCarroll%26aufirst%3DR.%2BG.%26aulast%3DBooty%26aufirst%3DL.%2BM.%26aulast%3DKnatko%26aufirst%3DE.%2BV.%26aulast%3DMeakin%26aufirst%3DP.%2BJ.%26aulast%3DAshford%26aufirst%3DM.%2BL.%2BJ.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DBrunori%26aufirst%3DG.%26aulast%3DSevin%26aufirst%3DD.%2BC.%26aulast%3DFallon%26aufirst%3DP.%2BG.%26aulast%3DCaldwell%26aufirst%3DS.%2BT.%26aulast%3DKunji%26aufirst%3DE.%2BR.%2BS.%26aulast%3DChouchani%26aufirst%3DE.%2BT.%26aulast%3DFrezza%26aufirst%3DC.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHartley%26aufirst%3DR.%2BC.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%26atitle%3DItaconate%2520Is%2520an%2520Anti-Inflammatory%2520Metabolite%2520That%2520Activates%2520Nrf2%2520Via%2520Alkylation%2520of%2520Keap1%26jtitle%3DNature%26date%3D2018%26volume%3D556%26spage%3D113%26epage%3D117%26doi%3D10.1038%2Fnature25986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Stress-Sensing Mechanisms and the Physiological Roles of the Keap1-Nrf2 System During Cellular Stress</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">16817</span>â <span class="NLM_lpage">16824</span>, <span class="refDoi">Â DOI: 10.1074/jbc.R117.800169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1074%2Fjbc.R117.800169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=28842501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GjsrzN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=16817-16824&author=T.+Suzukiauthor=M.+Yamamoto&title=Stress-Sensing+Mechanisms+and+the+Physiological+Roles+of+the+Keap1-Nrf2+System+During+Cellular+Stress&doi=10.1074%2Fjbc.R117.800169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress</span></div><div class="casAuthors">Suzuki, Takafumi; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">16817-16824</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Transcription factor Nrf2 (NF-E2-related factor 2) is a master regulator of cellular responses against environmental stresses.  Nrf2 induces the expression of detoxification and antioxidant enzymes and suppresses the induction of pro-inflammatory cytokine genes.  Keap1 (Kelch-like ECH-assocd. protein 1) is an adaptor subunit of Cullin 3-based E3 ubiquitin ligase.  Keap1 regulates the activity of Nrf2 and acts as a sensor for oxidative and electrophilic stresses.  In this review, we discuss the mol. mechanisms by which the Keap1-Nrf2 system senses and regulates the cellular response to environmental stresses.  In particular, we focus on the multiple stress-sensing mechanisms of Keap1 and novel regulatory functions of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx_R4Q7mWl67Vg90H21EOLACvtfcHk0ljPoyl9dHDTeg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GjsrzN&md5=478e4b84f6fd7f1cd79546b6f452b7d7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R117.800169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R117.800169%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DStress-Sensing%2520Mechanisms%2520and%2520the%2520Physiological%2520Roles%2520of%2520the%2520Keap1-Nrf2%2520System%2520During%2520Cellular%2520Stress%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D16817%26epage%3D16824%26doi%3D10.1074%2Fjbc.R117.800169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rachakonda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekhar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamer, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebler, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, M. L.</span></span> <span> </span><span class="NLM_article-title">Covalent Modification at Cys151 Dissociates the Electrophile Sensor Keap1 from the Ubiquitin Ligase Cul3</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">705</span>â <span class="NLM_lpage">710</span>, <span class="refDoi">Â DOI: 10.1021/tx700302s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx700302s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFGkt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=705-710&author=G.+Rachakondaauthor=Y.+Xiongauthor=K.+R.+Sekharauthor=S.+L.+Stamerauthor=D.+C.+Lieblerauthor=M.+L.+Freeman&title=Covalent+Modification+at+Cys151+Dissociates+the+Electrophile+Sensor+Keap1+from+the+Ubiquitin+Ligase+Cul3&doi=10.1021%2Ftx700302s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Modification at Cys151 Dissociates the Electrophile Sensor Keap1 from the Ubiquitin Ligase CUL3</span></div><div class="casAuthors">Rachakonda, Girish; Xiong, Ying; Sekhar, Konjeti R.; Stamer, Sheryl L.; Liebler, Daniel C.; Freeman, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">705-710</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The regulation of cellular stress responses to electrophiles and oxidants is mediated by the transcription factor NF-E2-related factor 2 (Nrf2), which, in turn, is regulated by CUL-E3 (CUL3) ligase-mediated ubiquitylation.  The Kelch-like ECH-assocd. protein 1 (Keap1) serves as an adapter between CUL3 and Nrf2.  We used the model electrophile N-iodoacetyl-N-biotinylhexylenediamine (IAB) to define the relationship among the adduction of Keap1 cysteine residues, structure, and function.  Exposure of Keap1 to IAB in vitro was accompanied by progressive loss of protein secondary structure, as monitored by CD spectroscopy and a loss of the ability to assoc. with recombinant CUL3.  Dissocn. of Keap1 from CUL3 in vitro was dependent upon C151 in Keap1.  A quant. mass spectrometry-based kinetic anal. of adduction in HEK293 cells expressing FLAG-Keap1 revealed that Cys151 was one of the most reactive residues in vivo and that it was required for IAB-mediated dissocn. of the Keap1-CUL3 interaction.  These results demonstrate that Cys151 adduction confers a crit. alkylation sensor function upon Keap1, making Keap1 unique among BTB CUL3 adapter proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaK6w3_TWIZLVg90H21EOLACvtfcHk0ljPoyl9dHDTeg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFGkt74%253D&md5=17881550b83aee61adfef4e2812d7647</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Ftx700302s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700302s%26sid%3Dliteratum%253Aachs%26aulast%3DRachakonda%26aufirst%3DG.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DSekhar%26aufirst%3DK.%2BR.%26aulast%3DStamer%26aufirst%3DS.%2BL.%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26aulast%3DFreeman%26aufirst%3DM.%2BL.%26atitle%3DCovalent%2520Modification%2520at%2520Cys151%2520Dissociates%2520the%2520Electrophile%2520Sensor%2520Keap1%2520from%2520the%2520Ubiquitin%2520Ligase%2520Cul3%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D705%26epage%3D710%26doi%3D10.1021%2Ftx700302s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copple, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibby, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeill, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2396</span>â <span class="NLM_lpage">2409</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVCis7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2396-2409&author=M.+H.+Wongauthor=H.+K.+Bryanauthor=I.+M.+Coppleauthor=R.+E.+Jenkinsauthor=P.+H.+Chiuauthor=J.+Bibbyauthor=N.+G.+Berryauthor=N.+R.+Kitteringhamauthor=C.+E.+Goldringauthor=P.+M.+O%E2%80%99Neillauthor=B.+K.+Park&title=Design+and+Synthesis+of+Irreversible+Analogues+of+Bardoxolone+Methyl+for+the+Identification+of+Pharmacologically+Relevant+Targets+and+Interaction+Sites&doi=10.1021%2Facs.jmedchem.5b01292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites</span></div><div class="casAuthors">Wong, Michael H. L.; Bryan, Holly K.; Copple, Ian M.; Jenkins, Rosalind E.; Chiu, Pak Him; Bibby, Jaclyn; Berry, Neil G.; Kitteringham, Neil R.; Goldring, Christopher E.; O'Neill, Paul M.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2396-2409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Semisynthetic triterpenoids such as bardoxolone Me (methyl-2-cyano 3,12-dioxooleano-1,9-dien-28-oate; CDDO-Me) (I) are potent inducers of antioxidant and anti-inflammatory signaling pathways, including those regulated by the transcription factor Nrf2.  However, the reversible nature of the interaction between triterpenoids and thiols has hindered attempts to identify pharmacol. relevant targets and characterize the sites of interaction.  Here, we report a shortened synthesis and SAR profiling of I, enabling the design of analogs that react irreversibly with model thiols, as well as the model protein glutathione S-transferase P1, in vitro.  We show that one of these analogs, CDDO-epoxide (II), is comparable to I in terms of cytotoxicity and potency toward Nrf2 in rat hepatoma cells and stably modifies specific cysteine residues (namely, Cys-257, -273, -288, -434, -489, and -613) within Keap1, the major repressor of Nrf2, both in vitro and in living cells.  Supported by mol. modeling, these data demonstrate the value of II for identifying site(s) of interaction with pharmacol. relevant targets and informing the continuing development of triterpenoids as novel drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjC_Ca8KocPLVg90H21EOLACvtfcHk0ljPoyl9dHDTeg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVCis7k%253D&md5=eb2c0d997a2b22ceb41b75c203bb27fc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01292%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DBryan%26aufirst%3DH.%2BK.%26aulast%3DCopple%26aufirst%3DI.%2BM.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DChiu%26aufirst%3DP.%2BH.%26aulast%3DBibby%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DN.%2BG.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Irreversible%2520Analogues%2520of%2520Bardoxolone%2520Methyl%2520for%2520the%2520Identification%2520of%2520Pharmacologically%2520Relevant%2520Targets%2520and%2520Interaction%2520Sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2396%26epage%3D2409%26doi%3D10.1021%2Facs.jmedchem.5b01292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eggler, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Breemen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span> <span> </span><span class="NLM_article-title">Modifying Specific Cysteines of the Electrophile-Sensing Human Keap1 Protein Is Insufficient to Disrupt Binding to the Nrf2 Domain Neh2</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">10070</span>â <span class="NLM_lpage">10075</span>, <span class="refDoi">Â DOI: 10.1073/pnas.0502402102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1073%2Fpnas.0502402102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=16006525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVeltbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=10070-10075&author=A.+L.+Egglerauthor=G.+Liuauthor=J.+M.+Pezzutoauthor=R.+B.+van+Breemenauthor=A.+D.+Mesecar&title=Modifying+Specific+Cysteines+of+the+Electrophile-Sensing+Human+Keap1+Protein+Is+Insufficient+to+Disrupt+Binding+to+the+Nrf2+Domain+Neh2&doi=10.1073%2Fpnas.0502402102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Modifying specific cysteines of the electrophile sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2</span></div><div class="casAuthors">Eggler, Aimee L.; Liu, Guowen; Pezzuto, John M.; van Breemen, Richard B.; Mesecar, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">10070-10075</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The risks of cancer and other degenerative diseases caused by reactive oxygen species and electrophiles can be reduced by the up-regulation of detoxifying enzymes.  A major mechanism whereby these protective enzymes are induced occurs through activation of the antioxidant response element (ARE) by the oxidative-stress sensor protein Kelch-like ECH-assocd. protein 1 (Keap1) and the transcription factor NF-E2-related factor 2 (Nrf2).  Under basal conditions, Keap1 sequesters Nrf2 in the cytoplasm by binding to its Neh2 domain.  Chem. inducers such as sulforaphane are known to react with Keap1 cysteine residues, thereby promoting Nrf2 nuclear accumulation and hence ARE activation.  A widely accepted model for Nrf2 nuclear accumulation is that modification of Keap1 cysteines leads directly to dissocn. of the Keap1-Nrf2 complex.  This model is based on studies with mouse proteins and has served as the exptl. basis and hypothesis for numerous investigations.  Through a combination of chem., mass spectrometry, and isothermal titrn. calorimetry methods, we have tested the direct-dissocn. model using a series of ARE inducers: sulforaphane, isoliquiritigenin, 15-deoxy-Î12,14-prostaglandin-J2, menadione, 1-Cl-2,4-dinitrobenzene, and biotinylated iodoacetamide.  Surprisingly, these data suggest that the direct disruption model for Keap1-Nrf2 is incorrect.  The relative reactivity of human Keap1 cysteines was detd.  In addn. to the same five cysteines identified for mouse Keap1, two highly reactive and previously unobserved cysteines were identified.  Based on these results, a model is proposed that should aid in the understanding of Keap1-Nrf2 signaling mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzm8XUMvM-97Vg90H21EOLACvtfcHk0lhwmbzyPKXGDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVeltbk%253D&md5=59b797c158c043a64dfe4b57d0a0edee</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0502402102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0502402102%26sid%3Dliteratum%253Aachs%26aulast%3DEggler%26aufirst%3DA.%2BL.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26aulast%3Dvan%2BBreemen%26aufirst%3DR.%2BB.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26atitle%3DModifying%2520Specific%2520Cysteines%2520of%2520the%2520Electrophile-Sensing%2520Human%2520Keap1%2520Protein%2520Is%2520Insufficient%2520to%2520Disrupt%2520Binding%2520to%2520the%2520Nrf2%2520Domain%2520Neh2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D10070%26epage%3D10075%26doi%3D10.1073%2Fpnas.0502402102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Diffusion Dynamics of the Keap1-Cullin3 Interaction in Single Live Cells</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>433</i></span>,  <span class="NLM_fpage">58</span>â <span class="NLM_lpage">65</span>, <span class="refDoi">Â DOI: 10.1016/j.bbrc.2013.02.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.bbrc.2013.02.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=23454126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlSis7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=433&publication_year=2013&pages=58-65&author=L.+Bairdauthor=A.+T.+Dinkova-Kostova&title=Diffusion+Dynamics+of+the+Keap1-Cullin3+Interaction+in+Single+Live+Cells&doi=10.1016%2Fj.bbrc.2013.02.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Diffusion dynamics of the Keap1-Cullin3 interaction in single live cells</span></div><div class="casAuthors">Baird, Liam; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">433</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-65</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Transcription factor NF-E2 p45-related factor 2 (Nrf2) regulates the expression of a network of genes encoding drug-detoxification, anti-inflammatory, and metabolic enzymes, as well as proteins involved in the regulation of cellular redox homeostasis.  Under basal conditions, Kelch-like ECH assocd. protein 1 (Keap1) targets Nrf2 for ubiquitination and proteasomal degrdn. via assocn. with Cullin3 (Cul3)-based Rbx1 E3 ubiquitin ligase.  Various small mols. (inducers) activate Nrf2 leading to upregulation of cytoprotective gene expression.  Inducers chem. modify specific cysteine residues of Keap1 which ultimately loses its ability to target Nrf2 for degrdn.  Dissocn. of the Keap1-Cul3 complex by inducers is one possible mechanism, but evidence in single live cells is lacking.  To investigate the diffusion dynamics of the Keap1-Cul3 interaction and the effect of inducers, we developed a quant. fluorescence recovery after photobleaching (FRAP)-based system using Keap1-EGFP and mCherry-Cul3 fusion proteins.  We show that Keap1-EGFP and mCherry-Cul3 interact in single live cells.  Exposure for 1 h to small-mol. inducers of 4 different types, the oleanane triterpenoid CDDO, the isothiocyanate sulforaphane, the sulfoxythiocarbamate STCA, and the oxidant hydrogen peroxide which target distinct cysteine sensors within Keap1 with potencies which differ by nearly 4000-fold, does not dissoc. the Keap1-Cul3 complex.  As inducers cause conformational changes in Keap1, we conclude that changes in conformation rather than dissocn. from Cul3 inactivate the repressor function of Keap1 leading to Nrf2 stabilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnBuWD94zRH7Vg90H21EOLACvtfcHk0lhwmbzyPKXGDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlSis7g%253D&md5=a18788a95811fbaca069dd986b945af2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2013.02.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2013.02.065%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DDiffusion%2520Dynamics%2520of%2520the%2520Keap1-Cullin3%2520Interaction%2520in%2520Single%2520Live%2520Cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2013%26volume%3D433%26spage%3D58%26epage%3D65%26doi%3D10.1016%2Fj.bbrc.2013.02.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paonessa, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Chemical Activation of Nrf2</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e35122</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0035122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1371%2Fjournal.pone.0035122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=22558124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFWltr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e35122&author=Y.+Liauthor=J.+D.+Paonessaauthor=Y.+Zhang&title=Mechanism+of+Chemical+Activation+of+Nrf2&doi=10.1371%2Fjournal.pone.0035122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of chemical activation of Nrf2</span></div><div class="casAuthors">Li, Yun; Paonessa, Joseph D.; Zhang, Yuesheng</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e35122</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">NF-E2 related factor-2 (Nrf2) promotes the transcription of many cytoprotective genes and is a major drug target for prevention of cancer and other diseases.  Indeed, the cancer-preventive activities of several well-known chem. agents were shown to depend on Nrf2 activation.  It is well known that chemopreventive Nrf2 activators stabilize Nrf2 by blocking its ubiquitination, but previous studies have indicated that this process occurs exclusively in the cytoplasm.  Kelch-like ECH-assocd. protein 1 (Keap1) binds to Nrf2 and orchestrates Nrf2 ubiquitination and it has been a widely-held view that inhibition of Nrf2 ubiquitination by chemopreventive agents results from the dissocn. of Nrf2 from its repressor Keap1.  Here, we show that while the activation of Nrf2 by prototypical chem. activators, including 5,6-dihydrocyclopenta-1,2-dithiole-3-thione (CPDT) and sulforaphane (SF), results solely from inhibition of its ubiquitination, such inhibition occurs predominantly in the nucleus.  Moreover, the Nrf2 activators promote Nrf2 assocn. with Keap1, rather than disassocn., which appears to result from inhibition of Nrf2 phosphorylation at Ser40.  Available evidence suggests the Nrf2 activators may block Nrf2 ubiquitination by altering Keap1 conformation via reaction with the thiols of specific Keap1 cysteines.  We further show that while the inhibitory effects of CPDT and SF on Nrf2 ubiquitination depend entirely on Keap1, Nrf2 is also degraded by a Keap1-independent mechanism.  These findings provide significant new insight about Nrf2 activation and suggest that exogenous chem. activators of Nrf2 enter the nucleus to exert most of their inhibitory impact on Nrf2 ubiquitination and degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHQw95dGtFnbVg90H21EOLACvtfcHk0lhwmbzyPKXGDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFWltr4%253D&md5=8b9417e76f781711ba9f1d993c017d0c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0035122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0035122%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPaonessa%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DMechanism%2520of%2520Chemical%2520Activation%2520of%2520Nrf2%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De35122%26doi%3D10.1371%2Fjournal.pone.0035122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">3100</span>â <span class="NLM_lpage">3112</span>, <span class="refDoi">Â DOI: 10.1128/MCB.00389-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.00389-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=27697860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitl2muro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=3100-3112&author=T.+Isoauthor=T.+Suzukiauthor=L.+Bairdauthor=M.+Yamamoto&title=Absolute+Amounts+and+Status+of+the+Nrf2-Keap1-Cul3+Complex+within+Cells&doi=10.1128%2FMCB.00389-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Absolute amounts and status of the Nrf2-keap1-cul3 complex within cells</span></div><div class="casAuthors">Iso, Tatsuro; Suzuki, Takafumi; Baird, Liam; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3100-3112</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 (NF-E2-related-factor 2) is essential for the oxidative and electrophilic stress responses.  Keap1 (Kelch-like-ECH-assocd.-protein 1), an adaptor for a cullin-3 (Cul3)-based ubiquitin ligase, regulates Nrf2 activity through proteasomal degrdn., and acts as a sensor for oxidative and electrophilic stresses.  The Keap1-Cul3 complex is a crit. regulator of the cellular Nrf2 level, and yet quant. information regarding their endogenous intracellular concns. in homeostatic conditions and during stress responses is unknown.  We analyzed the abs. amts. of the Nrf2, Keap1, and Cul3 proteins in five murine cell lines by comparison with serial dilns. of purified recombinant protein stds. in combination with quant. immunoblot analyses.  In the basal state, the amt. of Nrf2 was maintained at lower levels than those of Keap1 and Cul3 proteins, whereas the electrophilic agent diethylmaleate dramatically increased Nrf2 to a level greater than that of Keap1 and Cul3, resulting in the accumulation of Nrf2 in the nucleus.  In contrast, Keap1 and Cul3 did not display any changes in their abundance, subcellular localization, or interaction in response to electrophilic stimuli.  Our results demonstrate that the regulation of the Nrf2 protein level during stress responses is mediated by the activity but not the compn. of the Nrf2-Keap1-Cul3 complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPGVeaDYpE2bVg90H21EOLACvtfcHk0lir01hAOWxNBg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitl2muro%253D&md5=934eb0d47608ff480fd6765ff1cdf49c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FMCB.00389-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00389-16%26sid%3Dliteratum%253Aachs%26aulast%3DIso%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DAbsolute%2520Amounts%2520and%2520Status%2520of%2520the%2520Nrf2-Keap1-Cul3%2520Complex%2520within%2520Cells%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2016%26volume%3D36%26spage%3D3100%26epage%3D3112%26doi%3D10.1128%2FMCB.00389-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hur, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Modulators of Antioxidant Response Pathway</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">162</span>â <span class="NLM_lpage">173</span>, <span class="refDoi">Â DOI: 10.1016/j.cbpa.2010.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.cbpa.2010.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=21195017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFKitLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=162-173&author=W.+Hurauthor=N.+S.+Gray&title=Small+Molecule+Modulators+of+Antioxidant+Response+Pathway&doi=10.1016%2Fj.cbpa.2010.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule modulators of antioxidant response pathway</span></div><div class="casAuthors">Hur, Wooyoung; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-173</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor that regulates Antioxidant Response Element (ARE)-mediated transcription of a plethora of antioxidant and protective genes to counteract the harmful effects of reactive oxygen species or environmental carcinogens.  Studies have demonstrated that pre-emptive activation of the Nrf2-ARE pathway reinforces the cellular defense mechanism against oxidative stress and leads to protection in a variety of disease models.  Non-carcinogenic ARE inducers have been identified from a variety of chem. classes that enhance the transcriptional activity of Nrf2 through S-alkylation of reactive cysteines within the cellular redox sensor protein Keap1 (Kelch-like ECH assocd. protein 1).  Here we review the currently known small mol. ARE inducers and their reported biol. activities in various models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoULkW6Xdct7rVg90H21EOLACvtfcHk0lir01hAOWxNBg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFKitLg%253D&md5=2424082ba8c25672b6928b79461024ea</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DHur%26aufirst%3DW.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSmall%2520Molecule%2520Modulators%2520of%2520Antioxidant%2520Response%2520Pathway%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D15%26spage%3D162%26epage%3D173%26doi%3D10.1016%2Fj.cbpa.2010.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Templeton, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">10941</span>â <span class="NLM_lpage">10953</span>, <span class="refDoi">Â DOI: 10.1128/MCB.24.24.10941-10953.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.24.24.10941-10953.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=15572695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFSgsr%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=10941-10953&author=D.+D.+Zhangauthor=S.+C.+Loauthor=J.+V.+Crossauthor=D.+J.+Templetonauthor=M.+Hannink&title=Keap1+Is+a+Redox-Regulated+Substrate+Adaptor+Protein+for+a+Cul3-Dependent+Ubiquitin+Ligase+Complex&doi=10.1128%2FMCB.24.24.10941-10953.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex</span></div><div class="casAuthors">Zhang, Donna D.; Lo, Shih-Ching; Cross, Janet V.; Templeton, Dennis J.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10941-10953</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The bZIP transcription factor Nrf2 controls a genetic program that protects cells from oxidative damage and maintains cellular redox homeostasis.  Keap1, a BTB-Kelch protein, is the major upstream regulator of Nrf2 and controls both the subcellular localization and steady-state levels of Nrf2.  In this report, we demonstrate that Keap1 functions as a substrate adaptor protein for a Cul3-dependent E3 ubiquitin ligase complex.  Keap1 assembles into a functional E3 ubiquitin ligase complex with Cul3 and Rbx1 that targets multiple lysine residues located in the N-terminal Neh2 domain of Nrf2 for ubiquitin conjugation both in vivo and in vitro.  Keap1-dependent ubiquitination of Nrf2 is inhibited following exposure of cells to quinone-induced oxidative stress and sulforaphane, a cancer-preventive isothiocyanate.  A mutant Keap1 protein contg. a single cysteine-to-serine substitution at residue 151 within the BTB domain of Keap1 is markedly resistant to inhibition by either quinone-induced oxidative stress or sulforaphane.  Inhibition of Keap1-dependent ubiquitination of Nrf2 correlates with decreased assocn. of Keap1 with Cul3.  Neither quinone-induced oxidative stress nor sulforaphane disrupts assocn. between Keap1 and Nrf2.  Our results suggest that the ability of Keap1 to assemble into a functional E3 ubiquitin ligase complex is the crit. determinant that controls steady-state levels of Nrf2 in response to cancer-preventive compds. and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGone13ov1mSELVg90H21EOLACvtfcHk0lir01hAOWxNBg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFSgsr%252FL&md5=cc8f2a059999d82c91ef482fb8e385d8</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.24.10941-10953.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.24.10941-10953.2004%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DLo%26aufirst%3DS.%2BC.%26aulast%3DCross%26aufirst%3DJ.%2BV.%26aulast%3DTempleton%26aufirst%3DD.%2BJ.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DKeap1%2520Is%2520a%2520Redox-Regulated%2520Substrate%2520Adaptor%2520Protein%2520for%2520a%2520Cul3-Dependent%2520Ubiquitin%2520Ligase%2520Complex%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D10941%26epage%3D10953%26doi%3D10.1128%2FMCB.24.24.10941-10953.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeneuve, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Activation of Nrf2 by Arsenite and Monomethylarsonous Acid Is Independent of Keap1-C151: Enhanced Keap1-Cul3 Interaction</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>230</i></span>,  <span class="NLM_fpage">383</span>â <span class="NLM_lpage">389</span>, <span class="refDoi">Â DOI: 10.1016/j.taap.2008.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.taap.2008.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=18417180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVOjsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2008&pages=383-389&author=X.+J.+Wangauthor=Z.+Sunauthor=W.+Chenauthor=Y.+Liauthor=N.+F.+Villeneuveauthor=D.+D.+Zhang&title=Activation+of+Nrf2+by+Arsenite+and+Monomethylarsonous+Acid+Is+Independent+of+Keap1-C151%3A+Enhanced+Keap1-Cul3+Interaction&doi=10.1016%2Fj.taap.2008.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction</span></div><div class="casAuthors">Wang, Xiao-Jun; Sun, Zheng; Chen, Weimin; Li, Yanjie; Villeneuve, Nicole F.; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-389</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Drinking water contaminated with arsenic, a human carcinogen, is a worldwide health issue.  An understanding of cellular signaling events in response to arsenic exposure and rational designing of strategies to reduce arsenic damages by modulating signaling events are important to fight against arsenic-induced diseases.  Previously, the authors reported that activation of the Nrf2-mediated cellular defense pathway confers protection against toxic effects induced by sodium arsenite [As(III)] or monomethylarsonous acid [MMA(III)].  Paradoxically, arsenic has been reported to induce the Nrf2-dependent signaling pathway.  Here, the authors report the unique mechanism of Nrf2 induction by arsenic.  Similar to tert-butylhydroquinone (tBHQ) or sulforaphane (SF), arsenic induced the Nrf2-dependent response through enhancing Nrf2 protein levels by inhibiting Nrf2 ubiquitination and degrdn.  However, the detailed action of arsenic in Nrf2 induction is different from that of tBHQ or SF.  Arsenic markedly enhanced the interaction between Keap1 and Cul3, subunits of the E3 ubiquitin ligase for Nrf2, which led to impaired dynamic assembly/disassembly of the E3 ubiquitin ligase and thus decreased its ligase activity.  Furthermore, induction of Nrf2 by arsenic is independent of the previously identified C151 residue in Keap1 that is required for Nrf2 activation by tBHQ or SF.  Distinct mechanisms of Nrf2 activation by seemingly harmful and beneficial reagents provide a mol. basis to design Nrf2-activating agents for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGougWtyjknTaLVg90H21EOLACvtfcHk0lir01hAOWxNBg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVOjsLo%253D&md5=d64d1a0b41d671bb87fd69ea67053275</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2008.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2008.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DVilleneuve%26aufirst%3DN.%2BF.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DActivation%2520of%2520Nrf2%2520by%2520Arsenite%2520and%2520Monomethylarsonous%2520Acid%2520Is%2520Independent%2520of%2520Keap1-C151%253A%2520Enhanced%2520Keap1-Cul3%2520Interaction%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2008%26volume%3D230%26spage%3D383%26epage%3D389%26doi%3D10.1016%2Fj.taap.2008.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sou, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iemura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natsume, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">The Selective Autophagy Substrate P62 Activates the Stress Responsive Transcription Factor Nrf2 through Inactivation of Keap1</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">213</span>â <span class="NLM_lpage">223</span>, <span class="refDoi">Â DOI: 10.1038/ncb2021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1038%2Fncb2021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=20173742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFemsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=213-223&author=M.+Komatsuauthor=H.+Kurokawaauthor=S.+Waguriauthor=K.+Taguchiauthor=A.+Kobayashiauthor=Y.+Ichimuraauthor=Y.+S.+Souauthor=I.+Uenoauthor=A.+Sakamotoauthor=K.+I.+Tongauthor=M.+Kimauthor=Y.+Nishitoauthor=S.+Iemuraauthor=T.+Natsumeauthor=T.+Uenoauthor=E.+Kominamiauthor=H.+Motohashiauthor=K.+Tanakaauthor=M.+Yamamoto&title=The+Selective+Autophagy+Substrate+P62+Activates+the+Stress+Responsive+Transcription+Factor+Nrf2+through+Inactivation+of+Keap1&doi=10.1038%2Fncb2021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1</span></div><div class="casAuthors">Komatsu, Masaaki; Kurokawa, Hirofumi; Waguri, Satoshi; Taguchi, Keiko; Kobayashi, Akira; Ichimura, Yoshinobu; Sou, Yu-Shin; Ueno, Izumi; Sakamoto, Ayako; Tong, Kit I.; Kim, Mihee; Nishito, Yasumasa; Iemura, Shun-ichiro; Natsume, Tohru; Ueno, Takashi; Kominami, Eiki; Motohashi, Hozumi; Tanaka, Keiji; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-223</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Impaired selective turnover of p62 by autophagy causes severe liver injury accompanied by the formation of p62-pos. inclusions and upregulation of detoxifying enzymes.  These phenotypes correspond closely to the pathol. conditions seen in human liver diseases, including alc. hepatitis and hepatocellular carcinoma.  However, the mol. mechanisms and pathophysiol. processes in these events are still unknown.  Here we report the identification of a novel regulatory mechanism by p62 of the transcription factor Nrf2, whose target genes include antioxidant proteins and detoxification enzymes. p62 interacts with the Nrf2-binding site on Keap1, a component of Cullin-3-type ubiquitin ligase for Nrf2.  Thus, an overprodn. of p62 or a deficiency in autophagy competes with the interaction between Nrf2 and Keap1, resulting in stabilization of Nrf2 and transcriptional activation of Nrf2 target genes.  Our findings indicate that the pathol. process assocd. with p62 accumulation results in hyperactivation of Nrf2 and delineates unexpected roles of selective autophagy in controlling the transcription of cellular defense enzyme genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozHwUzLt-LiLVg90H21EOLACvtfcHk0lh3RnIDhO9Wpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFemsL8%253D&md5=f66692c056ff13937de3affac38f31c9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fncb2021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2021%26sid%3Dliteratum%253Aachs%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DKurokawa%26aufirst%3DH.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DSou%26aufirst%3DY.%2BS.%26aulast%3DUeno%26aufirst%3DI.%26aulast%3DSakamoto%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DNishito%26aufirst%3DY.%26aulast%3DIemura%26aufirst%3DS.%26aulast%3DNatsume%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DKominami%26aufirst%3DE.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DThe%2520Selective%2520Autophagy%2520Substrate%2520P62%2520Activates%2520the%2520Stress%2520Responsive%2520Transcription%2520Factor%2520Nrf2%2520through%2520Inactivation%2520of%2520Keap1%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26spage%3D213%26epage%3D223%26doi%3D10.1038%2Fncb2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Iaspp Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">561</span>â <span class="NLM_lpage">573</span>, <span class="refDoi">Â DOI: 10.1016/j.ccell.2017.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.ccell.2017.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=29033244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjs7zE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=561-573&author=W.+Geauthor=K.+Zhaoauthor=X.+Wangauthor=H.+Liauthor=M.+Yuauthor=M.+Heauthor=X.+Xueauthor=Y.+Zhuauthor=C.+Zhangauthor=Y.+Chengauthor=S.+Jiangauthor=Y.+Hu&title=Iaspp+Is+an+Antioxidative+Factor+and+Drives+Cancer+Growth+and+Drug+Resistance+by+Competing+with+Nrf2+for+Keap1+Binding&doi=10.1016%2Fj.ccell.2017.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding</span></div><div class="casAuthors">Ge, Wenjie; Zhao, Kunming; Wang, Xingwen; Li, Huayi; Yu, Miao; He, Mengmeng; Xue, Xuting; Zhu, Yifu; Zhang, Cheng; Cheng, Yiwei; Jiang, Shijian; Hu, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-573.e6</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) have emerged as important signaling mols. that play crucial roles in carcinogenesis and cytotoxic responses.  Nrf2 is the master regulator of ROS balance.  Thus, uncovering mechanisms of Nrf2 regulation is important for the development of alternative treatment strategies for cancers.  Here, we demonstrate that iASPP, a known p53 inhibitor, lowers ROS independently of p53.  Mechanistically, iASPP competes with Nrf2 for Keap1 binding via a DLT motif, leading to decreased Nrf2 ubiquitination and increased Nrf2 accumulation, nuclear translocation, and antioxidative transactivation.  This iASPP-Keap1-Nrf2 axis promotes cancer growth and drug resistance both in vitro and in vivo.  Thus, iASPP is an antioxidative factor and represents a promising target to improve cancer treatment, regardless of p53 status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgG9GfPOFfIrVg90H21EOLACvtfcHk0lh3RnIDhO9Wpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjs7zE&md5=f2e27a7dee5602a3aba046c0efb34ef7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2017.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2017.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DIaspp%2520Is%2520an%2520Antioxidative%2520Factor%2520and%2520Drives%2520Cancer%2520Growth%2520and%2520Drug%2520Resistance%2520by%2520Competing%2520with%2520Nrf2%2520for%2520Keap1%2520Binding%26jtitle%3DCancer%2520Cell%26date%3D2017%26volume%3D32%26spage%3D561%26epage%3D573%26doi%3D10.1016%2Fj.ccell.2017.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span> <span> </span><span class="NLM_article-title">Nrf2: Friend or Foe for Chemoprevention?</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">90</span>â <span class="NLM_lpage">99</span>, <span class="refDoi">Â DOI: 10.1093/carcin/bgp231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1093%2Fcarcin%2Fbgp231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=19793802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCgsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=90-99&author=T.+W.+Kenslerauthor=N.+Wakabayashi&title=Nrf2%3A+Friend+or+Foe+for+Chemoprevention%3F&doi=10.1093%2Fcarcin%2Fbgp231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2: friend or foe for chemoprevention?</span></div><div class="casAuthors">Kensler, Thomas W.; Wakabayashi, Nobunao</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-99</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Health reflects the ability of an organism to adapt to stress.  Stresses-metabolic, proteotoxic, mitotic, oxidative and DNA-damage stresses-not only contribute to the etiol. of cancer and other chronic degenerative diseases but are also hallmarks of the cancer phenotype.  Activation of the Kelch-like ECH-assocd. protein 1 (KEAP1)-NF-E2-related factor 2 (NRF2)-signaling pathway is an adaptive response to environmental and endogenous stresses and serves to render animals resistant to chem. carcinogenesis and other forms of toxicity, while disruption of the pathway exacerbates these outcomes.  This pathway can be induced by thiol-reactive small mols. that demonstrate protective efficacy in preclin. chemoprevention models and in clin. trials.  However, mutations and epigenetic modifications affecting the regulation and fate of NRF2 can lead to constitutive dominant hyperactivation of signaling that preserves rather than attenuates cancer phenotypes by providing selective resistance to stresses.  This review provides a synopsis of KEAP1-NRF2 signaling, compares the impact of genetic vs. pharmacol. activation and considers both the attributes and concerns of targeting the pathway in chemoprevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqshZPrMJ237bVg90H21EOLACvtfcHk0lh3RnIDhO9Wpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCgsQ%253D%253D&md5=dd79e8634cc9ca6ad8fde2d08f77a731</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgp231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgp231%26sid%3Dliteratum%253Aachs%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DWakabayashi%26aufirst%3DN.%26atitle%3DNrf2%253A%2520Friend%2520or%2520Foe%2520for%2520Chemoprevention%253F%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26spage%3D90%26epage%3D99%26doi%3D10.1093%2Fcarcin%2Fbgp231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takaya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satomi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Validation of the Multiple Sensor Mechanism of the Keap1-Nrf2 System</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">817</span>â <span class="NLM_lpage">827</span>, <span class="refDoi">Â DOI: 10.1016/j.freeradbiomed.2012.06.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.freeradbiomed.2012.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=22732183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKms7%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=817-827&author=K.+Takayaauthor=T.+Suzukiauthor=H.+Motohashiauthor=K.+Onoderaauthor=S.+Satomiauthor=T.+W.+Kenslerauthor=M.+Yamamoto&title=Validation+of+the+Multiple+Sensor+Mechanism+of+the+Keap1-Nrf2+System&doi=10.1016%2Fj.freeradbiomed.2012.06.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the multiple sensor mechanism of the Keap1-Nrf2 system</span></div><div class="casAuthors">Takaya, Kai; Suzuki, Takafumi; Motohashi, Hozumi; Onodera, Ko; Satomi, Susumu; Kensler, Thomas W.; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-827</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Keap1-Nrf2 system plays a crit. role in cellular defense against electrophiles and reactive O species.  Keap1 possesses a no. of Cys residues, some of which are highly reactive and serves as sensors for these insults.  Indeed, point mutation of Cys-151 abrogates the response to certain electrophiles.  However, this mutation does not affect the other set of electrophiles, suggesting that multiple sensor systems reside within the Cys residues of Keap1.  The precise contribution of each reactive Cys residue to the sensor function of Keap1 remains to be clarified.  Herem to elucidate the contribution of Cys-151 in vivo, the authors adopted transgenic complementation rescue assays.  Embryonic fibroblasts and primary peritoneal macrophages were prepd. from mice expressing the Keap1-C151S mutant.  These cells were challenged with various Nrf2 inducers.  It was found that some of the inducers triggered only marginal responses in Keap1-C151S-expressing cells, while others evoked responses in a comparable magnitude to those obsd. in the wild-type cells.  The authors found that tert-Bu hydroquinone, diethylmaleate, sulforaphane, and dimethylfumarate were Cys-151-preferable, whereas 15-deoxy-Î12,14-prostaglandin J2 (15d-PG-J2), 2-cyano-3,12-dioxooleana-1,9-diene-28-imidazolide, ebselen, nitro-oleic acid, and CdCl2 were Cys-151-independent.  Expts. with embryonic fibroblasts and primary macrophages yielded consistent results.  Expts. testing protective effects against the cytotoxicity of 1-chloro-2,4-dinitrobenzene of sulforaphane and 15d-PG-J2 in Keap1-C151S-expressing macrophages revealed that the former inducer was effective, while the latter was not.  These results thus indicate that there exists distinct utilization of Keap1 Cys residues by different chems. that trigger the response of the Keap1-Nrf2 system, and further substantiate the notion that there are multiple sensing mechanisms within Keap1 Cys residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHkfTRD-ZFrVg90H21EOLACvtfcHk0lgPqQfJ4fCkuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKms7%252FN&md5=2da3a0bd9d8d0ed8008dda3b30b1570a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2012.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2012.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DTakaya%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DOnodera%26aufirst%3DK.%26aulast%3DSatomi%26aufirst%3DS.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DValidation%2520of%2520the%2520Multiple%2520Sensor%2520Mechanism%2520of%2520the%2520Keap1-Nrf2%2520System%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D817%26epage%3D827%26doi%3D10.1016%2Fj.freeradbiomed.2012.06.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saito, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naganuma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furusawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichinose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">271</span>â <span class="NLM_lpage">284</span>, <span class="refDoi">Â DOI: 10.1128/MCB.00868-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1128%2FMCB.00868-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=26527616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A280%3ADC%252BC28znvFyjsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=271-284&author=R.+Saitoauthor=T.+Suzukiauthor=K.+Hiramotoauthor=S.+Asamiauthor=E.+Naganumaauthor=H.+Sudaauthor=T.+Isoauthor=H.+Yamamotoauthor=M.+Moritaauthor=L.+Bairdauthor=Y.+Furusawaauthor=T.+Negishiauthor=M.+Ichinoseauthor=M.+Yamamoto&title=Characterizations+of+Three+Major+Cysteine+Sensors+of+Keap1+in+Stress+Response&doi=10.1128%2FMCB.00868-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response</span></div><div class="casAuthors">Saito Ryota; Suzuki Takafumi; Hiramoto Keiichiro; Asami Soichiro; Naganuma Eriko; Suda Hiromi; Iso Tatsuro; Yamamoto Hirotaka; Morita Masanobu; Baird Liam; Yamamoto Masayuki; Furusawa Yuki; Negishi Takaaki; Ichinose Masakazu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and cellular biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Keap1-Nrf2 system plays a central role in cytoprotection against electrophilic/oxidative stresses.  Although Cys151, Cys273, and Cys288 of Keap1 are major sensor cysteine residues for detecting these stresses, it has not been technically feasible to evaluate the functionality of Cys273 or Cys288, since Keap1 mutants that harbor substitutions in these residues and maintain the ability to repress Nrf2 accumulation do not exist.  To overcome this problem, we systematically introduced amino acid substitutions into Cys273/Cys288 and finally identified Cys273Trp and Cys288Glu mutations that do not affect Keap1's ability to repress Nrf2 accumulation.  Utilizing these Keap1 mutants, we generated stable murine embryonic fibroblast (MEF) cell lines and knock-in mouse lines.  Our analyses with the MEFs and peritoneal macrophages from the knock-in mice revealed that three major cysteine residues, Cys151, Cys273, and Cys288, individually and/or redundantly act as sensors.  Based on the functional necessity of these three cysteine residues, we categorized chemical inducers of Nrf2 into four classes.  Class I and II utilizes Cys151 and Cys288, respectively, while class III requires all three residues (Cys151/Cys273/Cys288), while class IV inducers function independently of all three of these cysteine residues.  This study thus demonstrates that Keap1 utilizes multiple cysteine residues specifically and/or collaboratively as sensors for the detection of a wide range of environmental stresses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ9xHanSufiLv6AExegM5LLfW6udTcc2eb-gZnGCfM0Mbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28znvFyjsQ%253D%253D&md5=ecd882849726cacd9b6a3e5d706252e8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FMCB.00868-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00868-15%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DHiramoto%26aufirst%3DK.%26aulast%3DAsami%26aufirst%3DS.%26aulast%3DNaganuma%26aufirst%3DE.%26aulast%3DSuda%26aufirst%3DH.%26aulast%3DIso%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DFurusawa%26aufirst%3DY.%26aulast%3DNegishi%26aufirst%3DT.%26aulast%3DIchinose%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DCharacterizations%2520of%2520Three%2520Major%2520Cysteine%2520Sensors%2520of%2520Keap1%2520in%2520Stress%2520Response%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2015%26volume%3D36%26spage%3D271%26epage%3D284%26doi%3D10.1128%2FMCB.00868-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naidu, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">C151 in Keap1 Is the Main Cysteine Sensor for the Cyanoenone Class of Nrf2 Activators, Irrespective of Molecular Size or Shape</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">8</span>, <span class="refDoi">Â DOI: 10.1038/s41598-018-26269-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1038%2Fs41598-018-26269-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=29311689" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=8&author=S.+D.+Naiduauthor=A.+Muramatsuauthor=R.+Saitoauthor=S.+Asamiauthor=T.+Hondaauthor=T.+Hosoyaauthor=K.+Itohauthor=M.+Yamamotoauthor=T.+Suzukiauthor=A.+T.+Dinkova-Kostova&title=C151+in+Keap1+Is+the+Main+Cysteine+Sensor+for+the+Cyanoenone+Class+of+Nrf2+Activators%2C+Irrespective+of+Molecular+Size+or+Shape&doi=10.1038%2Fs41598-018-26269-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-26269-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-26269-9%26sid%3Dliteratum%253Aachs%26aulast%3DNaidu%26aufirst%3DS.%2BD.%26aulast%3DMuramatsu%26aufirst%3DA.%26aulast%3DSaito%26aufirst%3DR.%26aulast%3DAsami%26aufirst%3DS.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DC151%2520in%2520Keap1%2520Is%2520the%2520Main%2520Cysteine%2520Sensor%2520for%2520the%2520Cyanoenone%2520Class%2520of%2520Nrf2%2520Activators%252C%2520Irrespective%2520of%2520Molecular%2520Size%2520or%2520Shape%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D8%26doi%3D10.1038%2Fs41598-018-26269-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onyango, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Royce, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span> <span> </span><span class="NLM_article-title">Novel Synthetic Pyridyl Analogues of Cddo-Imidazolide Are Useful New Tools in Cancer Prevention</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">135</span>â <span class="NLM_lpage">147</span>, <span class="refDoi">Â DOI: 10.1016/j.phrs.2015.07.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1016%2Fj.phrs.2015.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=26238177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Ohu7nL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=135-147&author=M.+Caoauthor=E.+O.+Onyangoauthor=C.+R.+Williamsauthor=D.+B.+Royceauthor=G.+W.+Gribbleauthor=M.+B.+Spornauthor=K.+T.+Liby&title=Novel+Synthetic+Pyridyl+Analogues+of+Cddo-Imidazolide+Are+Useful+New+Tools+in+Cancer+Prevention&doi=10.1016%2Fj.phrs.2015.07.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention</span></div><div class="casAuthors">Cao, Martine; Onyango, Evans O.; Williams, Charlotte R.; Royce, Darlene B.; Gribble, Gordon W.; Sporn, Michael B.; Liby, Karen T.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">135-147</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Two new analogs of CDDO-Imidazolide (CDDO-Im), namely 1-[2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]-4(-pyridin-2-yl)-1H-imidazole ("CDDO-2P-Im") and 1-[2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]-4(-pyridin-3-yl)-1H-imidazole ("CDDO-3P-Im") have been synthesized and tested for their potential use as chemopreventive drugs.  At nanomolar concns., they were equipotent to CDDO-Im for inducing differentiation and apoptosis in U937 leukemia cells.  As inflammation and oxidative stress contribute to carcinogenesis, we also assessed their cytoprotective potential.  The new compds. suppressed inducible nitric oxide synthase (iNOS) expression in RAW264.7 macrophage-like cells and significantly elevated heme oxygenase-1 (HO-1) and quinone reductase (NQO1) mRNA and protein levels in various mouse tissues in vivo.  Most importantly, pharmacokinetic studies performed in vitro in human plasma and in vivo showed that each new analog was more stable than CDDO-Im.  Much higher concns. of the new derivs. were found in mouse liver, lung, pancreas and kidney after gavage in contrast to CDDO-Im.  Because of their better bioavailability and their excellent anti-inflammatory profile in vitro, CDDO-2P-Im and CDDO-3P-Im were tested for prevention in a highly relevant mouse lung cancer model, in which A/J mice develop lung carcinomas after injection of vinyl carbamate, a potent carcinogen.  CDDO-2P-Im and CDDO-3P-Im were as effective as CDDO-Im for reducing the size and the severity of the lung tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2mjNbgpfVX7Vg90H21EOLACvtfcHk0liJvOpYDGba0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Ohu7nL&md5=ca75bb49f2cada81875d6ec788ce5d9d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DM.%26aulast%3DOnyango%26aufirst%3DE.%2BO.%26aulast%3DWilliams%26aufirst%3DC.%2BR.%26aulast%3DRoyce%26aufirst%3DD.%2BB.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26atitle%3DNovel%2520Synthetic%2520Pyridyl%2520Analogues%2520of%2520Cddo-Imidazolide%2520Are%2520Useful%2520New%2520Tools%2520in%2520Cancer%2520Prevention%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D100%26spage%3D135%26epage%3D147%26doi%3D10.1016%2Fj.phrs.2015.07.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earnshaw, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tailor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddington, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitaker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naisbitt, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Amoxicillin and Clavulanate Form Chemically and Immunologically Distinct Multiple Haptenic Structures in Patients</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1762</span>â <span class="NLM_lpage">1772</span>, <span class="refDoi">Â DOI: 10.1021/acs.chemrestox.6b00253</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.6b00253" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOitr%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=1762-1772&author=X.+Mengauthor=C.+J.+Earnshawauthor=A.+Tailorauthor=R.+E.+Jenkinsauthor=J.+C.+Waddingtonauthor=P.+Whitakerauthor=N.+S.+Frenchauthor=D.+J.+Naisbittauthor=B.+K.+Park&title=Amoxicillin+and+Clavulanate+Form+Chemically+and+Immunologically+Distinct+Multiple+Haptenic+Structures+in+Patients&doi=10.1021%2Facs.chemrestox.6b00253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Amoxicillin and Clavulanate Form Chemically and Immunologically Distinct Multiple Haptenic Structures in Patients</span></div><div class="casAuthors">Meng, Xiaoli; Earnshaw, Caroline J.; Tailor, Arun; Jenkins, Rosalind E.; Waddington, James C.; Whitaker, Paul; French, Neil S.; Naisbitt, Dean J.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1762-1772</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amoxicillin-clavulanate (AC) is one of the most common causes of drug induced liver injury (DILI).  The assocn. between AC-DILI and HLA alleles and the detection of drug-specific T cells in patients with AC-DILI indicate that the adaptive immune system is involved in the disease pathogenesis.  In this study, mass spectrometric methods were employed to characterize the antigen formed by AC in exposed patients and the antigenic determinants that stimulate T cells.  Amoxicillin formed penicilloyl adducts with lysine residues on human serum albumin (HSA) in vitro, with K190 and K199 being the most reactive sites.  Amoxicillin-modified K190 and K199 have also been detected in all patients, and more extensive modification was obsd. in patients exposed to higher doses of amoxicillin.  In contrast, the binding of clavulanic acid to HSA was more complicated.  Multiple adducts were identified at high concns. in vitro, including those formed by direct binding of clavulanic acid to lysine residues, novel pyrazine adducts derived from binding to the degrdn. products of clavulanic acid, and a crosslinking adduct.  Stable adducts derived from formylacetic acid were detected in all patients exposed to the drug.  Importantly, anal. of hapten-protein adducts formed in cell culture medium revealed that the highly drug-specific T-cell responses were likely driven by the markedly different haptenic structures formed by these two drugs.  In this study the unique haptenic structures on albumin in patients formed by amoxicillin and clavulanic acid have been characterized and shown to function as chem. distinct antigens which can stimulate sep., specific T-cell clones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_m2wfS4tc67Vg90H21EOLACvtfcHk0liJvOpYDGba0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOitr%252FE&md5=58a31780a6928971a26a481119310416</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.6b00253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.6b00253%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DEarnshaw%26aufirst%3DC.%2BJ.%26aulast%3DTailor%26aufirst%3DA.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DWaddington%26aufirst%3DJ.%2BC.%26aulast%3DWhitaker%26aufirst%3DP.%26aulast%3DFrench%26aufirst%3DN.%2BS.%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DAmoxicillin%2520and%2520Clavulanate%2520Form%2520Chemically%2520and%2520Immunologically%2520Distinct%2520Multiple%2520Haptenic%2520Structures%2520in%2520Patients%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2016%26volume%3D29%26spage%3D1762%26epage%3D1772%26doi%3D10.1021%2Facs.chemrestox.6b00253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copple, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randle, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">The Hepatotoxic Metabolite of Acetaminophen Directly Activates the Keap1-Nrf2 Cell Defense System</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1292</span>â <span class="NLM_lpage">1301</span>, <span class="refDoi">Â DOI: 10.1002/hep.22472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=10.1002%2Fhep.22472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=18785192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Khu7zN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1292-1301&author=I.+M.+Coppleauthor=C.+E.+Goldringauthor=R.+E.+Jenkinsauthor=A.+J.+Chiaauthor=L.+E.+Randleauthor=J.+D.+Hayesauthor=N.+R.+Kitteringhamauthor=B.+K.+Park&title=The+Hepatotoxic+Metabolite+of+Acetaminophen+Directly+Activates+the+Keap1-Nrf2+Cell+Defense+System&doi=10.1002%2Fhep.22472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system</span></div><div class="casAuthors">Copple, Ian M.; Goldring, Christopher E.; Jenkins, Rosalind E.; Chia, Alvin J. L.; Randle, Laura E.; Hayes, John D.; Kitteringham, Neil R.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1292-1301</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 regulates the expression of numerous cytoprotective genes in mammalian cells.  We have demonstrated previously that acetaminophen activates Nrf2 in mouse liver following administration of non-hepatotoxic and hepatotoxic doses in vivo, implying that Nrf2 may have an important role in the protection against drug-induced liver injury.  Nrf2 activation has been proposed to occur through the modification of cysteine residues within Keap1, the cytosolic repressor of Nrf2.  We hypothesized that acetaminophen activates Nrf2 via the formation of its reactive metabolite N-acetyl-p-benzoquinoneimine (NAPQI), which may disrupt the repression of Nrf2 through the modification of cysteine residues within Keap1.  Here, we show that NAPQI can directly activate the Nrf2 pathway in mouse liver cells, inducing an adaptive defense response that is antagonized by RNA interference targeted against Nrf2.  Furthermore, mass spectrometric anal. shows that NAPQI selectively modifies cysteine residues in Keap1, both in recombinant protein in vitro and in cells ectopically expressing Keap1.  Using this cell-based model, we demonstrate that activation of Nrf2 by NAPQI and a panel of probe mols. [dexamethasone 21-mesylate, 15-deoxy-Î-(12,14)-prostaglandin J2, 2,4-dinitrochlorobenzene, and iodoacetamide] correlates with the selective modification of cysteine residues located within the intervening region of Keap1.  However, substantial depletion of glutathione (to less than 15% of basal levels) by buthionine sulfoximine, which does not directly modify Keap1, is also sufficient to activate Nrf2.  Conclusion: Nrf2 can be activated via the direct modification of cysteine residues located within the intervening region of Keap1, but also via the substantial depletion of glutathione without the requirement for direct modification of Keap1.  It is possible that both of these mechanisms contribute to the activation of Nrf2 by acetaminophen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtcE46973srVg90H21EOLACvtfcHk0liJvOpYDGba0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Khu7zN&md5=def185e4070451e65d9d921d432c4489</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fhep.22472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22472%26sid%3Dliteratum%253Aachs%26aulast%3DCopple%26aufirst%3DI.%2BM.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DChia%26aufirst%3DA.%2BJ.%26aulast%3DRandle%26aufirst%3DL.%2BE.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DThe%2520Hepatotoxic%2520Metabolite%2520of%2520Acetaminophen%2520Directly%2520Activates%2520the%2520Keap1-Nrf2%2520Cell%2520Defense%2520System%26jtitle%3DHepatology%26date%3D2008%26volume%3D48%26spage%3D1292%26epage%3D1301%26doi%3D10.1002%2Fhep.22472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CXI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CXI','PDB','4CXI'); return false;">PDB: 4CXI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NLB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NLB','PDB','5NLB'); return false;">PDB: 5NLB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NBL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NBL','PDB','5NBL'); return false;">PDB: 5NBL</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i23"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01088">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_21642"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01088?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01088</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Supplementary table and additional figures (Figures S1âS3) showing the formation of CDDO-Im protein adducts and the interaction of CDDO-Im with Keap1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Coordinates information for structure representation; Covalent binding of CDDO-Im to Tyr85 in Keap1 (PDB 4CXI) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formul strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_003.csv">CSV</a>)</p></li><li><p class="inline">Coordinates information for structure representation; Covalent binding of CDDO-Im to Tyr85 in Keap1 stabilises the Keap1-Cul3 complex (PDB 5NBL) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_004.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates information for structure representation; The effect of covalent binding of CDDO-Im to Cys489 in Keap1 on the interaction between Keap1 and Nrf2 (PDB 2FUL) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_005.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_001.pdf">jm0c01088_si_001.pdf (1.67 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_002.pdb">jm0c01088_si_002.pdb (173.99 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_003.csv">jm0c01088_si_003.csv (0.37 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_004.pdb">jm0c01088_si_004.pdb (633.51 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01088/suppl_file/jm0c01088_si_005.pdb">jm0c01088_si_005.pdb (386.54 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01088&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01088%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01088" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66797d7c3f1523c8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
